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 "Als Physiker, der sein ganzes Leben der nüchternen Wissenschaft, der Erforschung der 
Materie widmete, bin ich sicher von dem Verdacht frei, für einen Schwarmgeist gehalten zu 
werden. Und so sage ich nach meinen Erforschungen des Atoms dieses: Es gibt keine Materie 
an sich.  
Alle Materie entsteht und besteht nur durch eine Kraft, welche die Atomteilchen in 
Schwingung bringt und sie zum winzigsten Sonnensystem des Alls zusammenhält. Da es im 
ganzen Weltall aber weder eine intelligente Kraft noch eine ewige Kraft gibt - es ist der 
Menschheit nicht gelungen, das heißersehnte Perpetuum mobile zu erfinden - so müssen wir 
hinter dieser Kraft einen bewußsten intelligenten Geist annehmen. Dieser Geist ist der 
Urgrund aller Materie." 
"As a man who has devoted his whole life to the most clear headed science, to the 
study of matter, I can tell you as a result of my research about atoms this much: 
There is no matter as such. All matter originates and exists only by virtue of a force 
which brings the particle of an atom to vibration and holds this most minute solar 
system of the atom together. We must assume behind this force the existence of 
a conscious and intelligent mind. This mind is the matrix of all matter." 
Max Planck, 1944  “Das Wesen der Materie”  
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1. Introduction 
1.1 Organocatalysis 
1.1.1 Historical Background of Asymmetric Catalysis and Organocatalysis 
 
 In the second half of the 20th century, catalytic asymmetric inductions were successfully 
achieved by employing transition metal catalysis, which allowed sub-molar quantities of 
catalysts to be utilized in achieving high asymmetric inductions. The power of using transition 
metal catalysis in the formation of C-C bonds, C-heteroatom bonds enantioselectively have 
since been demonstrated by numerous research groups worldwide. Some of the most 
commonly utilized transition metals included palladium, ruthenium and rhodium complexes 
bearing a chiral ligand which provided the necessary chiral environment for an asymmetric 
induction.[1] The versatility of transition metals was and continues to be a fertile soil for many 
interesting methodologies to assemble complex molecules efficiently. In fact, transition metal 
catalysis is so promising that the quote from the widely respected organic chemist Professor 
Dieter Seebach is often cited from his famous 1990 review article ' Organic Synthesis - Where 
now?'[2]  
" The discovery of truly new reactions is likely to be limited to the realm of transition-metal 
organic chemistry, which will almost certainly provide us with additional 'miracle reagents' in 
the years to come'. (emphasis added) 
 Despite the promise of transition metal catalysis, the practical operating of such catalysts 
have proved to be rather challenging. One of the greatest challenges of transition metal 
catalysis is that such reactions required very stringent conditions such as rigorous Schlenk and 
degassing techniques or preparation in glove boxes. Moreover, these catalysts were often air 
and moisture sensitive which posed problems especially in long term storage and handling of 
such catalysts.   
 The watershed came in the turn of the 20th century, where the historical landmark in the 
field of asymmetric catalysis was witnessed at the onset of asymmetric organocatalysis. 
Specially designed organic molecules, mostly bearing chiral motifs derived from nature's 
chiral pool such as amino acids were used at catalytic amounts to effect bond formations 
enantioselectively. As one takes a closer look into literature, glimpses of organocatalysis were 
already existent as early as the 19th century.  
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Scheme 1. Pioneering examples of organocatalytic reactions 
 The first instance of an organocatalyzed Benzoin reaction was reported by Friedrich 
Wöhler and Justus von Liebig in 1832, where two equivalents of benzaldehyde reacted in the 
presence of cyanide as the catalyst to generate the α-hydroxyl ketone (Scheme 1, Eqn 1).[3] In 
1860, Justus von Liebig discovered another related reaction, where oxamide was synthesized 
from dicyan and water in the presence of the acetaldehyde catalyst (Scheme 1, Eqn 2).[4] 
However, it is noteworthy to mention that the term "organocatalysis" was not yet coined by 
Wöhler and Liebig in the 19th century, and its vast potential was also not yet realized in its 
early days. Another noteworthy contribution in this field is the piperidine catalyzed 
Knoevenagel condensation by Emil Knoevenagel in 1896 between dimethyl malonate with 
benzaldehyde to generate the condensation product.[5] 
 Subsequently, some sporadic reports of organocatalytic reactions were later discovered in 
the turn of the 20th century. In 1904, Wilhelm Ostwald defined the German terminology 
'Organische Katalysatoren' to describe small organic molecules which catalyses reactions. 
Bredig and Fiske reported a cinchona alkaloid catalyzed asymmetric addition of HCN to 
benzaldehyde, albeit with low enantioselectivities of 10%.[6] It is also important to highlight 
that Horst Pracejus reported in 1960 the methanolysis of a ketene using chiral cinchona 
alkaloid with moderate ee of 74%.[7] Pracejus also used the German terminology 'Organische 
Katalysatoren' which serves as a precedent of the research field scientists nowadays term 
'organocatalysis'.[7a] N-heterocyclic carbene (NHC) organocatalysis was also first reported by 
Sheehan et al. in 1966.[7c] The turning point in this research field occurred in 1971 and 1974, 
where industrial scientists from Schering AG and Hoffmann La-Roche utilized L-Proline 6 
successfully to catalyze an aldol condensation of 5 to yield the bicyclic tetrahydro-
indandiones or octahydro-napthalenediones 7 (Wieland-Miescher ketone) with excellent 
enantioselectivities (Scheme 2).[8a,b] This reaction is now known as the Hajos-Parrish-Eder-
Sauer-Wiechert reaction. The Wieland-Miescher ketone 7 can then be used as an important 
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chiral intermediate to synthesize steroids such as Progesterone 8. It is also significant to point 
out that Enders et al. achieved the first asymmetric NHC-organocatalyzed Benzoin/Stetter 
reaction in the late eighties. [8c,d] 
 
Scheme 2. Proline catalyzed formation of Wieland-Miescher Ketone. 
 Despite the pioneering efforts of organocatalysis by industrial chemists,  the next two 
decades saw no exceptional activity in this research field. The first recent breakthrough 
occured at the turn of the 21st century where efforts by List et al. and MacMillan et al. 
rejuvenated this research field into one of the main pillars of catalysis. List et al. on one hand, 
reinvestigated the Hajos-Parrish-Eder-Sauer-Wiechert reaction, coupled with experience in 
the Barbas research group in catalytic aldolases research, published the first (S)-Proline 6 
catalyzed asymmetric intermolecular aldol reaction of branched/aromatic aldehydes to yield 
the aldol products 11 with excellent enantioselectivities.[9] List et. al. also attributed the 
catalytic activation mode of this reaction to enamine activation of the aldehyde (Scheme 3, 
Eqn 1).  
 MacMillan et al. published almost simultaneously a complementary activation mode 
known as iminium activation where enals such as 12 could be achieved by a LUMO-lowering 
strategy by the usage of imidazolidinone catalyst 14 (Scheme 3, Eqn 2).[10] This strategy was 
successfully applied in the enantioselective Diels-Alder reaction of enals 12 with 
cyclopentadiene 13 to form the respective endo and exo products with excellent 
enantioselectivities. Moreover, MacMillan et. al. also explicitly used the English terminology 
'organocatalysis' in this seminal publication which defines the budding field of using small 
organic molecules as reaction catalysts at the watershed moment where the majority of 
asymmetric catalysis were done using transition metals.  
 With the above mentioned pioneering reports on organocatalysis, this concept gained 
rapid acceptance among the scientific community of organic chemists, since different chiral 
scaffolds such as those from nature's chiral pool can now be utilized to design novel organic 
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catalysts to effect asymmetric reactions previously known to be catalyzed only by transition 
metals.[11] With this, it is also useful to provide a current general classification of 
organocatalytic activation modes in this field (Scheme 4). 
 
Scheme 3. Pioneering reports of enamine and iminium catalytic activation. 
 An overview of the various modes of organocatalytic activation is schematically provided 
in Scheme 4. Generally, this is further subdivided into organocatalysts that bind directly to the 
reacting substrates through covalent bond formation, or through non-covalent interactions 
such as hydrogen bonding interactions or electrostatic/ion pair interactions. Firstly, catalysts 
that forms covalent bonds with the substrates include the widely used enamine or iminium 
activation that can be accessed by primary or secondary amine catalysis.[12] Such catalytic 
activation is commonly effected by the usage of either proline derived secondary amine 
catalysts or cinchona alkoloid derived primary amine catalysts. N-heterocyclic carbenes are 
also used to effect a1- d1 or a3-d3 umpolung reactions,[13] while phosphine catalysis has been 
used also by many research groups especially in Morita-Baylis-Hillman or aza-Morita-Baylis-
Hillman type reactions.[14]  
 Secondly, the formation of H-bonding networks between the catalyst and the reacting 
substrates is often used in organocatalysis. The usage of Brønsted acid catalysts such as 
BINOL-derived phosphoric acids or phosphoryl triflylamides,[15] as well as bifunctional 
catalysts such as thiourea or more recently,[16] squaramide catalysts are common with this 
activation mode.[17] Hydrogen bonding activation is often reminiscent of metal chelation type 
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activation which confers upon stereoselectivity by lowering the activation energy of the 
reacting substrates through substrate binding, rather than using steric influence to 'crowd out' 
unfavorable transition states.[18] 
Scheme 4. General classification of organocatalytic activation modes. 
 Last but not least, electrostatic interactions are also commonly used in organocatalysis. A 
widely utilized concept developed by List et al. known as asymmetric counteranion directed 
catalysis (ACDC) capitalizes on this activation mode, where the axial chiral phosphate 
counteranion can result in enantio-induction of the products.[19] This concept has also been 
proven to be extendable to transition metal catalysis where the counteranion binds 
electrostatically to transition metals such as palladium or gold catalysts.[20] On the other hand, 
chiral counter-cations are used in phase-transfer catalysts such as axial chiral ammonium 
catalysts,[21] or other protonated bifunctional catalysts such as thioamide or guanidinium 
catalysis.[22]  
1.1.2 Organocatalytic domino reactions  
 
 With the rapid explosion of reports in organocatalysis in the early 21th century, it 
gradually became imperative that greater efficiency of the organocatalysts needs to be 
realized, in order for more complex molecules with interesting molecular architecture to be 
accessed in a single pot fashion. Subsequently, it became evident that enamine and iminium 
activation mode can be accessed by the widely used proline derived catalysts since one 
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catalytic mode can be easily transformed into the other through a tautomeric-type equilibrium 
(Scheme 5).[23]   
 
Scheme 5. The versatility of enamine/iminium activation by secondary amine catalysis.  
 The versatility of the enamine\iminium activation modes allow multiple activation of the 
reacting substrates, and hence permitting chemists to design reactions that can form multiple 
stereogenic centres within the same reaction pot with only one organocatalyst. According to 
the definition by Beifuss and Tietze, where a domino reaction refers to "a process involving 
two or more consecutive reactions result as a consequence of the functionality formed by 
bond formation or fragmentation in the previous step",[24] as well as the taxonomical 
definition by Fogg and dos Santos, where a domino reaction refers to one-pot reactions where 
the catalyst is already present in the reaction pot at the onset of the reaction.[25] Such multiple 
bond and stereogenic centres formation using an organocatalyst is often termed as 
"organocatalytic domino reaction" or "organocatalytic cascade reaction" in literature.[23, 26] 
 This concept was then well capitalized by various research groups such as the Jørgensen 
and Enders research group to generate interesting molecular architectures with excellent 
enantioselectivities.[27] One significant example was reported by Enders et al. in 2006, where 
an elegant enamine/iminium/enamine triple cascade reaction generate densely functionalized 
cyclohexenes bearing multiple contiguous stereogenic centers catalyzed by the Jørgensen-
Hayashi type TMS-protected diphenylprolinol catalyst 17.[28]  
 Furthermore, organocatalytic domino reactions are not simply restricted in the area of 
secondary amine catalysis. This concept was subsequently extended to primary amine 
catalysis, Brønsted acid catalysis and very recently also in hydrogen bonding and NHC 
catalysis.[13d, 13e] 
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 Scheme 6. Enders organocatalytic enamine/iminium/enamine triple domino reaction. 
1.1.3 Recent advances in hydrogen bonding catalysis  
 
 While the majority of reported organocatalyzed reactions are rooted in amine catalysis, 
the use of hydrogen bonding catalysis (H-Bond catalysis) is comparatively limited. Hydrogen 
bonding catalysis is a biomimetic concept that has drawn considerable interest recently since 
nature employ a similar strategy in many biological systems such as proteases and aldolases. 
Moreover, the multiple H-bonds to the reacting substrates allows stereoinduction to be 
achieved through binding interactions, rather than sterically crowding out unfavorable 
transition states common to amino catalysis using bulky catalysts such as 17.  
 Pioneering efforts of hydrogen bonding catalysis were spearheaded by Curran et al., 
where they discovered that achiral urea derivative 26 could catalyze α-allylation of sulfoxides 
and Claisen rearrangements (Scheme 7, Eqn 1 and 2).[29] Curran et al. noticed a 20 to 70 fold 
acceleration when protic solvents are used and attributed this observed effect to a postulated 
bis-hydrogen bond stabilized transition state with the urea catalyst. A significant breakthrough 
in the utility of hydrogen bonding catalysis in 1998, where Jacobsen et al. serendipitously 
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discovered that asymmetric Strecker reactions can be realised through the use of thiourea 
catalyst 31 during a combinatorial screening of transition metal ligands.[30] Remarkly, such 
reactions can be done with an extremely low catalyst loading (2 mol%) of thiorea 31. This 
discovery also paved the way subsequently for hydrogen bonding catalysis to be utilized in 
development of a wide myraid of reactions including hydrophosphonation,[31] Mannich,[32] 
nitro-Mannich,[33] acyl-Mannich,[34] aza Morita-Baylis-Hillman[35] and Pictet-Spengler 
reactions.[36] 
 
Scheme 7. Pioneering reports on hydrogen bonding urea/thiourea catalysis. 
 While much of the pioneering literature documents reactions catalyzed by either urea or 
thiourea type derivatives, such reactions are reported to be rather sluggish with slow reaction 
rates. Moreover, the catalyst loadings required were rather high, ranging from 10-15 mol%, 
impeding it's widespread use especially in organocatalytic domino reactions. Other notable 
contributions to thiourea catalysis included Takemoto et al. who pioneered the widespread use 
of chiral thioureas bearing the cyclohexyldiamine chiral scaffold, as well as Soós et al.,[37] and 
Connon et al. who independently developed chiral thioureas bearing cinchona alkaloid 
moieties.[38]  
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 In the following decade after the first asymmetric thiourea catalyzed reaction was 
published by Jacobsen,[30a] most of the reported H-bonding catalyzed systems were performed 
with chiral thiourea derivatives. Interestingly, ten years lapsed before the group of Rawal et al. 
discovered that chiral squaramides are excellent hydrogen bond donor catalysts in 2008.[17a] 
This concept was borrowed from molecular recognition studies where squaramide derivatives 
are found to possess interesting cationic and anionic recognition properties.[39]  In addition, 
squaramides are also known biologically to be bioisosteres of urea derivatives.[40]  
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Scheme 8. Michael addition catalyzed by squaramide 35 pioneered by Rawal et al. 
 In his seminal publication,[17a] Rawal et al.  utilized a (−)-cinchonine derived squaramide 
to catalyze the Michael addition of malonates 33 to nitroolefins 34 (Scheme 8). Remarkably, 
the reaction proceeded smoothly at relatively fast reaction rates (9-24 h) with only 0.5 mol% 
of catalyst loadings. This publication reports one of the lowest catalyst loadings ever 
encountered in organocatalysis. On one hand, such sub-molar catalyst loadings rivals catalyst 
loadings which are utilized in transition metal chemistry. On the other hand, the ease of 
synthesis of chiral squaramide catalysts makes this class of H-bonding catalysts an extremely 
interesting motif for further catalytic development.[17b]  
 Rawal et al. attributed the marked increase in enantioselectively and the extreme low 
catalyst loadings to the difference in the distance of the hydrogen bond donors between a 
thiourea and a squaramide moiety (Scheme 8). Thiourea on one hand, has a distance of 2.13 Å 
between the two acidic H atoms, while the squaramide scaffold has the bis-amides positioned 
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at a larger distance of 2.72 Å, which the authors postulated to have a better activation effect 
on the nitroolefin unit and hence a better binding properties to the transition state. Rawal et al. 
subsequently also demonstrated that squaramide with low catalyst loadings can be used to 
enantioselectively catalyze α-aminations[41] and Friedel-Crafts type Mannich reactions of 
indoles on N-tosyl imines.[42] 
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Scheme 8. Representative examples of protonated H-bonding catalysts with higher acidity. 
 In addition, some research groups are increasingly interested in modulating the Brønsted 
acidity of thiourea and similar scaffolds by the development of protonated thiourea type 
catalysts (Scheme 8). The basis of this concept is to increase the affinity of the protonated 
hydrogen bonding catalyst on the substrates so as to have a tighter transition state, and hence 
resulting in higher activity, higher Brønsted acidity and better enantio-control on the reaction. 
Three notable examples of this strategy has been demonstrated by the research groups of 
Jacobsen,[22b] Seidel[22a] and Takenaka[43] where protonated H-bonding catalysts were used to 
achieve excellent and better enantio-induction as compared to their thiourea counterparts in 
Claisen rearrangements and Friedel-Crafts type reactions, respectively (Scheme 8). Such 
protonated catalysts usually utilize a chiral counter-cationic scaffold to effect 
enantioselectivity through H-bonding and electrostatic interactions, and the bulky non-
coordinating counteranion (BArF24−)[44] is often used to allow stronger electrostatic attractions 
of the cationic scaffold to the reacting substrates.  
1.1.4 Utility of H-Bonding catalysis in domino reactions 
 
 With the explosion of reports in utilizing thiourea, squaramides and protonated H-
bonding catalysts in different asymmetric methodologies, the focus of domino reactions in 
recent years was gradually shifted towards H-bonding catalyzed domino reactions. It was 
soon realized that these catalysts were generally very versatile and could generate complex 
molecular architectures similar to how an enzyme catalyzes a biological reaction in nature. 
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Some representative examples of these recent advances (2011 to 2013) in H-bonding 
catalyzed domino reaction will be summarized. 
 One excellent example was reported by Barbas et al. in 2011 (Scheme 9),[45] where they 
demonstrated that H-bonding thiourea 42 can be successfully utilized in a Michael/Henry 
domino reaction to form biologically interesting spirooxindoles 43 containing four contiguous 
stereogenic centres and three quartenary centres with up to excellent yields and 
enantioselectivities.  
 
Scheme 9. Enantioselective H-bonding catalyzed domino reaction to form spirooxindoles. 
 Jørgensen et al. also demonstrated recently that H-bonding activation can be merged with 
dienamine activation when proline-type scaffolds are derivatized with a squaramide moiety, 
hence opening up a new class of catalyst 46 that can tapped upon bifunctionality of secondary 
amine and H-bonding catalysis (Scheme 10).[46a] Utilizing catalyst 46, they reported a [2+2] 
cycloaddition reaction where highly functionalized cyclobutanes bearing four contiguous 
stereogenic centres can be generated enantioselectively.  
 Jørgensen et al. accounted the enantio-control of this domino reaction to the initial 
formation of the dienamine from enal 44 via transition state 48 (Scheme 10), which then 
attacks the nitroolefin 45 in a stereoselective fashion controlled by H-bonding between the 
squaramide moiety of 46 and the nitro group of 45. The resulting iminium formed after the 
first Michael addition then traps the nitronate anion to form cyclobutanes 47. 
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Scheme 10. Enantioselective synthesis of cyclobutanes by dual dienamine/H-bond activation.  
 
Scheme 11. Asymmetric synthesis of chromanes bearing three contiguous stereogenic centres. 
 In another very recent example (Scheme 11),[46b] Du et al. also demonstrated that sulfur 
Michael/Michael domino reactions can be realized with only 1 mol% of squaramide catalyst 
51 with relatively fast reaction rates (5-10 h). This methodology is particularly interesting 
since the utility of squaramides in domino reactions are comparatively rare and it opens up an 
avenue for highly complex molecular architecture to be accessed with only sub-molar 
amounts of catalysts rivaling that of transition metal catalysis.  
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1.2 Gold catalysis and its applications in organocatalysis 
 
1.2.2 Alkynophilicity in Au(I) catalysis 
 
 The first decade of the 21st century marked a rapid development in the area of 
organocatalysis. Another branch of catalysis, Au(I) catalysis,[47] has seen tremendous 
development in the same period. Au(I) complexes have an electronic configuration 
[Xe]4f145d106s1. They are bidentate and possess a linear geometry. While many other 
transition metals such as palladium, rhodium and iridium are widely used in organic synthesis, 
gold is one of the metals that remained largely untapped before the 21st century, possibly due 
to a misperception that gold complexes are relatively inert compared to other transition metals. 
Interestingly, early reports on the synthetic use of Au(I) complexes had its origins from 
industry.  
  
Scheme 12. Early industrial reports in homogeneous Au(I) catalysis through triple bond 
activation. 
 Interestingly, one of the earliest reports was by Togni et al. from Ciba-Geigy in 1989, 
where dihydrooxazoles could be synthesized enantioselectively from a chiral aldehyde and a 
ethyl isocyanoacetate through a Au(I) catalyzed cycloaddition reaction.[48] The enantio-
induction was achieved by the use of a chiral ferrocenylphosphine ligand in this reaction. The 
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cycloaddition reaction is believed to be catalyzed by the Au(I) activation of the cyano- triple 
bond.  
 Another industrial publication by Teles et al. from BASF AG in 1998 reported the use of 
[Me3PAu]+ complexes to catalyze the intermolecular addition of alcohols to alkynes, with 
turnover frequencies reaching up to 5400 h-1.[49] The authors also commented that such 
reactions are air and water insensitive and hence can be conducted under ambient conditions. 
This report is remarkable since the utility of gold complexes were rare in homogeneous 
catalysis before the turn of the 21st century.  
 At the turn of the century, Au(I) catalysis witnessed an explosion of publications where 
the majority of the reported reactions involved the activation of alkynes by a Au(I) or Au(III) 
complexes. Au(I) catalysis has the obvious advantage of easy handling due to it's general 
tolerance towards moisture and air, hence allowing such reactions to be conducted under 
"open-flask" conditions. This property of Au(I) catalysis is a marked contrast to other 
transition metals such as palladium or ruthenium since vigorous Schlenk or degassing 
techniques are required in such transition metals to prevent catalyst deactivation. To allow 
better understanding of the inherent activation by gold complexes, it is necessary to now 
provide the definitions of "π-acids" and "alkynophilicity", which underpins the general 
reactivity of gold complexes. 
 The inherent affinity of gold or platinum complexes to alkynes is defined by Fürstner and 
Davies as "alkynophilicity".[47d, 47e] Alkynophilicity is generally observed when "π-acid" 
catalysts are utilized. Fürnster and Davies also defined π-acids as "any metal fragment that 
binds to a carbon-carbon multiple bond, and thereby deprives it of part of its electron 
density". Au(I) complexes exerts its catalytic influence as a π-acid through deprivation of 
electron density of a carbon carbon multiple bond, such as alkynes. This inherent strong 
Lewis acidity encountered in Au(I) catalyzed reactions is attributed to relativistic effects that 
is characteristic of gold complexes. While the detailed quantum mechanical explanation of 
relativistic effects is beyond the scope of this thesis, it is sufficient to understand that this 
results in the relativistic contraction of the 6s orbitals and the expansion of the 5d orbitals, 
hence accounting for the high Lewis acidity of gold complexes, especially Au(I) complexes. 
 Since one of the main focus of this PhD research is on the merging of Au(I) catalysis and 
organocatalysis in one-pot sequential reactions (vide infra, will be further elaborated in 
section 1.2.3), a model reaction depicting the activation mode of Au(I) catalysis is provided 
diagrammatically in Scheme 13. The model alkyne substrate 60, containing an intramolecular 
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tethered nucleophile will be used to illustrate this point. In the field of Au(I) catalysis, many 
different nucleophiles ranging from heteroatoms such as oxygen, nitrogen and sulfur,[50] as 
well as carbon nucleophiles such as enolates and electron rich heteroaromatics are capable of 
attacking a Au(I) activated alkyne.[51] 
 
Scheme 13. Basic mechanistic principles of Au(I) catalysis. 
 The commercially available Au(I) precursors such as the commonly used Ph3PAuCl are 
inactive as catalysts since they have both coordination sites occupied by a phosphine ligand 
and a chlorine atom respectively. Such Au(I) complexes are commonly denoted as LAuX in 
the  literature, where L can be a phosphine or a NHC ligand, and X denotes a halide.  
 In order for catalysis to occur for Au(I) complexes, a silver salt co-catalyst such as 
AgSbF6 containing a bulky non-coordinating counteranion is added to LAuX to 
thermodynamically abstract the halide from the gold complex as AgX. This results in a 
metathesis reaction where an empty coordination site is generated at the active cationic Au 
complex (denoted as LAu+) which is now catalytically active. Due to the alkynophilicity of 
LAu+ as a carbophilic Lewis acid, it activates the alkyne of the substrate by forming the gold-
alkyne complex 61.  
 Upon π-activation, the internal nucleophile of substrate 60 then attacks the alkyne 
through a trans-addition pathway to form the vinyl-gold intermediate 62, where a covalent 
Au-C bond is now formed. It is widely reported that such vinyl-Au intermediates 62 are non-
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classical cationic in nature, where vinyl-Au and Au-carbenoid intermediates might exists in 
situ. Hence, many different cationic type rearrangements of the Wagner-Meerwein type are 
often encountered in Au(I) catalysis, resulting in skeletal rearrangements.  
 Finally, a proton transfer process, known as protodeauration is required in order to cleave 
the Au-C to form the product 63 and to regenerate the active Au(I) catalyst back into the 
catalytic cycle. The proton source for the protodeauration originates normally from the 
attacking nucleophile, although there are also reports of adding an external proton source to 
accelerate protodeauration in some systems.  
 In addition to alkynes, other multiple bond functionalities such as allenes and alkenes are 
also demonstrated to be feasible substrates for Au(I) activation although alkynes form the 
majority of the reported examples.[47f, 52]  
1.2.3 Concepts behind merging organocatalysis and Au(I) catalysis 
 
 At the beginning of this PhD project in 2010, a new niche area was in its budding phase 
where organic chemists were exploring the possibilities of combining transition metal 
catalysis and organocatalysis within the same reaction pot, since such a strategy would allow 
unprecedented access towards structures that were previously not possible.[53] While many 
metals such as palladium, silver, rhodium and copper catalysis were reported to be plausible 
as good transition metal candidates for such a strategy, the amount of publications 
documenting the usage of Au(I) catalysis formed the majority.[53] During that stage, the 
advantages of Au(I) catalysis with organocatalysis was not yet fully conceptualized, although 
there were some seminal publications and highlight articles predicting the vast potential of 
this organo/Au(I) merger strategy.[54]  
 Building upon the introduction to Au(I) catalysis in section 1.2.2, it is worthwhile to 
conceptualize the rationale behind the merging of organocatalysis and Au(I) catalysis in one-
pot coooperative or multicatalytic sequential reactions,[55] since such binary catalytic systems 
have gained popularity among the scientific community in recent years. While most literature 
reports emphasize the advantages of either organocatalysis or Au(I) catalysis, there are indeed 
certain practical shortcomings for each catalytic activation mode that can be circumvented if 
the complementary advantages of both catalytic modes can be exploited. 
 Organocatalysis on one hand, witnessed a breathtaking explosion of reports in the 
efficient construction of diverse structures with extremely high asymmetric induction. 
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However, the success of an organocatalytic methodology often required the strict presence of 
some functional groups which include aldehydes, α,β-unsaturated aldehydes or ketones, as 
well as nitro functionalities to allow for efficient hydrogen bonding activation. Activation of 
certain carbon carbon functionalities such as alkynes, allenes and other olefins are exteremely 
rare in organocatalysis with the exception of NHC catalysis, since hydroacylation reactions 
were recently reported for the attack of an umpolung nucleophile on a triple bond.[56] These 
isolated examples are unfortunately not general and are only applicable within certain fixed 
classes of substrates. Cationic rearrangements were almost unheard of in organocatalysis, with 
only one very recent example documenting a Brønsted acid catalyzed Wagner-Meerwein type 
pinacol rearrangement reported by Alexakis et al.[57] 
 Au(I) catalysis on the other hand is known to be effective in cationic type rearrangements 
of the Wagner-Meerwein type,[47l] since it's non-classical carbocationic reactivity is well-
known. Moreover, it's alkynophilicity also provides an effective solution towards the 
ineffectiveness of organocatalysts in activating alkynes and related functionalities. Moreover, 
this non-classical carbocationic reactivity also allows us to access cyclization modes that are 
rare in organocatalysis, such as formation of medium-sized (7-8 membered) rings which are 
by far more versatile with Au(I) or transition metal catalysis. Moreover, this non-classical 
carbocationic reactivity of Au(I) also provides huge opportunities to tap into cationic type 
cascade reactions involving 1,2-alkyl shifts which are not common in organocatalysis.[47l, 58] 
In addition, organocatalytic methodologies generally involved reactions accessing 5-exo-trig 
or 6-exo-trig cyclization modes, as the nature of the electrophiles are normally Michael 
acceptors or carbonyl derivatives which are sp2 hybridized. One limitation of these cyclization 
modes is that they are not as versatile as dig cyclization modes on alkynes predicted by 
Baldwin's rules,[59] since the permitted dig-cyclization modes include exo- and endo- 
cyclizations which can generate five up to eight membered rings.  
 Another interesting aspect of Au(I) catalysis is its moisture and air tolerance, which 
makes it an excellent candidate to combine with organocatalysis within a one-pot reaction, 
since organocatalysis, such as amine catalysis, often require the presence of water for the 
progression of its catalytic cycle. 
 The Enders research group has recently published a review on this research field,[60] 
where we systematically classified currently known examples of merging organocatalysis and 
Au(I) catalysis into the following three classifications (Scheme 14): 
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Scheme 14. Classifications of known combinations of organo- and Au(I) catalysis  
 The classification in Scheme 14 is based on the taxonomical definations by Fogg and dos 
Santos.[25] The first type A classification is known as cooperative tandem catalysis, since both 
the organocatalyst and the Au catalyst are cooperatively involved in the same catalytic cycle. 
Moreover, both organo and Au catalysts must be present in this case at the beginning of the 
reaction.  
 One of the classical examples of a type A reaction is the first seminal publication in this 
field reported by Kirsch et al. in 2008.[61] In this report, alkyne aldehydes 64 could be cyclized 
to the racemates of the cyclohexanes 66 or cyclohexenes 68 under the cooperative catalytic 
effect of a secondary amine 65 or 67 and an appropriate Au(I) catalyst (Scheme 15). In this 
case, both the amine catalyst and the Au(I) catalyst were present in the reaction flask at the 
onset of the reaction, hence fulfilling the Fogg and dos Santos classification as cooperative 
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tandem catalysis.[25] Depending on the substituent R (R= Me or H), exocyclic alkene 66 or an 
endocyclic alkene 68 could be formed respectively. 
 
Scheme 15. First publication in cooperative amine/Au(I) catalysis by Kirsch et al. 
 Kirsch et al. attributed their binary catalytic strategy to an enamine activation of the 
aldehyde to form the respective enamine, as well as a concomitant activation of the terminal 
alkyne to form the Au(I)/alkyne complex denoted in transition state 70. This dual activation 
strategy then results in a carbocyclization reaction where the nucleophilic enamine attacks the 
electrophilic activated alkyne. Upon cyclization, cyclohexane 71 is formed. In the case where 
no α-substitutent is present on the aldehyde 64, 71 will preferentially isomerize to the 
thermodynamically favoured internal alkene 72. If a methyl substitutent is present on the α-
position of educt 64, the quartenary centre formed on the α-carbon will then preclude alkene 
isomerization in cyclohexane 66.  
 This carbocyclization strategy was subsequently further developed by Jørgensen et al. 
enantioselectively where the bulky TMS-protected diarylprolinol catalyst 75 was used firstly 
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to effect iminium activation on enal 74.[62] Alkyne tethered malonate 73 then attacks 74 to 
form the Kirsch-type intermediate 76, which then cyclizes to form cyclohexene 77 
enantioselectively. The utility of cinchona alkaloid derived primary amines were  also used by 
Jørgensen et. al. to synthesize bicyclic enones enantioselectively through a similar strategy.[63] 
 
Scheme 16. Enantioselective synthesis of chiral cyclohexenes by an iminium, enamine/Au(I) 
sequential strategy by Jørgensen et al.. 
 The second classification is a type B merger, where it is often denoted as sequential or 
relay multicatalysis in the literature. One representative example is provided by Alexakis et. 
al. (Scheme 17),[64] where aldehyde 78 and alkyne-tethered nitroolefins 79 were subjected to 
enamine catalysis by catalyst (S)-17 to form the Michael adduct. Subsequently, the Au(I) 
catalyst was added which triggered the oxa-cyclization of the oxygen on the aldehyde onto the 
alkyne moiety to form the chiral tetrahydrofurans 80 enantioselectively.  
 It is worthwhile to note that type B merger reactions are often challenging due to the 
deactivation of the organocatalysis on the Au(I) catalyst. This is frequently encountered in the 
literature, since organocatalysts such as amine or H-bonding catalysts often contain multiple 
heteroatoms such as nitrogen or oxygen, which can bind to the catalytic active Au(I) species 
to poison the catalyst, hence resulting in catalyst deactivation. The strategy that most research 
groups adopt to overcome the organocatalyst deactivation is by adding a suitable Brønsted 
acid, such as pTSA (Scheme 17) to regenerate the catalytically active Au(I) species and 
ensure that the progression of the Au(I) catalytic cycle is unhindered.[63-64] 
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Scheme 17. Enantioselective synthesis of tetrahydrofurans via a type B amine/ Au(I) catalysis 
merger. 
 
Scheme 18. Enantioselective synthesis of tetracyclic indole derivatives via a type B chiral 
Brønsted acid/ Au(I) catalysis merger. 
 Another example of a type B reaction was demonstrated by Dixon et al., where a chiral 
Brønsted acid can be used in tandem with Au(I) catalysis (Scheme 18).[65] It is interesting to 
note in this case that the sequence of catalyst addition has been reversed compared to the 
preceding examples described. Au(I) catalysis was first used to catalyze the 5-endo-dig 
cyclization of propagylic acids 82 into enol lactones 83. Subsequently, the effect of Brønsted 
acid 86 evoked the dehydrative condensation of tryptamine 81 with 83 to form the N-
acycliminium intermediate 84. The chiral counteranion derived from phosphoric acid 86 then 
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ensures that the final Pictet-Spengler type cyclization proceeds smoothly to form the desired 
tetracyclic derivatives 85 enantioselectively. 
 A type C classification is a special class of reaction (Scheme 14), in which the Au(I) 
active species used in the methodology contains a chiral counteranion, which is generally 
derived from axial-chiral BINOL based phosphoric acids. In general, such reactions are 
purely Au(I) catalyzed reactions that derives it's enantioinduction from the chiral scaffold of 
the counteranion of an organo-Brønsted acid catalyst via ACDC (vide supra, Section 1.1.1). 
In an unprecedented report, Toste et al. described in 2007 that Au(I) complexes containing the 
phosphoric acid derived counteranion 91 can be successfully used in hydroalkoxylation and 
hydroamination reactions of functionalized allenes such as 87 and 89. The resulting 
tetrahydrofurans 88 and pyrrolidines 90 could be accessed using this methodology with 
excellent enantioselectivities. 
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Scheme 19. Enantioselective hydroalkoxylation of hydroamination by the ACDC strategy. 
1.3 Multiple reactivity of the indole substrate 
 
 With the plethora of concepts of interest ranging from H-bonding catalysis to 
organocatalytic domino reactions and finally to the combination of organocatalysis and Au(I) 
catalysis described in the preceding sections (Sections 1.1 - 1.2), it is also the focus of the 
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author to explore the reactivity of the indole substrate using the above mentioned concepts. 
The indole heterocycle is an extremely interesting heteroaromatic compound due to its 
multiple positional reactivities that can be exploited by various substrate derivatizations. This 
section serves as a brief introduction to the reactivity of the indole substrate 91, with special 
emphasis on the pyrrolic segment of the indole heterocycle.  
 
Scheme 20. Positional reactivities on the indole substrate and the classical C3 nucleophilicity. 
 The indole heterocycle is well known as a π-excessive heterocycle where multiple 
transformations can be achieved by derivatization of the C3, C2 and N1 positions (Scheme 
20).[66] The C3 functionalization is the most commonly known reactivity of the indole 
substrate, where Friedel-Crafts type reactions are well known in standard organic chemistry 
textbooks. It is also well exploited in organocatalysis,[67] especially in Friedel-Crafts type 
Michael additions where functionalized Michael adducts such as 94 are well known in the 
literature.[68] The basis of the C3 reactivity is the imbedded enamine that is inherent in the 
pyrrolic segment of substrate 92, which confers nucleophilicity to C3.  
 In addition, the C2 electrophilicity of the indole substrate is recently gaining much 
attention from the scientific community.[69] While indole is known to undergo nucleophilic 
substitution or addition reactions, the C2 electrophilicity can be exploited if a suitably C3 
functionalized indole such as 95 with a tethered internal nucleophile (denoted as NuH) is used 
(Scheme 21). Upon an enamine-type attack on an electrophile by a chiral catalyst, 95 can 
trigger the formation of a transient iminium intermediate 96 in situ, which is electrophilic on 
the C2 position. The nucleophilic component on the C3 tether can then trap this iminium 
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intermediate to dearomatize the pyrrolic portion of the indole scaffold to generate indolines 97 
bearing multiple stereogenic centres.[70] 
 
Scheme 21. C2 iminium-type reactivity of the indole substrate. 
 An elegant example utilizing the C2 electrophilic strategy was published by You's 
research group in 2011 (Scheme 21),[71] where indoles 98 bearing a tethered α,β-unsaturated 
ketone is subjected to an iminium/enamine domino reaction catalyzed by quinine-derived 
primary amine 99. The first iminium activation of 98 triggered the formation of the 
spirocyclic iminium intermediate 101, which now confers upon electrophilicity on the C2 
position. Intermediate 101 is then directly trapped by the enamine functionality to generate 
densely functionalized indolines 100 with excellent enantioselectivities. 
 As a minor sidenote, the N1 nucleophilicity was also widely exploited in various 
organocatalytic domino reactions, especially by Enders et. al. where aza-Michael reactions 
could be capitalized to generate interesting molecular frameworks.[72] This important N-
nucleophilic property of indoles will however not be further elaborated as it is outside the 
discussion scope of this PhD thesis.  
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1.4 Overview of the PhD projects 
 
This research work can be sub-divided into two major components:  
1) The first part of the PhD thesis was centered in the development of one-pot sequential 
strategies that combines the complementary advantages of organocatalysis and transition 
metal catalysis/additives to access C3, C2 annulated indoles from cheap and easily available 
C3, C2-unsubstituted indoles. (Section 1.3.1, vide infra) 
2) The second part of the PhD thesis involved the development of novel hydrogen-bonding 
catalyzed domino reactions that challenges the current frontiers of organocatalytic domino 
reactions, using indole/oxindole as a nucleophilic domino trigger. (Section 1.3.2, vide infra) 
1.3.1 Merging organocatalysis and transition metals in one pot sequential reactions 
 
Scheme 22. Merging hydrogen bonding catalysis and Au(I) catalysis.  
 The first project involved the reaction of C3, C2-unsubstituted indoles 102 with a suitably 
designed bi-acceptor substrate 103 utilizing an organo-/Au(I) binary catalytic system to effect 
a double Friedel Crafts type reaction to access 104 through an unprecedented cyclization 
mode enantioselectively (Scheme 22). 
 
Scheme 23. Merging hydrogen bonding catalysis and Ag(I) additives.  
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 Subsequently in the second project, organocatalysis was combined with an appropriate 
transition metal additive AgSbF6 to access a biologically interesting class of annulated indoles, 
tetrahydrocarbazoles 107 enantioselectively via a Friedel-Crafts type Michael/Ciamician 
Plancher rearrangement sequence (Scheme 23). This methodology was also subsequently 
applied in the efficient synthesis of a known 5-HT6 receptor antagonist. 
1.3.2 New concepts in organocatalytic domino reactions 
 
Scheme 24. H-bonding catalyzed domino reaction with bifunctional kinetic control. 
 Furthermore, with the careful design of suitable substrates such as o-carbaldehyde 
nitroolefin 109, we envisaged in the third project that a H-bonding catalyzed Michael/Henry 
domino reaction can be used to access the kinetic cis-vicinal indanes 110 using a newly 
developed concept known as bifunctional kinetic control (Scheme 24). 
 
Scheme 24. Fast H-bonding catalyzed domino reaction with low catalyst loadings. 
 The final project was concerned with the development of an efficient organocatalytic 
Michael/Henry domino reaction of oxindole 111 on o-carbaldehyde nitroolefin 112 that 
overcomes conventional organocatalytic problems of high catalyst loadings and slow reaction 
rates. We extended the concept of bifunctional kinetic control to access cis-vicinal indanes 
113 bearing four contiguous stereogenic centers.  
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2. Results and Discussion 
 
2.1 Merging organocatalysis and Au(I) catalysis through a sequential double 
Friedel-Crafts type reaction 
 
2.1.1 Literature known methods to access annulated indoles 
 
 The interest in accessing annulated indoles have grown dramatically in recent years due 
to its prevalence in natural products especially in indole-containing alkaloids.[73] Interestingly, 
naturally occuring indole alkaloids are frequently annulated in the C2 and C3 positions. 
Examples of annulated indole containing alkaloids include carbazoles such as haptaphylline 
114 and murrayacine 115, as well as β-carbolines such as yohimbine 116 and reserpine 117. 
 
Scheme 25. C2,C3-annulated indoles found in natural products. 
 A look into current literature also revealed that synthetic methods to access annulated 
indoles is widespread with most methods in recent years concentrating in the research field of 
organocatalysis and gold catalysis. However, a closer inspection into literature also showed 
that most of the currently available strategies required a prefunctionalized indole, either on the 
C3 or the C2 position before any annulation can be realized. The commonly utilized 
cyclization modes to access annulated indoles is schematically represented in Scheme 26.  
 The first cyclization strategy (Scheme 26, Eqn 1) is often associated with a C3-
substituted substrate 119 containing an electron withdrawing group (EWG), such 
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functionalities are often seen in Michael acceptors. Upon the catalytic activation by either an 
organocatalyst or a transition metal catalyst, a single Friedel-Crafts type reaction at the C2 
position of substrate 119 will occur, resulting in a cyclization reaction yielding C3,C2-
annulated indole 118. 
 
Scheme 26. Current synthetic strategies to access annulated indole frameworks. 
 
Scheme 27. Examples of C2 cyclization strategies in literature. 
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 Some literature examples of such an intramolecular Friedel-Crafts strategy through a C2 
cyclization mode reported include organocatalyzed Pictet Spengler reactions on C3-tethered 
tryptamine 124 or 127 catalyzed by either thiourea catalyst 125 to form annulated indole 126 
(Scheme 27, Eqn 1) reported by Jacobsen et al.,[36] or by a chiral Brønsted acid to form 
annulated indole 130 (Scheme 27, Eqn 2).[74] 
 Moreover, the C3 cyclization strategy is also well documented in the literature with an 
excellent example reported by Bandini et al. where they utilized enantioselective bimetallic 
Au(I) catalysis to access tetrahydrocarbazoles 132 enantioselectively through a C3 cyclization 
strategy (Scheme 28, Eqn 1).[75] On the other hand, a N-cyclization strategy to access N1, C2 
annulated indoles was excellently demonstrated by You et al. through an aza-Michael reaction 
on a Michael acceptor tethered to a C2-prefunctionalized indole (Scheme 28, Eqn 2).[76]  
 
Scheme 28. Indole annulation via C3 Friedel-Crafts type reaction, or N1 aza-Michael reaction. 
 Moreover, we wanted to tap upon Au(I) catalysis in indole chemistry since there was a 
literature precedence of unusual cyclization modes for Au(I) catalyzed hydroindolinations 
pioneered by Echavarren et al..[77] In this seminal report,[77a, 77b] cyclization modes such as 7-
exo-dig and 8-endo-dig were observed by utilizing either Au(I) catalysis or Au(III) catalysis 
respectively (Scheme 29), providing a facile access towards such macrocycles since they are 
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an important structural motif in indole alkaloids such as deoxyisoaustamide 139 and 
okaramine N 140. Moreover, such cyclization modes are unheard of in organocatalysis at the 
onset of this project, hence a multicatalytic strategy would be extremely interesting to access 
such compounds enantioselectively. This project was conducted in cooperation with my 
bachelor student Jan Badorrek, where he contributed to part of the synthesis of substrate 147 
and two examples of the reaction scope. My master student Ramona Pirwerdjan contributed to 
the screening of various transition metals catalysts. 
 
Scheme 29. Gold catalyzed synthesis of seven/eight ring containing annuated indoles. 
2.1.2 Retrosynthetic analysis and synthesis of starting materials 
 
 With the above mentioned precedences of indole annulations before the start of this 
project, we were wondering if annulated C3,C2 indoles could be directly accessed using a 
multicatalytic procedure that do not require a prefunctionalized indole, i.e. a C3, C2-
unsubstituted indole. The rationale behind this lies in the cost effectiveness and easy 
availability of unsubstituted indoles. With the growing reports of binary catalytic systems, 
especially in the merging of organocatalysis and Au(I) catalysis (vide supra, section 1.2.3), 
we envisaged that a sequential disconnection strategy at C2 and C3 might help us access 
chiral seven-membered ring containing annulated indoles 141 in a one-pot fashion from 
C3,C2-unsubstituted indoles 142 and a specially designed o-alkyne nitroolefin 143. The 
nitroolefin functionality in 143 allows us to access into H-bonding catalysis and the alkyne 
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moiety taps upon the alkynophilicity of Au(I) catalysis to allow a novel entry into Au(I) 
catalyzed Wagner-Meerwein type rearrangement cascades.  
 Since compound 143 was a literature unknown compound, a facile synthetic route was 
designed in order to access this derivative in the shortest possible route (Scheme 31).  
 
Scheme 30. Disconnection to access seven-ring containing tetracyclic indole derivatives. 
 Starting from commercially available o-bromobenzaldehyde 144a, b (Scheme 31), a 
facile Sonogashira coupling catalyzed by palladium tetrakis generated the internal o-alkyne 
carbaldehyde 146 with generally good yields ranging from 64-79%. Compound 146a-c was 
then subjected to a Henry/condensation sequence to generate the o-alkyne nitroolefin 147 
with moderate to good yields of 52-68%. Two reliable methods were found to generate 147 
effectively. Method A (Scheme 31) uses a strong inorganic base KOH to generate the 
nitronate anion from nitromethane which then undergoes Henry reaction to form the 
nitroaldol product within 15 minutes. The crude product nitroaldol obtained was then 
subjected to water elimination reaction by the use of MsCl and NEt3 to generate 147a. 
Method B is a more direct synthesis where ammonium acetate and nitromethane were brought 
to reflux and the resulting nitroolefins 147b, c were directly purified by flash column 
chromatography. 
 Scheme 31. Synthesis of o-alkyne nitroolefin starting material 147. 
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 While method B seems to be a more straightforward method, it is also useful to know that 
method A generates the corresponding nitroolefin in a much cleaner fashion than method B, 
which requires overnight trituration in pentane/ether after flash column chromatography in 
order to yield the pure starting material 147 (See experimental section). Since indole 142 is 
also commercially available, we proceeded then to test our disconnection hypothesis (Scheme 
30). 
2.1.3 Catalyst screening and optimization of conditions 
 
 As the practical execution of a multicatalytic sequential reaction is rather complex, and 
many different factors such as catalyst type and additives might affect any single step of both 
catalytic cycles, a truncation of the complexity of this one-pot sequence is necessary. Since 
the literature reported organocatalyzed Michael addition of indoles on nitroolefin were known 
to be sluggish and slow,[68a, 68b, 78] we selected 5-OMe indole 148 as our test substrate since it 
has the highest nucleophilicity due to the presence of electron donating group which activates 
the indole ring by the +M effect (Scheme 32). Moreover, since the Michael addition of 
indoles onto nitroolefins is widely known to be catalyzed by H-bonding catalysts such as 
thioureas, the first step is to find out the optimal catalyst for the first Friedel-Crafts type 
Michael addition step.  
 A wide spectrum of thiourea and thioamide catalysts were screened to determine the 
optimal catalyst for the sequential reaction (Scheme 32). When thiourea catalysts 150, 151, 
152 and 153 were tested, the Michael addition reaction proceeded very slowly even at 20 mol% 
of catalyst loadings at RT, ranging from eight to 12 days. Although catalyst 150 was 
previously reported by Ricci et al. to be a good H-bonding catalyst, which provided very good 
enantio-induction in similar Friedel-Crafts type Michael additions, we only noticed a modest 
33% ee when substrate 147a was utilized. Functionalizing the -OH group with a phosphate 
moiety in catalyst 151 was tried in an attempt to increase the H-bonding affinity of the 
reacting substrates, however, only a small rise in enantioselectivity to 39% ee was observed. 
Interestingly, the Takemoto's thiourea 152 provided the highest enantio-induction of 45% ee 
among all the thioureas tested, and the chiral Jacobsen's catalyst 153 disappointingly  
provided a racemic product 149.  
 When the Seidel's thioamide catalyst ent-37 was tested, a significant increase of 
enantioselectivity to 89% ee was achieved at RT, with a drastic reduction of reaction time to 
one day (Scheme 32).[22a] A further reduction of the reaction temperature to −30 °C gave an 
Results and Discussion 
33 
 
excellent yield (91%) and excellent enantioselectivity (95% ee) in one day, which 
substantiates the use of catalyst ent-37 as the organocatalyst for our sequential reaction. 
 
Scheme 32. H-Bonding catalyst screening. [a] All reactions were conducted on a 0.2 mmol 
scale of nitroalkene 5a with indole 4a. [b] Yields of isolated 149 after flash column 
chromatography. [c] Determined by HPLC analysis on a chiral stationary phase.  
 
 With the successful determination of the optimal organocatalyst to form 149, we then 
proceeded to screen the transition metal catalyst which would allow us to access the 
tetracyclic annulated indole derivatives 154 (Table 1). While a myraid of transition metals 
were tested with substrate 149, palladium, copper, silver and indium complexes failed to 
provide the desired C2 cyclization to form the annulated indole product (Table 1, Entry 5-8). 
On the other hand, the range of Au(I) catalysts screened all provided the desired annulated 
indole 154 (Table 1, Entry 1-4), which is attributed to the alkynophilicity of Au(I) catalysis 
compared to other transition metals (Section 1.2.2, vide supra). Moreover, we also determined 
that the counteranion of the Au(I) catalyst has an effect on the yields of product 154, with the 
NTf2− counteranion providing the optimal yield for the Au(I) catalyzed hydroindolination 
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reaction. The Ph3PAuNTf2 complex was also reported in some publications to provide greater 
air and thermal stability to the Au(I) complexes,[79] which makes it easier for us to adjust our 
reaction conditions when we combine the organocatalytic step with the Au(I) catalyzed step. 
Table 1. Screening of transition metal catalysts[a] 
 
 
 
 
 
 
 
 
[a]
 All reactions were conducted on a 0.05 mmol scale of nitroalkene 5a with indole 4a. [b] 
Yields of isolated 154a after flash column chromatography. 
 With the optimized organocatalyst ent-37 and Au(I) catalyst Ph3PAuNTf2 determined, we 
then proceeded to the next stage of the optimization where both catalysts are combined 
sequentially in the same reaction flask to achieve a type B sequential reaction (vide supra, 
section 1.2.3, Scheme 14). When the optimized organocatalyzed conditions (Scheme 32) was 
subjected to the multicatalytic sequence, i.e. addition of 10 mol% Ph3PAuNTf2 directly after 
the completion of the first Friedel-Crafts type Michael addition by TLC monitoring, only 
Entry Metal Catalyst  Cat. Loading (%) Yield (%)[b] 
1 PPh3AuNTf2 10 99 
2 PPh3AuSbF6 10 95 
3 PPh3AuBF4 10 60 
4 PPh3AuOTf 10 94 
5 PdCl2 10 - 
6 CuOTf.1/2C6H6 10 - 
7 AgOTf 10 - 
8 InCl3 10 - 
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traces of the product 150 could be detected, even with slight warming of the reaction mixture 
to 40°C in the second Au(I) catalyzed step (Table 2, Entry 1).  
Table 2. Optimization of one-pot multicatalytic sequence[a] 
 
 
 
 
 
 
[a]
 All reactions were conducted on a 0.2 mmol scale of nitroalkene 5a with indole 4a. [b] 
Yields of isolated 154a after flash column chromatography. [c] Determined by HPLC analysis 
on a chiral stationary phase [d] The reaction was conducted at RT to 40°C [e] Reaction was 
conducted at RT to reflux temperature. 
 
 Addition of protic additives such as tBuOH was first attempted (Table 2, Entry 7) in 
order to investigate if the smooth progression of the Au(I) catalytic cycle might be hampered 
by the protodeauration step. However, tBuOH did not yield any measurable cyclization 
product. Upon utilizing strong Brønsted acid additives such as pTSA and DPP 
(diphenylphosphate), an increase in yields was observed for the cyclized product (Table 2, 
Entry 2-6). The optimized condition was achieved when 75% pTSA was used as the additive 
to yield almost quantitative yields of 150 with excellent enantioselectivities obtained (Table 2, 
Entry 5). We attributed the requirement of a strong Brønsted acid additive to the deactivation 
effect of the heteroatom containing organocatalyst ent-37 on the Au(I) catalyst, resulting in 
Au(I) poisoning. This observation and postulate is consistent with literature known type B 
organo/Au(I) sequential reactions before the publication of this project,[63-64, 80] as well as 
Entry Ph3PAuNTf2 [mol %] Additive Yield [%][b] ee [%][c] 
1[d] 10 - - - 
2[d] 10 25% pTSA 40 95 
3[e] 10 50% pTSA 50 96 
4[e] 10 50% DPP 42 93 
5[e] 10 75% pTSA  99 97 
6[e] 10 100% pTSA 80 97 
7[e] 10 1.5 equiv. tBuOH - - 
8[e] 0 75% pTSA  - - 
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some recent advancements in this research field,[81] where pTSA or DPP were used to 
regenerate the catalytically active Au(I) catalyst. 
 As it is widely known that there exist an isolobal analogy between Au(I) and H+, Au(I) 
catalyzed reactions could also theoretically be Brønsted acid catalyzed.[82] Hence, it is 
imperative that a control experiment was conducted where the exact optimized conditions (75 % 
pTSA additive) was used without the addition of any Au(I) complex, to ensure that the Au(I) 
species is actually catalyzing the second sequential step and not the pTSA additive (Table 2, 
Entry 8). The control experiment revealed that no detectable product 150 was obtained when 
Au(I) catalyst is absent. 
2.1.4 Determination of substrate scope and gram scale example of methodology 
 
 Having now obtained the optimized conditions for the sequential reaction (Table 2, Entry 
5), we then proceeded to develop the substrate scope of this H-bonding/Au(I) catalyzed 
multicatalytic strategy (Table 3). In general, this methodology tolerates a wide series of C2, 
C3-unsubstituted indoles 148a-d bearing different substituents on the benzenoid ring, as well 
as o-alkyne substituted nitroolefin bearing electron withdrawing substitutent such as F in 
147b and electron donating substituents such as methyl in 147c. It was also observed that the 
yields of the sequential reactions were generally very good, ranging from 51% (Table 3, 154c) 
to 96% (Table 3, 154f). It is also rather prominent that indoles bearing the 5-Me substituent 
generally gave excellent yields (Table 3, 154b, f and j), which can most likely be attributed to 
the high nucleophilicity of the indole C3 position, which further aids in the Au(I) cyclization 
step. Moreover, the enantioselectivities of this methodology are excellent, with all examples 
ranging from 95% to 99%, which shows a significantly higher enantio-inductions 
comparatively to the ones reported by Seidel et. al.[22a] 
 Since our methodology documents the first report where such tetracyclic indole 
derivatives 150a-l could be accessed enantioselectively, a four gram scale reaction (relative to 
147a) was also conducted to ensure that this methodology could also be effectively scaled-up 
for potential industrial applications (Scheme 33). 
 
 
 
Results and Discussion 
37 
 
Table 3. Substrate scope of the one-pot multicatalytic sequence[a,b] 
 
[a]
 All reactions are conducted on a 0.8 mmol scale of 147a-c and indole 148a-d. [b] Absolute 
configurations were deduced by analogy to the crystal structure of 154l. [c] Times for 
organocatalytic step+gold catalyzed cyclization step. [d] Yields of isolated 154a-l after flash 
column chromatography. [e] Determined by HPLC analysis on a chiral stationary phase.   
 
 To our delight, the gram scale reaction could be conducted at almost three times lower 
catalyst loadings of 3 mol% ent-37, and half as much Ph3PAuNTf2 catalyst loadings of 5 mol% 
154 R1 R2 R3 t[c] [h] Yield[d] [%] ee[e] [%]  
a 5-OMe  H H 24+19 78  97 
b 5-Me  H H 36+30 92  97 
c H  H H 48+38 51 97 
d 7-Me  H H 37+31 70  98 
e 5-OMe  H F 22+20 67  97 
f 5-Me  H F 16+29 96  95 
g H  H F 21+25 81 98 
h 7-Me  H F 21+25 78  99 
i 5-OMe  Me  H 18+42 80 97 
j 5-Me  Me H 27+15 94  98 
k H  Me H 25+67 79  97 
l 7-Me  Me  H 25+41 60  98 
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comparatively to the 0.8 mmol scale methodology (Table 3, 154b). Moreover, the yields were 
still excellent at 93% and the enantioselectivity was only marginally reduced to 93% ee. 
 
Scheme 33. Gram scale synthesis of 154b using reduced catalyst loadings. 
2.1.5 31P NMR mechanistic tests for possible Au(I) deactivation by organocatalyst 
  
 
Scheme 33. Overlay of 31P NMR spectra of (a) pure PPh3AuNTf2 (top spectra) (b) 1:1 ratio of 
ent-37/ PPh3AuNTf2 (bottom spectra) in CDCl3 on a 300 MHz NMR spectrometer. 
 To further understand qualitatively the deactivation effect of the organocatalyst ent-37 on 
the PPh3AuNTf2 catalyst, a 31P NMR study was undertaken to determine the influence of the 
organocatalyst on the chemical shift of the phosphorus atom on the PPh3 ligand (Scheme 33). 
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Shi et al. have previously conducted 31P NMR studies on Au(I) complexes ,which revealed 
that the greater the downfield NMR shift of the Au(I) species, the more covalent (less cationic) 
and hence the lower reactivity of the Au(I) complex. Hence the shifting of 31P NMR 
resonances towards higher values has a direct inference towards the greater deactivation effect 
of a Au(I) species in a multicatalytic reaction.[79c]  
 In Scheme 33a, a control 31P NMR experiment on pure PPh3AuNTf2 revealed a resonance 
of 31.8 ppm which is consistent with literature reported values.[79c] In a separate control 
experiment shown in Scheme 33b, a 1:1 (molar ratio) of catalyst ent-37 and PPh3AuNTf2 
were mixed and interestingly, a downfield shift of approximately 2.3 ppm was observed at 
34.1 ppm, which is consistent with the formation of a more stable covalent adduct which 
reduces the reactivity of the Au(I) catalyst.[79c] 
 
Scheme 34. Overlay of 31P NMR spectra of (a) Au(I) cyclization of 149 to 154a in a stepwise 
reaction without ent-137 present (top spectra). (b) using our organo/Au(I) multicatalytic 
methodology (bottom spectra) on a 300 MHz NMR spectrometer. 
 In Scheme 34(a), we conducted a 31P NMR experiment on the cyclization of the Michael 
adduct 149 into 154a in the absence of ent-37 in the reaction mixture. 15 minutes into the 
reaction, two resonance peaks at 43.6 ppm and 30.9 ppm were observed which were assigned 
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 to the Au-C intermediate and the free Au(I) catalyst respectively. Conversely, when 
accessed utilizing our multicatalysis strategy (the second Au(I) catalyzed step was conducted 
at 80°C for seven hours) in scheme 34(b), two resonance peaks at 46.2 ppm and 3
were observed which showed a general trend of a 3 ppm downfield shift similar to a catalyst 
deactivation pattern observed in scheme 33(b). 
 Furthermore, we conducted another control 
additive was added prior to Au(I
80°C . This control experiment revealed similar resonances as scheme 34(b), which gave us 
evidence that the Au(I) deactivation effect is present in our multicatalytic system regardless 
whether pTSA was added or not. However, only the presence of  
product 154a, which may suggest that 
species required for the Au(I) catalyst cycle to proceed.
2.1.5 Determination of abs
 
Figure 1. X-ray crystal structure of (
 The absolute configuration of the annulated indole product 
unambiguously by analogy to the X
proof of the (R) absolute configuration at the stereogenic centre. Moreover, this absolute 
configuration was also consistent with previously reported Friedel
addition reactions of indoles reported by Ricci 
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31P NMR experiment where no 
) addition, and then seven hours heating of this reaction at 
pTSA produces the cyclized 
pTSA helps to regenerate the catalytically active Au(I) 
 
olute configuration and molecular constitution
 
R)-154l, crystal was grown from benzene.
150 a
-ray crystal structure of 154l (Figure 1), which provided 
-Crafts type Michael 
et. al. utilizing a thiourea catalyst with an 
 
154a was 
4.1 ppm 
pTSA 
 
[83]
  
-l was determined 
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identical cis-aminoindanol chiral scaffold.[68a, 68b] Moreover, the 7-endo-dig cyclization mode 
in the Au(I) catalyzed step is also confirmed by this X-ray structure.   
2.1.6 Further derivatization of the large scale product 
 
Scheme 35. Further derivatization of tetracyclic indole derivatives 154b. 
 To demonstrate further possible transformations of derivative 154b which was obtained 
from the large scale reaction (Scheme 33, section 2.1.4), a facile NaBH4 nitro-reduction 
cataylzed by NiCl2.6H2O was carried out to obtain primary amine 155 with very high yields 
of 86% (Scheme 35). As the enantioselectivity of the amine intermediate 155 could not be 
determined by chiral HPLC due to it's high polarity, it can then be further functionalized 
through a peptide coupling reaction with either (−)-camphanic chloride or p-bromobenzoyl 
chloride to form peptide 156 and 157 respectively with good to very good yields. Since (−)-
camphanic chloride is a chiral derivatizing agent (>99% ee from commercial sources), a 
resulting 96:4 d.r. of product 156 would translate to a 92% ee of amine 155. 
Enantioselectivity of peptide 157 was also determined by chiral HPLC to be 91% ee, hence 
showing that no racemization occured in the intermediate derivatization steps. 
2.1.5 Proposed mechanism for organo-/Au(I) multicatalysis 
 
 Based on our empirical data in the previous sections, as well as studies undertaken by 
other research groups such as Echavarren et al.,[77] a mechanistic proposal is provided in 
Scheme 36 to explain the one pot multicatalytic formation of annulated indole product 154a-l. 
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Scheme 36. Mechanistic proposal of H-bonding/Au(I) multicatalytic cycles. 
 Starting from substrates o-alkyne nitroolefin 147 and C3,C2-unsubstituted indole 148 
(Scheme 36),  catalyst ent-37 forms multiple H-bonding interactions with both substrates in a 
highly rigidified transition state TS 158. The high relative topicity of the rigidified TS 158 
allows indole 148 to attack the β-position of the nitroolefin from the Si-face, resulting in the 
formation of Michael adduct 159 with excellent enantioselectivity. As ent-37 re-enters the 
organocatalytic cycle, intermediate 159 then enters the Au(I) catalytic cycle. 
 The active Au(I) catalyst, denoted as LAu+ then π-activates the alkyne moiety of 159 due 
to its high alkynophilicity to form the activated π-complex 160. The Au(I)-activated alkyne 
then evokes a second Friedel-Crafts type attack from the C3 of indole onto the alkyne in a 6-
endo-dig cyclization mode to generate the spirocyclic indolenine intermediate 161 which is 
now electrophilic on the C2 position. While it is often known in the literature that the 
indolenine intermediate can be trapped with a nucleophile to form indolines (vide supra, 
section 1.3), Au(I) catalysis generates non-classical carbocationic intermediates such as 161, 
which allow a Wagner-Meerwein type 1,2-alkyl shift to form intermediate 162 in a net ring 
expansion reaction.  
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 Finally, the rearomatization of the indole ring in 162 expels one proton which provides 
the thermodynamic driving force for protodeauration to occur, hence allowing the Au(I) 
catalyst to be regenerated into the catalytic cycle. As the knowledge of indolenine 
intermediates especially in ring expansions was fairly limited at the time this project was 
conducted in 2010-2011,[69a, 69b] an indirect mechanistic test was formulated in order to 
augment the claim that intermediates such as 161 are plausable (Scheme 37).  
 
Scheme 37. Indirect mechanistic test proving the plausibility of the formation of indolenine 
spirocycles such as 161. 
 The idea behind this indirect mechanistic test is to disrupt the 1,2-alkyl shift by using a 
C2-substituted indole substrate 163. Upon subjecting indole 163 to the organo-/Au(I) 
multicatalytic strategy, spirocyclic product 164 could be isolated, albeit in extremely low 
yields. We reasoned that the low yields could be attributed to disturbance of the crucial 
protodeauration step, since in this case, no rearomatization could provide the thermodynamic 
driving force to expel a proton. The only way protodeauration could occur is by indole NH 
deprotonation, which is highly unfavored. Nonetheless, the very fact that 164 could be 
isolated and characterized provided ample evidence that a double Friedel-Crafts type reaction 
on C3 forming a spirocyclic indolenine is a viable mechanism, in which the seven-membered 
ring formation could be accounted for.  
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2.2 Enantioselective synthesis of tetrahydrocarbazoles through a sequential 
Michael addition/ Ciamician Plancher rearrangement sequence. 
 
2.2.1 Biological significance of tetrahydrocarbazoles 
 
 Building upon what was achieved in the first project (Section 2.1) in accessing annulated 
indoles through a sequential binary organo-/Au(I) catalytic system, we then shifted our focus 
onto another class tricyclic frameworks known as tetrahydrocarbazoles with a six membered-
ring fused onto the C3 and C2 position of indole (Scheme 38). Accessing 
tetrahydrocarbazoles is of great significance, since this structural motif is often found in 
numerous natural products and pharmaceutical agents (Scheme 38). 
 
Scheme 38. Bioactive tetrahydrocarbazoles 
 Some naturally occuring indole alkoids such as Uleine 165 and gilbertine 166 isolated 
from Aspidosperma gilbertii contain the tetrahydrocarbazole motif.[84] Moreover, ramatroban 
167 (marketed name Baynas) from Bayer containing the tetrahydrocarbazole unit is used 
clinically for the treatment of coronary artery disease and asthma.[85] In addition, another 
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tetrahydrocarbazole WAY-253752 168 is currently developed by a U.S. pharmaceutical 
company Wyeth as a dual SSRI/5-HT1A antagonist for the treatment of depression.[86] One 
interesting bioactive analogue that caught our attention was tetrahydrocarbazole 169, as there 
is a recent increase in interest of this compound as a highly potent 5-HT6 neuro-receptor 
antagonist (Ki = 2 nM).[87] Compound 169 was developed by Glennon et al. as a 
conformationally restricted analogue of MS-245 (170), a well known 5-HT6 receptor 
antagonist.[88] The 5-HT6 receptor is an important therapeutic target, since central nervous 
system (CNS) diseases such as Alzheimer's disease and schizophrenia could potentially be 
treated by targeting this receptor. 
 Another notable point is that literature reported studies of 169 has always been on the 
racemic mixture, since there lack of known methodologies to access this derivative 
enantioselectively, despite biological reports reaffirming that chiral 5-HT6 antagonists do have 
significantly differences in affinity on the 5-HT6 receptor.[89] Therefore, it is imperative to 
develop a methodology that can access derivative 169 efficiently and enantioselectively. 
2.2.2 Literature methodologies to access tetrahydrocarbazoles  
 
 While it is well documented in the literature that many catalytic methodologies ranging 
from transition metal catalyzed to organocatalytic domino reactions are able to generate 
tetrahydrocarbazoles enantioselectively, the utility of such protocols to access a known useful 
tetrahydrocarbazole derivative remains rare. 
 Xiao et al. for instance demonstrated in 2010 that it was possible to construct 
tetrahydrocarbazoles 173 bearing two contiguous stereogenic centres by an iminium/enamine 
organocatalytic domino reaction of vinyl indole 171 on enals 172 catalyzed by TMS-protected 
diphenylprolinol 75 (Scheme 39, eqn 1).[90] On the other hand, You et al. also shown in 2012 
that an appropriate transition metal catalyst such as iridium complexes bearing a chiral ligand 
can catalyze a Friedel-Crafts type allylic dearomatization/stereospecific migration sequence to 
yield tetrahydrocarbazole 175 with very high to excellent enantioselectivities (Scheme 39, eqn 
2).[91] Other transition metal complexes such as platinum[92] or gold complexes[75, 93] are also 
reported to be effectively utilized to access tetrahydrocarbazoles asymmetrically. In addition, 
some groups have also reported the utility of sequential reactions or multicatalytic protocols 
to access complex tetrahydrocarbazole containing compounds.[94] 
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Scheme 39. Organocatalytic and transition metal catalyzed protocols to access 
tetrahydrocarbazoles.  
 One significant example published by List et al. in accessing tetrahydrocarbazoles 
enantioselectively deserves special mention since it is one of the rare examples that a useful 
biologically validated target has been synthesized using a Brønsted acid catalyzed protocol 
(Scheme 40).[95] In this report, List et al. successfully achieved the first known asymmetric 
Fischer indolization strategy, where they subjected 4-substituted cyclohexane-derived 
phenylhydrazones 176 to Brønsted acid catalysis to realize a [3,3]-sigmatropic aza-cope 
rearrangement reaction. Interestingly, the usage of SPINOL-derived phosphoric acid 177 
provided the Fischer indolization product 178 with up to excellent yields and 
enantioselectivities. Moreover, tetrahydrocarbazole 178 could be further derivatized to 
achieve a formal total synthesis of (R)-ramatroban, where precursor 179 could be synthesized 
with very good enantioselectivities in three further steps from 178.  
 List et al. attributed the high enantioselectivities to a dynamic kinetic resolution pathway, 
where one of the enantiomers of racemic 176 selectively undergoes the [3,3]-sigmatropic 
rearrangement, while the other enantiomer can be easily converted to the more favorable 
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enantiomer. An amberlite cationic exchange resin was also instrumental in this methodology 
for catalyst 177 to be regenerated.  
 
Scheme 40. Fischer indolization strategy to access tetrahydrocarbazoles. 
2.2.3 The Ciamician Plancher rearrangement 
 
  As previously discussed in the first organo-/Au(I) multicatalysis project (vide supra, 
Section 2.1.1), many cyclization strategies exist in the literature to access annulated indoles, 
which include C2 or C3 Friedel-Crafts type cyclization strategies (Scheme 26). Upon closer 
scrutiny of the literature reported examples, it is evident that recent strategies most involved a 
C2 cyclization on either a Michael acceptor or a carbonyl-derivative such as imines, which are 
generally acceptors containing a sp2-hybridized electrophilic centre. In contrast, a C2 
cyclization on sp3 acceptor such as a alkyl halide has almost been neglected in the past 30 
years. This is rather surprising, since C2 cyclizations in this fashion, commonly known as the 
Ciamician Plancher rearrangement (alternatively also known as the Plancher rearrangement) 
in the literature, might provide chemists a practical access into useful tetrahydrocarbazole 
frameworks such as 5-HT6 antagonist 169 (Scheme 38). 
 The Ciamician Plancher rearrangement was discovered by Ciamician and Plancher et al. 
in the late 19th century, where it was then realized that indole such as 180 could be poly-
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alkylated with four equivalents of alkyl halide (R-X) to form an indolium iodide salt 186 at 
high temperatures (Scheme 41).[96] The interesting point of this reaction was that a quartenary 
centre was generated at C3 of product 186, which provides a clue towards the actual poly-
alkylation mechanism on the indole substrate. It is generally a consensus that after the first 
alkylation step forming C3 substituted indole 182, the subsequent Friedel-Crafts alkylation 
occurs at C3 to form 183, one of the alkyl groups at C3 then migrates to C2 through a 
Wagner-Meerwein type shift to form intermediate 184, which rearomatize to 185. Another C3 
and nitrogen double alkylation forms finally 186. This C3 to C2 alkyl shift occuring during 
indole alkylations with alkyl halides is then widely known in literature as the Ciamician 
Plancher rearrangement.[97] 
 
Scheme 41. Early reports on the Ciamician Plancher rearrangement. 
 In addition, the 1,2-alkyl shift mechanism instead of a direct C2 attack was later 
confirmed in 1967 by Jackson and Smith et. al. where radioactive tritium labeled indolyl-
butanol 187 was subjected to a BF3/Et2O Lewis acid catalyzed cyclization. Interestingly, the 
cyclized tetrahydrocarbazole product 189 has the radioactive label scrambled between 
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position 1 and position 4 in a 1:1 ratio.[98] This observation substantiates a symmetric 
spirocyclic indolenine intermediate such as 188 would be crucial, since there would be a 50% 
chance that the tritium labeled carbon would undergo 1,2-migratory shift, rather than a direct 
C2 attack where no scrambling of the radiolabel should be observed. 
2.2.4 Retrosynthetic analysis of sequential reaction 
 
 
Scheme 42. Retrosynthetic analysis of bioactive tetrahydrocarbazole 169. 
 Starting from the potent 5-HT6 antagonist 169 (vide supra, Section 2.2.1) which we 
intended to access enantioselectively, a functional group interconversion (FGI) provides 
derivative 190 which contains a nitro moiety that opens up possibilities in utilizing an 
organocatalytic strategy. Subsequently, sequential one-pot Michael addition disconnection 
adjacent to C3 and a Ciamician Plancher rearrangement disconnection next to C2 provide us a 
facile entry into such tetrahydrocarbazoles, simply starting from commercially available C3, 
C2- unsubstituted indole 191 and an aliphatic halo-nitroalkene 192. While 192 is not 
commercially available, the utility of such halo-nitroalkenes has previously been reported by 
Chuan Wang from our research group in organocatalytic domino reactions,[99] and the 
synthetic route towards derivative 192 is easily achievable from commercially available 
starting materials. 
2.2.5 Synthesis of the iodo-nitroalkene substrate 
 
 The synthesis of the iodo-nitroalkene 192 was based on a modified procedure that was 
previously published by our group.[99] While the original report utilized MsCl to access 
derivative 194 after the first Henry reaction, this was not reproducible when this reaction was 
performed. However, a slight modification from MsCl to trifluoroacetic acid anhydride 
(TFAA) for the dehydration step produced the nitroolefin 194 with acceptable yields (15% 
Results and Discussion 
50 
 
over two steps). Subsequently, a Finkelstein reaction was performed by refluxing 194 with 
NaI in acetone for three hours to yield the desired substrate 192 with very good yields (87%). 
 
Scheme 43. Synthesis of the iodo-nitroolefin 192 substrate. 
2.2.6 Optimization of H-bonding catalyzed/ Ag+ mediated sequential reaction 
 
 Our initial attempts in accessing tetrahydrocarbazoles 190 with the Seidel's catalyst ent-
37 were unsuccessful, due to the fact that the Ciamician Plancher rearrangement reaction was 
not occuring even when the reaction was heated under reflux for 25 hours in chloroform. This 
was an expected outcome since literature reports required extremely high temperatures (> 
100°C) for C2 of indole to be alkylated by an alkyl halide. With the knowledge of Au(I) 
catalysis from the previous project (vide infra, Section 2.1), where the halide abstraction 
concept is widely used to generate the thermodynamically stable AgX using a silver co-
catalyst (vide supra, section 1.2.2), we wondered if this concept is transferable in this case to 
effect an iodide abstraction from 192 to effect a C-C bond formation through the Ciamician 
Plancher rearrangement. 
 Interestingly, when a silver additive AgSbF6 was added after the first Michael addition 
step using catalyst ent-37 (Table 4, entry 2), we observed an appreciable formation of the 
targeted tetrahydrocarbazole 196 with 91% yield and moderate enantioselectivity of 73% ee. 
However, the silver mediated Ciamician Plancher rearrangement step was rather sluggish at 
room temperature (2 days reaction). Encouraged by this result, we then screened other 
hydrogen bonding catalysts such as thiourea 150, 153 and 197, as well as squaramide 198 to 
determine the best catalyst for the sequential reaction. Moreover, we also realized that the 
reaction time of the Ciamician Plancher rearrangement could be effectively reduced to 2 hours 
just by heating the reaction to reflux (80 °C oil bath temperature). 
 Unfortunately, all the thiourea catalysts (Table 4, entry 1, 3 and 4) reacted sluggishly for 
the first Michael addition step, and their yields and enantioselectivities were inferior 
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compared to ent-37. The squaramide catalyst 198 also provided lower yields and 
enantioselectivity relative to ent-37. 
Table 4. Optimization of the reaction conditions[a] 
 
[a]
 All reactions were conducted on a 0.3 mmol scale of nitroolefin 11 (1 equiv) and indole 10 
(1.5 equiv). [b] Yields of isolated 196 after flash column chromatography. [c] Determined by 
HPLC analysis on a chiral stationary phase. [d] The AgSbF6 mediated Ciamician-Plancher 
rearrangement was carried out at RT for 2d. 
Entry Catalyst t [d] cat. Loading [mol %] Solvent T [°C] Yield [%][b] ee[%][c] 
1 150 3.5 10 CHCl3 23 75 60 
    2[d] ent-37 1 10 CHCl3 23 91 73 
3 197 11.5 10 CHCl3 23 42 3 
4 153 11.5 10 CHCl3 23 64 20 
5 198 3.5 5 CHCl3 23 28 17 
6 ent-37 1 10 DCE 23 71 55 
7 ent-37 1 10 DCM 23 80 64 
8 ent-37 0.5 10 C6H5Cl 23 85 76 
    9 ent-37 4 10 C6H5Cl −25 81 87 
10 ent-37 4 10 C6H5Cl −37 81 88 
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 With the best hydrogen bonding catalyst determined to be ent-37, the other parameters of 
this sequential reaction were then optimized. A solvent screening was conducted where other 
common solvents such as DCM, DCE and chlorobenzene were screened at room temperature 
(Table 4, entry 6-8). While DCE and DCM gave lower enantioselectivities of 55% ee and 66% 
ee respectively, chlorobenzene provided a slightly superior enantioselectivity of 76% ee 
(Table 4, entry 8) compared to chloroform (Table 4, entry 2). 
 After determining chlorobenzene to be the best solvent for the sequential reaction, the 
reaction temperature was lowered to determine it's effect on the enantioselectivity (Table 4, 
entry 9-10). The optimized condition was finally determined to be −37°C in chlorobenzene 
(Table 4, entry 10) which gives a very good yield of 81% and very good enantioselectivities 
of 88% ee of the tetrahydrocarbazole product 196. 
 Having now established the optimal conditons, we then continued on to determine the 
substrate scope of this sequential reaction (Table 5). This methodology was proven to be very 
versatile, and a wide range of C3,C2-unsubstituted indoles ranging from indoles bearing 
electron withdrawing groups (Table 5, 196 c, g, h, i) as well as indoles bearing electron 
donating groups (Table 5, 196 b, d and e) were tolerated. The tetrahydrocarbazole products 
196 a-k were also generated with moderate to very good yields (33-81%) and very good to 
excellent enantioselectivities (86-96% ee). In addition, benzoindole 195k, a pharmaceutically 
important scaffold that is rarely used in catalytic methodologies also generated the desired 
annulated product 196k with moderate yield (40%) and excellent enantioselectivity (96%). 
 In certain examples where electron withdrawing substituents were used (Table 5, 196c, g, 
h), 3 equivalents of  indole 195 has to be added since electron withdrawing functional groups 
resulted in a significant decrease in the nucleophilicity of these substrates. A large excess of 
indole is hence required to shift the equilibrium more towards the products. This lower 
reactivity is also evident from the longer reaction times between 7-17 days required for these 
electron deficient substrates. 
 Moreover, these tetrahydrocarbazole derivatives 196 form conglomerates easily, and 
hence their enantioselectivities could be further raised to more than 95% ee simply by a single 
recrystallization in methanol or benzene (Table 4, 196 b, d and h). The easy crystallization of 
such compounds also provided another advantage for a possible industrial use of this 
methodology in future.  
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Table 5. Substrate scope of the sequential reaction[a,b] 
 
[a]
 Reactions were generally conducted on a 0.6 mmol scale of nitroolefin 192 (1 equiv) and 
indole 195 a-k (1.5 equiv). [b] Absolute configurations are deduced by analogy to the crystal 
structure of 196h. [c] Yields of isolated 196 after flash column chromatography. [d] Determined 
by HPLC analysis on a chiral stationary phase. [e] Values in parentheses indicate enantiomeric 
excesses after single recrystallization in methanol or benzene. [f] 3 equiv. of the corresponding 
indole used.  
 
 
 
196 R Time for 1st sequential step [d] Yield [%][c] ee [%][d] 
a H 4 68 90 
b 5-OMe 4 66             87 (98)[e] 
     c[f] 5-Br 17 33 90 
d 5-Me 1.5 81             89 (97)[e] 
e 6-Me 1.5 79 86 
f 7-Me 2 51 93 
  g[f] 5-F 7.5 58 87 
  h[f] 5-Cl 13.5 70             91 (95)[e] 
i 6-Cl 12 58 87 
j 5-Ph 3.5 74 88 
k - 5 40 96 
 2.2.6 Determination of absolute configuration 
 
Figure 2. X-ray crystal structure of (
 The absolute configuration of 
ray structure of 5-Cl derivative 
stereogenic centre is umabiguously determined to be (
2.2.7 Proposal mechanism of the Michael/Ciamician Plancher rearrangement 
sequence  
 
 To explain the formation of the tetrahydrocarbazole product 
(Scheme 44), indole 195 first undergo
Crafts type Michael addition enantioselectively. The control of enantioselectivity is suggested 
to proceed via transition state 
hydrogen bond interactions between catalyst 
This first Michael addition step then forms the iodo
organocatalyst ent-37 re-enters the catalytic cycle.
 Upon the addition of stoichiometric amounts of the silver additive AgSbF
acid Ag+ interacts favorably with the soft iodine Lewis base to form an activated complex 
The formation of this activated complex is instrumental in the execution of the Ciamic
Plancher rearrangement. In this case, the nucleophilic C3 position of 
electrophilic carbon of the C
thermodynamically stable AgI on the opposite end. This provides the thermod
force for this reaction since AgI now precipitates out of the reaction mixture, evoking the 
Results and Discussion
54 
 
 
R)-196h, crystal was grown from methanol.
196a-k was determined by analogy to the single crystal X
196h grown from methanol and the configuration of t
R) (Figure 2).  
196
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formation of the spirocyclic indolenine intermediate 200, which is now electrophilic on the 
C2 position. 
 
Scheme 44. Mechanistic proposal of the H-Bonding / Ag+ mediated Ciamician-Plancher 
rearrangement sequence 
 Similarly to the mechanism proposed for the ring expansion in the Au(I) catalyzed 
Friedel-Crafts type hydroindolination reaction in the first project, indoleine 200 can now 
undergo a 1,2-migratory shift to form intermediate 201. A final rearomatization of the indole 
heterocycle assist in the departure of one proton which now recombines with the 
hexafluoroantimonate (SbF6−) anion to expel the super acid HSbF6 and generates the desired 
chiral tetrahydrocarbazole product 196. 
2.2.8 Concise asymmetric total synthesis of 5-HT6 antogonist (R)-169  
 
 As previously discussed in section 2.2.1, one of the objective of this project is to open a 
new entry into derivative 169 enantioselectively, as there are no known methods in the 
literature at the onset of this project in doing so. With the successful development of this 
organocatalyzed Michael addition/Ag+ mediated Ciamician-Plancher rearrangement sequence, 
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we proceeded to develop a concise synthetic route towards enantio-enriched 169 utilizing our 
original disconnection strategy outlined in Scheme 42 (vide supra, Section 2.2.4). 
 Firstly, we doubled the scale of the synthesis of derivative 196b using the developed 
sequential methodology. While there is a very slight reduction of enantioselectivity to 84% ee, 
a simple recrystallization in methanol provides the enantio-enriched tetrahydrocarbazole 196b 
with an excellent enantiomeric excess of 96%. 
 
Scheme 45. A concise asymmetric total synthesis of (R)-196 without intermediate 
chromatographic purification. 
 With the enantio-enriched tandem product 196b in hand, we subjected this substrate to a 
three step total synthesis without any intermediate purification by flash column 
chromatography. The first step of this series was a nickel chloride catalyzed nitro-reduction of 
196b using NaBH4 to generate the corresponding amine 202, which then underwent a 
reductive amination reaction in the prescence of formaldehyde and NaCNBH3 to yield the 
dimethylated producted 203. Finally, the indole nitrogen of 203 was protected with the 
PhSO2- group and purified to yield the desired 5-HT6 antagonist (R)-196 with a good 43% 
yield over three steps. Moreover, none of these three steps resulted in the racemization of the 
tetrahydrocarbazole since (R)-169 was obtained in 97% ee. This concise strategy also 
demonstrated the power of our one-pot sequential methodology to access enantio-enriched 
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bioactive tetrahydrocarbazoles such as 169 which is otherwise not possible using conventional 
procedures. 
2.3 A kinetically controlled asymmetric organocatalytic Michael/Henry 
domino reaction through H-Bonding activation to access cis-vicinal indanes 
 
 Departing from enantioselective sequential reactions that were developed in the last two 
projects, the second part of this doctoral thesis seeks to utilize hydrogen bonding catalysis to 
effect organocatalytic domino reactions to generate synthetically useful frameworks, with the 
concomittant formation of multiple bonds and stereogenic centres at high efficiencies. 
2.3.1 Importance of the cis-vicinal indane scaffold 
 
 We were initially interested in the indane scaffold bearing cis-vicinal substituents since 
such motifs are often encountered in biologically active molecules and are often utilized as 
chiral scaffolds in ligands or catalysts (Scheme 46). 
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Scheme 46. Examples of pharmaceutical agent, ligands and catalysts bearing a cis-vicinal 
indane scaffold. 
 The pioneering use of the cis-vicinal scaffold originated from the pharmaceutical industry, 
where Merck researchers incorporated this motif into the development of the HIV protease 
inhibitor, Crixivan 204 which currently still remains as one of the top drugs for HIV anti-
retroviral treatment.[101] Moreover, the chiral cis-vicinal indane scaffold is also prevalent in 
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asymmetric catalysis as a catalyst building block to achieve high enantioselectivities. One 
example is the bis(oxazoline) ligand 205 which is often encountered in transition metal 
catalysis.[102] In the field of organocatalysis, the cis-vicinal indane building block is used in 
NHC catalysis such as the Rovis NHC precatalyst 206, the Ricci's thiourea catalyst 150 often 
used in Michael addition reactions, the Seidel's thioamide catalyst ent-37 which is one of the 
most commonly used hydrogen bonding catalyst in this PhD thesis. Oxazaborolidines such as 
207 are also an important class of reducing agents used in enantioselective reductions.  
2.3.2 Difficulties in accessing the cis-vicinal indane scaffold enantioselectively 
 
 While the significance of the cis-vicinal indane scaffold is well known, there remain 
many challenges in accessing this motif enantioselectivity. The widely used industrial method 
to synthesize this scaffold is through the Merck process (Scheme 47).[103] 
 
Scheme 47. Industrial synthesis of cis-aminoindanol via the Merck process. 
 In this synthesis, the first step involved the enantioselective Jacobsen epoxidation of 
indene 208 to form the corresponding epoxide 209 with very good enantioselectivity of 88% 
ee. A benzamide crystallization under acidic Ritter conditions in the presence of acetonitrile is 
required to thermodynamically stabilize cis-indane scaffold 210, since the trans-indane 
scaffold is the thermodynamically preferred product of the epoxide opening reaction. A final 
hydrolysis of the benzamide 210 yields the enantio-enriched cis-aminoindanol 211. This 
problem of the formation of the trans-vicinal indane product, which is the thermodynamic 
product is also evident in some other methodology reported in literature. 
 In 2012, Csákÿ et al. reported a LDA mediated Michael/Michael domino reaction 
between ortho-substituted bis-Michael acceptors 212 and imine-esters 213, to form the 
racemic thermodynamic product trans-214 (Scheme 48, eqn 1). An explanation provided by 
the authors involved the formation of the lithium enolate 214a after the first Michael addition 
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step, which positions the vicinal substituents in the trans-position to minimize steric crowding, 
hence explaining the trans relative configuration of the indane product 214.[104] 
 
Scheme 48. Literature examples in accessing thermodynamic all-trans vicinal indanes. 
 Another very recent report in early 2013 by Sun et al. documents the usage of o-
carbaldehyde-α,β-unsaturated ketones 215 as a bi-acceptor in a DBU 217 catalyzed aza 
Michael/Henry domino reaction (Scheme 48, eqn 2). In this domino reaction, amine 216 first 
attack the Michael acceptor of 215 at the β-position. The α-position which is subsequently 
nucleophilic then attacks the aldehyde moiety in an intramolecular Henry reaction to furnish 
the thermodynamic product 218 racemically with good to excellent yields and up to excellent 
diastereoselectivities. The formation of the thermodynamic product 218 could also possibly 
be attributed to an intermediate similar to 214a before the Henry cyclization step, where the 
vicinal substituents are trans-positioned to avoid steric crowding. 
2.3.3 Kinetic strategy to access the cis-vicinal indane products 
 
 Since it is imperative to access cis-vicinal indanes enantioselectively due to it's 
importance and usefulness (vide supra, Section 2.3.1), a kinetic strategy is required to prevent 
the trans-positioning of the vicinal substituents in the Henry cyclization step. Starting from 
the useful cis-vicinal nitroindanol 219 in our retrosynthetic analysis (Scheme 49), we 
reasoned that a functional group interconversion to the cis-nitroindanol 220 would help us 
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better tap into organocatalytic domino methodologies. A further Henry disconnection would 
allow us to access the postulated cis-oriented transition state 221, in which a H-bonding 
catalyst helps to kinetically position the nitro and the aldehyde moiety in the cis-relative 
configuration.  A further Michael disconnection would help us realize this domino reaction 
from simple substrates such as o-carbaldehyde nitroolefin 222 and an appropriate nucleophile 
to evoke this domino reaction. 
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Scheme 49. Retrosynthetic analysis of the hydrogen bonding catalyzed Michael/Henry 
domino reaction to form the kinetic cis-vicinal indane. 
 Another important challenge facing the successful execution of this strategy is the correct 
choice of a nucleophile (denoted as Nu in Scheme 49), which regioselectively attacks the 
nitroolefin moiety of 222 instead of the aldehyde moiety, to prevent side reactions which 
might decrease the overall yield of the cascade product. Common carbonyl derived enolates 
are predicted to be poor candidates for this domino reaction since an alternative aldol side 
reaction is highly probable, therefore we chose C3,C2-unsubstituted indoles which would 
undergo Friedel-Crafts type Michael additions regioselectively on the nitroolefin. Moreover, 
literature known examples of nucleophilic attack by indoles on an aldehyde solely proceeds 
under highly basic conditions which is absent in a hydrogen bonding catalyzed system.  
2.3.4 Synthesis of the o-carbaldehyde nitroolefin substrates 
 
 The syntheses of the o-acetal nitroolefin precursors 224a-c were performed using 
literature known procedures starting from commercially available o-bromocarbaldehyde 223 
(Scheme 50).[105] The acetal precursors 224a-c were then converted to their corresponding 
aldehydes by an acid catalyzed acetal deprotection, by stirring the precursor in 2N HCl and 
acetone at room temperature. The deprotected substrates 225a-c can then be easily isolated 
and purified by the addition of distilled water, which precipitates the product out as a powder 
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which can be filtered, washed with pentane and dried under vacuum with moderate to 
excellent yields, depending on the substituent R on the benzene ring. 
 
Scheme 50. Synthesis of the o-carbaldehyde nitroolefin 225a-c. 
2.3.5 Catalyst screening and optimization of conditions 
 
 First, a series of H-bonding catalyst were screened to determine the optimal catalyst for 
the domino reaction. It is noteworthy to point out that the usage of activated 3Å molecular 
sieves is pivotal in this reaction, without which the desired cascade product will not be 
generated. Moreover, it was also observed that the dryness of the molecular sieves had a 
significant impact on the enantioselectivities, hence it is essential that powdered 3Å molecular 
sieves are freshly dried under high vacuum under the heating of a heat gun for a few hours 
before usage to ensure optimal results. The catalyst screen revealed that the cis-vicinal indane 
product 227 is generated only when the thiourea/squaramide catalyst contains a cis-
aminoindanol moiety. Therefore only catalyst 150 (Table 6, entry 1), catalyst 228 (Table 6, 
entry 2) and ent-37 (Table 6, entry 5) produced the desired product 227 at room temperature. 
 Hydrogen bonding catalyst 152 and 198 bearing basic moieties gave a complex mixture 
upon reaction of 225a with 226, which was attributed to a decomposition of the base sensitive 
cascade product 227. The best catalyst for this domino reaction is the Seidel's catalyst ent-37 
(Table 6, entry 5), since it provided almost quantitative yield of 98% and a very high 
enantioselectivity of 87% ee. With the optimal catalyst determined, we proceeded to screen 
other solvents for this new domino reaction. However, a range of solvents ranging from 
chlorinated arenes (Table 6, entry 6-9) to non polar toluene (Table 6, entry 10) provided 
diastereo- and enantioselectivities lower than CHCl3. 
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Table 6. Catalyst screening and optimization of the reaction conditions.[a,b] 
 
 [a]
 Reactions were conducted on a 0.2 mmol scale of o-benzaldehyde nitroolefin 225a (1 
equiv.) and indole 226a (1.2 equiv.). [b] The relative and absolute configuration of 227a was 
determined by X-ray crystallography. [c] Yield of isolated 227a after flash column 
chromatography. [d] Determined by 1H NMR. [e] Determined by HPLC analysis on a chiral 
stationary phase. [f] These reactions were conducted on a 0.5 mmol scale of o-benzaldehyde 
nitroolefin 225a. 
Entry Cat. t 
[h] 
x 
[mol%] 
Solv. T  
[°C] 
Yield 
[%][c] 
d.r[d] ee 
[%][e] 
1 150 24 20 CHCl3 23 99 9:1      68 
2 228 136 10 CHCl3 23 34 9:1 34 
3 152 16 20 CHCl3 23 - - - 
4 198 7 10 CHCl3 23 - - - 
5 ent-37 14 15 CHCl3 23 98 9:1 87 
6 ent-37 15 15 1,2-diCl benzene 23 57 8:1 72 
7 ent-37 15 15 1,3-diCl 
benzene 
23 85 6:1 85 
8 ent-37 16 15 2,4-diCl 
benzene 
23 85 4:1 86 
9 ent-37 16 15 1,2,4-triCl 
toluene 
23 83 6:1 82 
10 ent-37 15 15 toluene 23 80 5:1 81 
11 ent-37 21 15 CHCl3 0 99 5:1 95 
12[f] ent-37 15 5 CHCl3 0 99 9:1 90 
13[f] ent-37 17 10 CHCl3 0 96 10:1 93 
Results and Discussion 
63 
 
 Upon lowering of the reaction temperature to 0 °C (Table 6, entry 11) at 15 mol% of ent-
37, the enantioselectivity increased to 95% ee, however, the diastereoselectivity in this case 
decreased to 5:1 d.r. Finally, the catalyst loadings were adjusted in an attempt to improve the 
diastereoselectivity of this domino reaction. A decrease of the catalyst loading of ent-37 to 5 
mol% (Table 6, entry 12) resulted in a slight decrease of enantioselectivity to 90%, with an 
increase of diastereoselectivity to 9:1 d.r. Attempting the domino reaction at 10 mol% catalyst 
loading of ent-37 provided the optimal balance of diastereo- and enantioselectivity (10:1 d.r., 
93% ee) with almost quantitive yields of 96% (Table 6, entry 13). With the best conditions of 
the Michael/Henry domino reaction obtained, we then proceeded to screen the scope of the 
domino reaction. 
2.3.6 Substrate scope of the Michael/Henry domino reaction 
 
 The domino reaction was very versatile and a wide range of substrates were successfully 
tested in the domino reaction. C3,C2-unsubstituted indoles including those bearing electron 
donating groups (Table 7, 227b, e, f, h, k, m) and electron withdrawing groups (Table 7, 
227c, d, g, i) were well tolerated in this methodology to give excellent enantioselectivities. 
The substitution pattern on the o-carbaldehyde nitroolefin 225a-c could be permutated to 
include a electron donating group such as OMe, as well as a electron withdrawing group such 
as F. In all the 13 examples screened, the cis-vicinal indane product 227a-m was obtained as 
the major diastereomer. Most of the cascade products obtained in this domino reaction (10 
examples) had yields exceeding 90%, with two examples (Table 7, 227e, m) reaching almost 
quantitative yields (>99% yield). 
 With regards to the diastereoselectivity, a slight reduction to 7:1-9:1 d.r. was observed 
when indoles bearing electron withdrawing groups were used in the domino reaction (Table 7, 
227c, d, g). One possible explanation is a background epimerization reaction that exist in this 
domino reaction, where the kinetic product 227 is epimerized to the minor diastereomer, 
which is the thermodynamic product 1-epi-227 (vide infra, section 2.3.7). Moreover, electron 
withdrawing indoles generally are less nucleophilic due to lower nucleophilicities in such 
substrates, hence explaining the longer reaction times observed in this domino reaction (Table 
7, 227c, d, g) . With longer reaction times, the cis-kinetic product 227 has a greater propensity 
to epimerize into the trans-thermodynamic product 1-epi-227. Nevertheless, all the kinetic 
cascade products were formed with excellent enantioselectivities of more than 90% ee. 
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Table 7. Scope of the kinetically controlled Michael-Henry domino reaction.[a,b]                         
 
 [a]
 Reactions were conducted on a 0.5 mmol scale of o-benzaldehyde nitroolefin 225a-c (1 
equiv.) and indole 226a-j (1.2 equiv.). [b] Relative and absolute configuration of the major 
diastereomer was determined by analogy to the X-ray crystal structure of derivative 227a. [c] 
Determined by 1H NMR. [d] Determined by HPLC analysis on a chiral stationary phase, 
values in parentheses indicate the ee of the minor diastereomer 1-epi-227a-m. [e] Yields of 
isolated 227a-m after flash column chromatography.  
 
 
227 R1 R2 time [h] d.r[c] ee[%] [d] Yield[%][e] 
a H H 17 10:1 93 (88) 96 
b 5-MeO H 16 9:1 91 (90) 94 
c 5-Cl H 43.5 7:1 92 (92) 61 
d 5-Br H 72 9:1 90 (81) 64 
e 5-Me H 17.5 10:1 90 (91) >99 
f 7-Me H 17 11:1 97 (95) 95 
g 5-F H 73 9:1 91 (87) 91 
h 6-Me H 18 11:1 91 (89) 98 
i 6-Cl H 63.5 11:1 90 (89) 90 
j - H 18 9:1 95 (93) 74 
k 7-Me Cl 16.5 17:1 91 (99) 90 
l H MeO 19.5 11:1 94 (89) 94 
m 5-Me MeO 18 11:1 93 (86) >99 
 2.3.7 Determination of the absolute configuration and the identity of the minor 
diastereomer 
 
 The absolute and relativ
unambiguously determined by X
was grown from a saturated CH
temperature. The identity of the sing
measuring a chiral HPLC on the measured X
major diastereomer. 
Figure 3. X-ray crystal structure of 
 To have a deeper understanding of the reaction mechanism of the domino reaction, a base 
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OH
N
93% ee
10:1 (cis:tran
227a
(kinetic pro
Scheme 51. Thermodynamic base catalyzed 
Results and Discussion
65 
e configuration of the kinetic cascade product
-ray crystallography of derivative 227a. The single crystal 
2Cl2 solution of 227a by slow evaporation at room 
le crystal as the major diastereomer was also ensured by 
-ray crystal to confirm it's identity as the kinetic 
227a, single crystal was grown from CH
227a was conducted to determine the identity of the 
NO2
H
s) d.r
(catalytic)
1:1 Xylene:CH2Cl2
6h, RT NO2
OH
NH
1-epi-227a
93% ee
6:1 (t rans:cis) d.r
(diastereomeric reversal)
>99%
duct) (thermodynamic produc
TMG
cis/trans epimerization of the kinetic product.
 
 was 
 
2Cl2.[106] 
t)
 
 
Results and Discussion 
66 
 
 In the presence of tetramethylguanidine (TMG) as a basic catalyst, the kinetic product 
227a undergoes a retro Henry/ Henry base catalyzed epimerization to yield quantitatively the 
thermodynamic product 1-epi-227a within six hours. The interesting observation from this 
epimerization experiment is the diastereomeric reversal from the cascade product (d.r. 10:1 
cis:trans) to the thermodynamic product (d.r 6:1 trans:cis) which was evident by comparing 
the integration ratios in 1H NMR spectroscopy. The thermodynamic product retains the 
enantioselectivity of 93% ee of the kinetic product, which further confirms the epimerization 
nature and not racemization of the product.  
 The trans-trans relative configuration of 1-epi-227a was determined by long range 2D 
NOESY contacts of this compound (Figure 3). It is crucial to understand that NOESY 
interpretation for five-membered rings such as indanes is different from commonly seen six-
membered rings such as cyclohexanes. In six-membered rings, NOESY contacts observed by 
coupling of vicinal protons (three bonds spacing) are often used accurately in the 
determination of relative configuration, however this is not the case for five-membered rings. 
In five-membered rings, NOESY contacts of vicinal protons can be observed even when the 
protons are positioned trans- relative to each other, since five-membered rings often show 
conformational flexibility equilibrating in a mixture of envelope and twist conformers.[107] 
Therefore, only 1,3-cis (four bonds spacing and above) and other long range NOESY 
couplings can be effectively used for interpretation of relative configuration. 
NO2
O
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1-epi-227a
H2
H4
H1
H3
1,3-cis
NOE
1,3-cis
NOE
 
Figure 3. Long range NOESY contacts to determine relative configuration of 1-epi-227a. 
 The 2D-NOESY experiment on 1-epi-227a revealed that a strong NOE contact was 
observed between H1 and H3 (Figure 3), proving that these two protons have a 1,3-cis-relative 
configuration to each other. Moreover, H4 on the hydroxyl group shows a clear NOE contact 
with H2, proving basis that H4 and H2 too have a 1,3-cis-relative configuration (Figure 3). 
 To further provide basis of the trans-relationship between the hydroxyl and the nitro 
groups on 1-epi-227a, we utilized a method initially reported by Quideau et. al. to compare 
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the 13C NMR values of the α-hydroxyl carbon (carbon directly adjacent to the -OH group) and 
the β-hydroxyl carbon  (carbon adjacent to the nitro group). [107a] The 13C NMR values of a 
trans-relationship would reflect a downfield shift comparatively to that having a cis-
relationship, with the β-hydroxyl carbon showing a more pronounced downfield shift in the 
13C NMR resonance. 
Table 8. Comparison of the α and β-hydroxyl effects on the 13C NMR. 
 
 
 
 
 
 The 13C NMR shifts of C1 (α-hydroxyl carbon) and C2 (β-hydroxyl carbon) of kinetic 
product 227a and thermodynamic product 1-epi-227a are summarized as above (Table 8). The 
differences in the 13C shifts between the α-hydroxyl carbons (4.0 ppm) and β-hydroxyl 
carbons (6.1 ppm) are consistent with that reported in literature for similar five-membered 
hydroxyl containing rings.[107a] Therefore, these 13C NMR experiments further confirm the 
accurate relative configuration assignment of derivative 227a as being the cis-vicinal product 
and 1-epi-227a as the trans-vicinal product. 
2.3.8 Further derivatization of the cis-nitroindanol cascade product  
 
 To demonstrate possible applications of the cis-nitroindanol cascade product as a chiral 
building block, 227a was first recrystallized in CH2Cl2 to obtain the enantio-enriched 227a 
with excellent diastereoselectivity (20:1 d.r.) and enantioselectivity (99% ee). 
 
13C Chemical 
Shift 
Kinetic Product 
227a 
Thermodyamic 
Product 1-epi-
227a 
Difference in 
Chemical Shift 
C1 (α-effect) 74.8 ppm 78.8 ppm 4.0 ppm 
C2 (β-effect) 94.1 ppm 100.2 ppm 6.1 ppm  
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Scheme 52. Transformation of the cascade product to the corresponding thioamide derivative. 
 The enantio-enriched 227a was then transformed to its corresponding amine by a nickel 
chloride catalyzed NaBH4 reduction. The crude amine product is then directly transformed to 
thioamide 229 by stirring with thioester 228 in CH2Cl2 at room temperature. This thioamide 
derivative 229 is obtained with moderate yield of 45% over two steps with preservation of 
diastereo- and enantioselectivity at 98% ee, >20:1 d.r.  Thioamide 229 could potentially be 
developed into a thioamide protonated catalyst similar to the Seidel's catalyst ent-37 with a 
novel chiral scaffold. 
2.3.9 Proposed mechanism of Michael/Henry domino reaction and epimerization 
 
 
Scheme 53. Proposed mechansim of the domino Michael/Henry reaction and epimerization. 
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 To explain the newly developed Michael/Henry domino reaction mechanistically, we 
propose an enantioselective H-bonding catalyzed mechanism by ent-37 in the first Michael 
addition step through transition state TS 230, which allows the C3 position of C3,C2-
unsubstituted indole 226a to attack the Si-face of the o-carbaldehyde nitroolefin 225a with 
excellent enantio-control (Scheme 53). After installation of this first stereogenic centre, ent-
37 further binds both the nitro and the carbaldehyde functionality in a cis-matched transition 
state TS 231. The term 'bi-functional kinetic control' was introduced by us in this publication 
to explain the effect of the H-bonding catalyst to position both nitro and the aldehyde group 
kinetically in the cis relative configuration, to impede the thermodynamic trans-vicinal 
configuration.[108] TS 231 ensures that the final intramolecular Henry cyclization reaction 
generates the kinetic cis-vicinal nitroindanol product 227a. 
 On the other hand, when the kinetic product 227a is subjected to a catalytic amount of 
TMG, TMG being a basic catalyst deprotonates the hydroxyl group to evoke a retro-Henry 
reaction which opens up the indane ring to form TS 232. The open conformation of TS 232 
without the presence any bi-functional catalyst would prefer the thermodynamically stable 
trans-positioning of the nitro and aldehyde moieties. When TS 232 finally undergoes ring 
closure via the Henry reaction, the thermodynamic trans-trans product 1-epi-227a is formed 
which still retains the enantioselectivity of the kinetic product 227a. The formation of 1-epi-
227a is also consistent with literature precendences (vide supra, Scheme 48),[104, 109] where the 
trans-trans product is formed as the major diastereomer under basic conditions. 
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2.4 Asymmetric domino synthesis of indanes bearing four contiguous 
stereogenic centres by sub-mol% loadings of a squaramide in minutes 
 
 Building upon the indole Michael addition/Henry domino reaction that was developed in 
section 2.3 that generates cis-vicinal indanes bearing three contiguous centres 
enantioselectively via bi-functional kinetic control, the final project of this PhD seeks to 
challenge the frontiers of currently known organocatalytic domino reactions by generating 
complex molecular structures rapidly with low catalyst loadings. 
2.4.1 Literature precedences in Michael additions of Boc-oxindoles 
 
 While the utility of C3, C2-unsubstituted indoles as a nucleophilic trigger for an 
organocatalytic domino reaction was demonstrated in the last project, we were interested in 
exploring oxindoles in organocatalytic domino reactions,[110] since there is a surge in the 
usage of oxindole substrates in the literature as well as in our research group recently in 
organocatalytic methodogies. 
 
Scheme 54. Pioneering publications of organocatalyzed Michael additions of oxindoles.  
 One of the organocatalytic pioneering publication in this area was by Barbas et al. in 
2009, where a thiourea 235 was utilized to catalyze the enantioselective Michael addition of 
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N-Boc-protected oxindole 233 on nitroolefins 234 to generate two contiguous stereogenic 
centres with one quartenary centre in the Michael adduct 236 (Scheme 54, eqn 1).[111] The 
enantioselectivities of the Michael product was generally from very good to excellent. 
Another independent report was made by Maruoka et al. in the same year,[112] where they 
demonstrated that axial chiral phase transfer catalyst 237 can be used effectively to catalyze 
this Michael addition of N-Boc-oxindoles to generate the Michael adduct 236 with low to 
excellent enantioselectivities depending on the substitution pattern of the substrates. 
 Our workgroup then capitalized on this concept, where former co-worker Dr. Chuan 
Wang demonstrated in 2012 that TMS-protected dialkylprolinol 237 can function as a 
Brønsted base catalyst to trigger the Michael addition of oxindole 233 on nitroolefins to 
generate the enantiomer of the Michael adduct ent-236 (Scheme 55, eqn 1),[113] compared to 
previous reports by Barbas et al. and Maruoka et al.[111-112] A limitation of this methodology is 
the low temperature (−60°C) that is required to achieve excellent enantioselectivities of 
product ent-236. 
 
Scheme 55. Previous work on nucleophilic oxindoles by our group. 
 In a separate publication by Dr. Chuan Wang from our group (Scheme 55, eqn 2), a bi-
functional squaramide catalyst 239 was found to be an excellent catalyst to effect the first 
organocatalytic asymmetric sulfenylation of N-Boc-oxindoles to generate the sulfenylated 
oxindoles 240 with up to excellent enantioselectivities.[114] An interesting aspect of this 
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methodology was that squaramide catalyst 239 can be utilized at lower catalyst loadings and 
usually results in faster reaction rates and products with higher enantioselectivities 
comparatively to their thiourea counterparts. This postulate was further confirmed by another 
very recent publication by Xiao et al., where squaramide 243 can be used at extremely low 
catalyst loadings (1 mol%) to generate complex spirocyclic structures 244 enantioselectively 
bearing three contiguous stereogenic centres at fast reaction rates of 5 minutes to 3 hours 
(Scheme 56).[115] 
 
Scheme 56. Squaramide catalyzed rapid domino reactions by Xiao et al.  
2.4.2 Designing an 'ideal' domino reaction 
 
 A review of most organocatalytic domino reactions that are encountered in literature 
nowadays revealed that these required rather high catalyst loadings of between 5-20 mol%,[26a, 
26b, 26d]
 and very often stereogenic centres are lost due to elimination reactions such as aldol 
condensations. Moreover, many of these methodologies require reaction times longer than one 
day and low temperature control are often required to ensure an excellent enantioselectivity. 
 With these limitations, it was our objective to design a domino reaction that fulfills the 
following four critera: 
• Useful molecular frameworks should be accessed with sub-mol% of organocatalysts 
that rivals transition metal catalysis. 
• Maximum stereogenic centres should be generated per bond formation (the theoretical 
maximum should be two stereocentres per C-C bond formation). 
• Short reaction times. 
• Ambient reaction conditions without temperature control. 
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 With the above targets in mind, this project was then conducted in cooperation with my 
fellow PhD colleague Daniel Hack where he synthesized one of the nitroolefin substrate 225d 
and two examples in the reaction scope 246k and l.  
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Scheme 57. Comparing efficiency of Michael/Henry domino reactions  
 Referring to Scheme 57 (eqn 1), the previous Michael/Henry domino reaction project 
consisted of the use of indole 226 which is nucleophilic of the C3 position. This nucleophilic 
centre is sp2 hybridized (Scheme 57, bold circle). The resulting kinetically controlled domino 
reaction creates three contiguous stereogenic centres in the cis-vicinal nitroindanol product 
227. A simple calculation revealed that a total of three stereogenic centres and two C-C bonds 
were formed in this reaction, yielding a theoretical 1.5 stereogenic centres per bond formation. 
 Conversely, the rise in the utility of nucleophilic N-Boc-oxindoles (vide supra, Section 
2.4.1) provided us a platform to design a domino reaction (Scheme 57, eqn 2), where 
oxindole 245 is nucleophilic at the C3 position. This nucleophilic carbon is now sp3 
hybridized (Scheme 57, hollow circle). The nucleophilic attack of oxindole 245 on an o-
carbaldehyde nitroolefin 225 would then generate four stereogenic centres and two C-C bond 
formation in cascade product 246. This in turn translates into a theoretical of 2 stereogenic 
centres per bond formation in this Michael/Henry domino reaction. The synthesis of one of 
the o-carbaldehyde nitroolefin substrate 225d was conducted by Daniel Hack and his results 
are presented in Scheme 58.   
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Scheme 58. Synthesis of substrate 225d by Daniel Hack. 
 The synthesis of the o-acetaldehyde was executed using literature known procedures from 
the commercially available fluorinated o-bromobenzaldehyde 224d.[105] The deprotection of 
the acetal 224d using 2N HCL resulted in the desired substrate 225d with a yield of 64% 
(analog to procedure in scheme 50). The substrate 225d could be easily precipitated from the 
reaction mixture by the addition of distilled water, subsequent washing with pentane and 
drying over high vacuum yields the pure product without further purification. 
2.4.3 Methodology testing and optimization of conditions 
 
 The initial intention was to use the TMS-protected dialkylprolinol 237 (Scheme 55, eqn 1) 
as the organocatalyst in a Brønsted base catalyzed Michael/Henry reaction as a domino 
extension of the Michael addition methodology previously developed by Dr. Chuan Wang in 
our workgroup.[113] This initial test reaction between oxindole 245a and o-carbaldehyde 
nitroolefin 225a (Table 9, entry 1) yielded the desired polyfunctionalized indane product 246 
with high yields and moderate enantioselectivities of 44% ee. Encouraged by this initial result, 
a lowering of the reaction temperature to −25 °C, keeping other parameters constant was 
attempted (Table 9, entry 2). Although the lower temperature improved the yields to almost 
quantitative, the enantioselectivity only showed a modest increase to 59% ee.  
 Building upon these results, we then proceeded to screen a series of different catalysts to 
determine the optimal organocatalyst for the domino reaction. Commonly utilized proline 
derived catalysts 75 and 17 were tested in this reaction, however this switch from alkyl to aryl 
substitution on the catalyst resulted in a decrease of enantioselectivities to −17% ee and 27% 
ee respectively (Table 9, entry 3 and 4). In addition, the quinine derived primary amine 
catalyst 248 was also tested in this methodology (Table 9, entry 5). While enantioselectivity 
showed in this case a marked increase to 80% ee, the diastereoselectivity was reduced to 8:1 
d.r. Moreover, the yields were also relatively lower at 32% using catalyst 248. 
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Table 9. Optimization of the reaction conditions.[a,b]                         
 
[a] Conducted on a 0.1 mmol scale of 245a (1 equiv.) and 0.12 mmol scale of 225a (1.2 
equiv.). [b] The relative and absolute configuration of 3a was assigned by analogy to 2D 
NOESY of 246a, b and comparing with literature data. [c] Yields of isolated 246a after flash 
column chromatography. [d] Determined by 1H NMR. [e] Determined by HPLC analysis on a 
chiral stationary phase. [f] This reaction was conducted at −25 °C. [g] Reactions were 
conducted on a 0.5 mmol scale of 245a (1 equiv.) and 0.6 mmol scale of 225a (1.2 equiv.). [h] 
Reaction was conducted on a 0.55 mmol scale of 245a (1.1 equiv.) and 0.5 mmol scale of 
225a (1 equiv.).  
Entry Cat. t 
(h/min) 
Cat. Loading 
(mol%) 
Yield 
(%)[c] 
d.r[d] ee 
(%)[e] 
1 237 18 h 10 77 >20:1     44 
2[f] 237 18 h 10 99 >20:1 59 
3 75 23 h 10 97 >20:1 −17 
4 17 2 h 10 78 >20:1 27 
5 248 16.5 h 10 32 8:1 80 
6 152 16.5 h 20 66 7:1 −91 
7 239 2.5 h 10 98 >20:1 −93 
8 198 1.5 h 10 99 >20:1 95 
9 198 15 min 5 96 20:1 91 
10[g] 198 40 min 1 68 >20:1 90 
11[g] 198 45 min 0.5 81 >20:1 91 
12[h] 198 45 min 0.5 93 >20:1 93 
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 Recognizing the fact that simply Brønsted base activation by deprotonating oxindole 245 
might not be sufficient enough to realize excellent enantioselectivities in this cascade reaction, 
we then turned our attention to hydrogen-bonding bi-functional catalysts that contain 
Brønsted basic moieties. This might help to rigidify both the oxindole substrate 245 and the 
nitroolefin substrate 225a in a transition state with multiple H-bonding network to the catalyst. 
 Our hypothesis was confirmed when the Takemoto thiourea catalyst 152 was tested 
(Table 9, entry 6). In this case, the cascade product was generated with moderate yield of 
66%, moderate d.r. of 7:1 and excellent enantioselectivity of −91% ee. Subsequently, 
squaramide catalyst 239 bearing the same chiral scaffold of 152 was attempted (Table 9, 
entry 7). To our delight, the squaramide catalyst gave an almost quantitative yield of the 
cascade product within 2.5 hours, with excellent enantioselectivity −93% ee and excellent 
diastereoselectivity >20:1. Furthermore, the usage of quinine derived squaramide 198 yielded 
the cascade product within 1.5 hours with a slight improvement in enantioselectivity to 95% 
ee, excellent d.r. of  >20:1 and almost quantitative yield (Table 9, entry 8). It is noteworthy to 
emphasize that catalyst 198 generates product 246 which is the enantiomer of the cascade 
product ent-246 generated by catalyst 239, and this was used as our basis of comparison of 
the chiral HPLC data in the subsequent reaction scope.  
 Keeping our aim of developing a domino reaction with sub-mol% catalyst loading, the 
catalyst loading of 198 was then reduced. By reducing the catalyst loading to 5 mol% (Table 9, 
entry 9), the cascade product was formed within 15 minutes almost quantitatively (96%), with 
excellent diastereo- and enantioselectivity (>20:1 d.r., 91% ee). Interestingly, a further 
reduction of the catalyst loading to sub-mol% (Table 9, entry 10 and 11) required an elevated 
reaction time of 40-45 min, with excellent diastereo- and enantioselectivites achieved. Finally, 
the stoichiometric ratios of reactants 225a and 245a were adjusted (Table 9, entry 12), and 
the optimal condition was obtained at simply 0.5 mol% of catalyst 198 at room temperature 
within 45 min. In this instance (Table 9, entry 12), the domino reaction provided excellent 
yields of 93%, and excellent diastereo- and enantioselectivities (>20:1 d.r., 93% ee) of the 
cascade product 246. 
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2.4.4 Substrate scope of the Michael/Henry domino reaction catalyzed by sub-mol% 
of squaramide 
 
 With the optimized conditions now achieved, we then proceeded to screen the substrate 
scope of this efficient Michael/Henry domino reaction. 
Table 10. Substrate scope of the Michael/Henry domino reaction.[a,b]                        
 
 
 
 
 
 
 
[a] The reaction was conducted on a 0.55 mmol scale of 245a-n (1.1 equiv.) and 0.5 mmol 
scale of 225a-d (1 equiv.). [b] The relative and absolute configuration of 246a-l was assigned 
by analogy to 2D NOESY of 246a,b and comparison with literature data. [c] Determined by 
HPLC analysis on a chiral stationary phase. [d] Yields of isolated 246a-n after flash column 
chromatography. [e] Conducted with 1 mol% of catalyst 198 for 20 min. [f] 3 equiv. oxindole 
246m was used, reaction time was extended to 220 min. [g] 3 equiv. oxindole 246n was used, 
d.r was 12:1 in this case. 
246 R1 R2 R3 ee(%)[c] Yield[%][d] 
a Me Ph H 93 93 
b Me Ph Cl 90 89 
c Me Ph MeO 90 95 
d Me Ph F 90 83 
e H Ph H 90 86 
f H Ph Cl 90 92 
g H Ph MeO 90 92 
h H Ph F 89 87 
i Me p-Ph-Ph H 98 87 
       j[e] Me p-Ph-Ph Cl 99 83 
k Me p-Ph-Ph MeO 89 92 
l Me p-Ph-Ph F 91 90 
m H Me Cl 39 39 
n H H Cl 73 44 
o H 2-thiophenyl Cl - - 
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O
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 Upon the screening of various substrates in this methodology, we found out that this 
domino protocol was exteremly efficient and tolerant for a wide range of functional groups. 
This included substrates bearing electron donating groups such as 246c, g and k, as well as 
substrates containing electron withdrawing groups such as 246b, d, f, h, j and l. For the entire 
reaction scope in table 10, the enantioselectivities of the cascade products 246a-l were 
excellent from 89-99% ee. The diastereoselectivities were all > 20:1 d.r. and the yields ranged 
from 83-92% which reflects the overall excellent efficiency of this protocol. 
 In 246j, the methodology required an increase of the catalyst loading to 1 mol% to 
achieve the excellent enantioselectivity (99% ee) reported. However, we also noticed that the 
reaction was finished within 20 minutes at room temperature, requiring only less than half the 
reaction time comparatively to other examples.  
 One limitation of this methodology is that R2 required a phenyl or phenyl derivative 
substitutent. When a methyl substitutent (Table 10, 246m) or a hydrogen substitutent (Table 
10, 246n) were tested, yields and enantioselectivity became inferior. Decomposition was 
observed in the reaction and workup when a thiophene substituent was used in R2 (Table 10, 
246o) and the cascade product could not be isolated. One explanation is that the presence of a 
phenyl group on R2 is crucial in this methodology to stabilize the carbanion formed at C3 of 
the oxindole. 
2.4.5 Determination of the relative and absolute configuration of the cascade 
product 
 
 While much effort was devoted towards obtaining X-ray quality crystals for relative and 
absolute configuration assignment of 246, no suitable crystals could be obtained for a wide 
range of derivatives, solvents and crystallization techniques attempted. Therefore, we then 
utilized long range 2D NOESY contacts to aid us in determining the relative configuration of 
derivatives 246a and 246b (Figure 4).  
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Figure 4. Long range NOESY contacts to determine relative configuration of 246a,b 
 Derivatives 246a and 246b were chosen for the 2D NOESY experiment because both 
compounds have a distinctive 1H NMR aromatic singlet for proton H4 (red, 1H NMR: δ = 6.90 
ppm) which allows us to use an unambiguous long range reference point for our NOESY 
assignment. Moreover, the important protons H1, H2 and H3 are all well and clearly separated 
in the 1H NMR spectra of these two derivatives, allowing better resolution of the 2D NOESY 
spectra. 
 The important long range NOESY contacts for our structural elucidations are all marked 
out in figure 4. For both derivatives, we detected consistently three important reference points. 
These include the following resonances: 1) H4 and H1 has a NOESY contact, 2) H4 and H2 
has a NOESY contact and 3) H4 and H3 has a NOESY contact. Since all three protons H1, H2 
and H3 lie at equal or more than five covalent bonds away from H4, their relative cis 
relationship could be accurately determined by long range NOESY contacts (vide supra, five 
membered rings relative configuration previously discussed in section 2.3.7). 
 Given our previous experience in accessing indole containing cis-nitroindanol products 
(vide supra, Section 2.3), we took a further step to confirm the accuracy of the stuctural 
elucidation by comparing the α and β hydroxyl effects on the 13C NMR resonances with 
known literature values (Table 11). This provide us another line of evidence that the 
aminoindanol cascade products 246 are indeed cis-positioned. 
 
 
 
 
Results and Discussion 
80 
 
Table 11. Comparison of α and β hydroxyl effects on the 13C NMR shift 
 
13C NMR shift C1 C2 
Compound 246a 75.7 ppm 91.9 ppm 
Compound 246b 75.2 ppm 91.9 ppm 
Compound 227 74.8 ppm 94.1 ppm 
 
 In Table 11, the important carbon numberings of the indane ring are provided. In this 
instance, the C1 and C2 resonances are crucial since those corresponding to cascade products 
246a and 246b can be compared to 227a, where the X-ray crystal structure was 
unambiguously determined (Section 2.3.7, Figure 3). As seen in the table above, C1 and C2 
of derivative 246a and 246b matches closely with the corresponding 13C NMR resonances of 
the cis-kinetic product 227a, thus proving that the nitro and the hydroxyl groups in cascade 
product 246 are indeed cis-positioned. 
 With the relative configuration confirmed, the absolute configuration on C3 and C4 could 
be determined by assuming a similar reaction pathway of this Michael/Henry domino reaction 
with literature known Michael additions of N-Boc-oxindole that was previously published by 
Dr. Chuan Wang from our workgroup (Scheme 55, eqn 1).[113] During our catalyst screening 
(Table 9, entry 1 and 2), the relative topicity is the same utilizing catalyst 237 (the same 
catalyst employed by Dr. Chuan Wang in Scheme 55, eqn 1) and catalyst 198 in our protocol. 
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2.4.6 Large scale protocol and further derivatization  
 
Scheme 59. Gram scale synthesis of cascade product 246g and further transformation. 
 Given the high efficiency of this protocol that meets all the four criteria previously laid 
out at the onset of this project (vide supra, section 2.4.2), a gram scale synthesis of the 
cascade product 246g was carried out (Scheme 59). To our delight, the gram scale reaction 
proceeded faster within 15 minutes with reproducible results in both yields and 
enantioselectivities (91% yield, 89% ee) compared to the reaction scope (Table 10, 246g). 
However, we noticed a slight decrease in diastereoselectivity (17:1 d.r.) in this case. This 
lower d.r. was overcomed by simply triturating 246g in diethylether overnight, which raises 
the d.r. to >20:1. 
 To demonstrate further possible transformation of cascade product 246g, a facile Boc-
deprotection was carried out by stirring 246g with TFA at room temperature. This 
deprotection procedure was very facile and almost quantitative amount of product 247 could 
be obtained after 2 hours, with retention of ee and d.r. (88% ee, >20:1 d.r.).  
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2.4.7 Proposed mechanism of the Michael/Henry domino reaction  
 
Scheme 60. Proposed mechanism of the Michael/Henry domino reaction. 
 The proposed mechanism for this efficient Michae/Henry domino reaction is provided in 
scheme 60. The squaramide catalyst 198 first interacts with oxindole 245 and o-carbaldehyde 
nitroolefin 225a-n through multiple hydrogen bonding interactions, which results in the 
rigidified transition state TS 248. TS 248 controls the relative topicity of this reaction, where 
a Si-Re attack of the oxindole 245 and 225a-n generates two stereogenic centre in the first 
Michael addition step. 
 In the second domino step, the proposed mechanism involved catalyst 198 hydrogen 
bonding both the nitro and the aldehyde group of the Michael adduct in a cis-oriented 
transition state TS 249 via bi-functional kinetic control (explained and introduced in section 
2.3.9). The subsequent Henry reaction then generates the cascade product 246a-n with the 
nitroindanol functionalities positioned cis relative to each other. This releases the H-bonding 
catalyst 198 which then re-enters the catalytic cycle.  
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3. Research Summary and Conclusion 
 
 In the time frame of this PhD thesis, a total of four different synthetic methodologies 
ranging from multicatalytic systems, sequential reactions to organocatalytic domino reactions 
were developed and the results were also published in peer reviewed journals. The main 
conclusions of these projects will be briefly summarized in the following sections: 
3.1 Merging organocatalysis and Au(I) catalysis in a one-pot sequential 
protocol 
 
Scheme 61. Merging organocatalysis and Au(I) catalysis in a double Friedel-Crafts type 
reaction 
 The first project involved the development of a binary catalytic system which combines 
the complementary advantages of hydrogen bonding catalysis and Au(I) catalysis (Scheme 
61). Utilizing such a binary catalytic system was a relatively new concept at the onset of this 
PhD thesis in 2010 and have grown to a relatively mature field currently. In this protocol, the 
synergistic enamine and iminium type properties of the indole heterocycle were exploited. 
Hence the first organocatalytic step allowed installation of stereogenic information into the 
Michael adduct based on the nucleophilic C3 enamine type reactivity of indole. 
 The second sequential step required the addition of Ph3PAuNTf2 catalyst. It was essential 
that a pTSA Brønsted acid additive was added to prevent the poisoning of the Au(I) catalyst. 
31P NMR experiments were also conducted to study the Au(I) deactivation effect by the 
organocatalyst. Interestingly, the Au(I) catalyzed step resulted in a 7-endo-dig cyclization 
mode to form derivative 154, a phenomenon which we attributed to the initial formation of a 
spirocyclic intermediate, followed by a ring expansion and finally protodeauration. The 
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resulting absolute configuration of the seven-ring constitution was determined unambiguously 
by single crystal X-ray crystallography.  The yields of this methodology ranged from 
moderate to excellent, and the enantioselectivities were all above 95% ee. 
3.2 Merging organocatalysis and Ag(I) additives in a sequential 
Michael/Ciamician Plancher rearrangement sequence. 
 
Scheme 62. Merging organocatalysis and Ag(I) additives to synthesize tetrahydrocarbazoles. 
 In the second project, we realized by the proper design of a corresponding iodo-
nitroalkene 192, we are able to easily access a pharmaceutically useful scaffold, 
tetrahydrocarbazoles 196 enantioselectively by a one-pot Michael/Ciamician-Plancher 
sequence.  
 The first sequential step involved the hydrogen bonding catalyzed Friedel-Crafts type 
Michael addition of C3,C2-unsubstituted indole 195 on the iodo-nitroalkene 192 to generate a 
C3-iodo-tethered Michael adduct. Subjecting this Michael adduct to a second sequential 
addition of stoichiometric amounts of AgSbF6 provides access to a widely forgotten reaction, 
the Ciamician-Plancher rearrangement. We postulate that this rearrangement, which normally 
occurs under harsh conditions, is thermodynamically driven by the precipitation of the 
thermodynamically stable AgI salt which is observable in the reaction tube, which then 
resulted in the formation of 196 enantioselectively.  
 Moreover, the 5-OMe derivative 196b can then be easily converted within three synthetic 
steps, without any intermediate chromatographic purification to a highly potent 5-HT6 
antagonist (R)-169, which is a conformationally constrained analog of MS-245, with 
preservation of enantioselectivity. This project also documents the first enantioselective 
access of such bioactive analogs.  
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3.3 Enantioselective kinetic access of cis-vicinal indanes through a H-
bonding catalyzed Michael/Henry domino reaction 
 
Scheme 63. Organocatalytic Michael/Henry domino reaction via bi-functional kinetic control. 
 The third project marks the start of the second phase of my PhD, where the focus was 
shifted towards developing novel methodologies for organocatalytic domino reactions using 
hydrogen bonding catalysis (Scheme 63).  
 Interestingly, C3, C2-unsubstituted indoles proved to be a valuable substrate in this case. 
A skillful utilization of a bi-acceptor substrate such as o-carbaldehyde nitroolefin 225, which 
was never utilized as a domino reaction substrate in the literature before this project, provided 
an unprecedented access into rarely encountered cis-vicinal indanes such as 227. The 
successful execution of this strategy required a kinetically controlled mechanism, since most 
of the literature known cascade reactions resulted in the thermodynamic trans-vicinal  indane. 
 Our proposal of this mechanism involved a matched transition state where the hydrogen 
bonding catalyst ent-37 binds both the nitro- and the aldehyde moieties in the cis-position, 
helping to impede the trans-orientation if the reaction proceeded purely thermodynamically. 
The yields of the cascade product 227 were generally from good to quantitative and a X-ray 
structure also confirms the absolute and relative configuration of this kinetic product. 
 We also demonstrated that this cis-kinetic product can be epimerized at the hydroxyl-
carbon to the trans-thermodynamic product quantitatively, simply by stirring the cascade 
product in a catalytic amount of a strong base (TMG). No racemization was observed 
however in the epimerization reaction. 
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3.4 Asymmetric domino access of indanes bearing four contiguous 
stereocentres catalyzed by sub-mol% of a squaramide 
 
 
Scheme 64. Asymmetric Michael/Henry domino reactions by sub-mol% catalyst loading in 
minutes. 
 In the fourth and final project, we extended the concept of bifunctional kinetic control by 
designing a N-Boc-oxindole 245 triggered Michael/Henry domino reaction that generates cis-
vicinal nitroindanols 246 bearing four stereogenic centres with only 0.5 mol% catalyst loading 
of squaramide 198.  
 The interesting aspect of this domino reaction is that it has high conservation of 
stereogenic information, where a maximum of two stereogenic centres per bond formation can 
be effected successfully with this protocol. Moreover, the reaction rate of this methodology is 
very fast and most examples were completed within 45 minutes, furnishing product 246 in 
very good to excellent yields, very good to excellent enantioselectivities and almost perfect 
diastereoselectivities (>20:1 d.r.) for the cis-kinetic product 246. One limitation of this 
methodology is that the substituent R2 of oxindole 245 is crucial, and our experiments 
confirmed the fact that other substituents such as H or alkyl groups destabilizes the resulting 
carbanion formed and hence lower yields and ees are observed. A gram scale reaction was 
attempted for this protocol and the results were reproducible in the gram scale as compared to 
the 0.5 mmol scale within the reaction scope. 
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4. Future directions and perspectives 
 
 While this PhD thesis yielded interesting insights into different aspects of organocatalysis, 
I strongly believe that the projects presented herein opened up many new possibilities into 
other novel and new methodologies that are yet to be discovered. One possible extension of 
this PhD project will be the exploration of the pyrrole heterocycle, which is one of the focus 
of my successor Daniel Hack in the merging of organocatalysis and Au(I) catalysis.  
 
Scheme 65. Possible combinations of organocatalysis and Au(I) catalysis. 
 It is noteworthy that pyrrole has a similar π-excessive heterocycle similar to indole, 
which confers it's nucleophilicity on the C2 position by a dienamine type mechanism. The C2 
nucleophilicity could possibly provide access towards novel architectures unseen in indole 
chemistry. One possible extension of the multicatalysis project is summarized schematically 
in Scheme 65, where a sequential binary catalytic system allow access into annulated pyrroles 
251 or 252, which is difficult to predict. In this case, Au(I) catalysis might either provide an 
interesting access via a 7-endo-dig cyclization mode into seven membered ring containing 
fused pyrrole derivatives similar to the first project in this thesis, or alternatively access the 6-
exo-dig cyclization to form 252. The author believes that fine tuning the sterics of the 
phosphine ligand attached to the Au(I) catalysis might be pivotal in such an endeavor to 
provide regioselectivity.  
 
 Scheme 66. Possible aza or sulfa Michael/ Henry domino reactions. 
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 Another possible extension of this PhD thesis could be choosing an alternative 
nucleophilic trigger in the Michael/Henry domino reaction demonstrated in projects 3 and 4. 
It might be possible to either utilize thiols or amines to trigger an aza or sulfa Michael/Henry 
domino reaction on o-carbaldehyde nitroolefin 225 to generate other types of indanes 253 or 
254, which might possess a different relative configuration depending whether kinetic control 
or thermodynamic control is part of the mechanistic pathway. The author believes in this case 
that chiral Brønsted base catalysis might be a potential area to explore since the 
thermodynamic all trans-indane products 253 or 254 might be generated in this fashion. 
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5. Experimental Part 
 
General Information on the Preparative Work 
General Information 
All reactions were performed in oven-dried glassware. All moisture sensitive reactions were 
carried out using standard Schlenk techniques and under argon unless stated otherwise. All 
reactions were conducted using PTFE-coated magnetic stirrers. 
All solvents were distilled, purified and dried according to standard procedures prior to use. 
Absolute THF and Et2O were distilled over sodium-lead (Sovona) alloy/benzophenone under 
argon. Absolute CH2Cl2 were purchased directly from Acros. Absolute methanol was distilled 
over calcium chloride under argon. Absolute DMF was purchased from Acros. 3Å powdered 
molecular sieves were purchased from Acros and preactivated at 220 °C overnight under high 
vacuum and stored in a Schlenk flask before use. 
Reaction Control 
Analytical TLC were performed using SIL G-25 UV254 from MACHERY NAGEL and 
visualized either with ultraviolet radiation at 254 nm or through staining with potassium 
permanganate or vanillin solution, following by heating with a heat gun.  
Flash Column Chromatography 
Glass columns with varying diameters and lengths with or without fritted discs were used for 
different purifications. Generally, a low air over-pressure of maximum 0.5 bars was used to 
push the eluting solvent. Flash column chromatographies were performed using silica gel 60 
(particle size range 0.040-0.063 mm) from Merck-Schuchardt as the stationary phase. After 
isolation and purification of the product, the combined fractions were concentrated using a 
rotary evaporator under reduced pressure. 
Storage of the synthesized compounds 
Depending on the nature of the synthesized compounds, they were stored at room temperature, 
in a refrigerator at 0 °C or in a freezer at −24 °C in a sealed glass container or round bottom 
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flask. Air sensitive compounds were normally purged with argon and stored in a Schlenk flask 
at −24 °C in a freezer.  
Commercially available reagents 
Starting materials and reagents were purchased directly from commercial suppliers (Acros, 
Sigma Aldrich, TCI Europe, ABCR, Fluorochem, Apollo Chemicals, Carbolution, Strem and 
Alfa Aesar) and used without further purifications unless otherwise stated. n-BuLi (1.6 M in 
hexanes) were purchased from ACROS Organics and used from freshly opened bottles. All 
other reagents used were available in the laboratories of the workgroup. 
General Information on the Analytical Methods 
Yields 
The yields were calculated based on the analytical mass of the isolated, vacuum dried purified 
products after flash column chromatography. 
Analytical HPLC 
Apparatus: Hewlett-Packard 1050 Series or Agilent 1100 instrument either with achiral or 
chiral stationary phases. 
Column (achiral):  LiChrosorb Si 60 (7 µm) (250 mm x 4.6 mm) 
 Kromasil 100 Sil (5 µm) (150 mm x 4 mm) 
Column (chiral): Chiralpak AS (10 µm) (250 mm x 4.6 mm) 
 Chiralpak OD (10 µm) (250 mm x 4.6 mm) 
 Chiralpak AD (10 µm) (250 mm x 4.6 mm) 
 Chiralpak IA (5 µm) (250 mm x 4.6 mm) 
 Chiralpak OJ (10 µm) (250 mm x 4.6 mm) 
 Chiralpak IC (5 µm) (150  mm x 4.6 mm) 
 Merck (S, S)-Whelk O1 (5 µm) (250 mm x 4 mm) 
Preparative HPLC 
Apparatus: Gilson Abimed with UV/ IR detector. 
Column (achiral): LiChrosorb Si 60 (7µm) (250 x 25 mm). 
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Melting points 
Apparatus: Tottoli-melting point apparatus Büchi 540 
Melting points were determined in an opened capillary tube. 
Polarimetry (Optical Rotation) 
Apparatus: Perkin-Elmer P241 
Sample concentrations are reported in g/dL. 
NMR spectroscopy 
1H NMR Spectroscopy 
Apparatus: Varian Gemini 300 (300 MHz), Mercury 300 (300 MHz), Varian Inova 400 (400 
MHz), Varian Innova 600 (600 MHz). 
13C NMR Spectroscopy 
Apparatus: Varian Gemini 300 (75 MHz), Mercury 300 (75 MHz), Varian Inova 400 (101 
MHz), Varian Innova 600 (151 MHz). 
19F NMR Spectroscopy 
Apparatus: Varian Inova 400 (376 MHz), Varian Innova 600 (564 MHz). 
31P NMR Spectroscopy 
Apparatus: Varian Gemini 300 (121 MHz), Mercury 300 (121 MHz). 
Spectrums were acquired at ambient temperatures for all cases with tetramethylsilane as the 
internal standard. The chemical shifts for 1H NMR, 13C NMR, 19F NMR and 31P NMR are 
reported in parts per million (ppm), with coupling constants reported in Hertz (Hz). The 
following abbreviations are used for spin multiplicity: s = singlet, d = doublet, t = triplet, q = 
quartet, m = multiplet.  
Mass Spectrometry  
Apparatus: Finnigen SSQ7000 (Standard conditions: EI, 70 eV; CI, 100 eV) for low 
resolution mass spectrometry measurements. ThermoFisher Scientific LTQ-Orbitrap XL (ESI/ 
HRMS ESI) for low and high resolution ESI measurements.  
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Results are reported by presenting the mass of the fragments (m/z) as a proportion of intensity 
compared to the base peak (100%) in percentage. Only signals presenting a high intensity 
(>10%) or characteristic signals (generally M+, [M+Na] + or [M+K] +) are reported. 
IR Spectroscopy  
Apparatus: Perkin-Elmer FT-IR Spectrum 100 with Diamant/KRS5 ATR-unit.  
Sample infrared absorption bands are reported in cm-1. Signals with transmissions greater than 
90% were not reported.  
Elemental Analysis 
Apparatus: Vario EL Element Analyser. 
A sample was determined to be authentic when each of the ∆C, ∆H and ∆N value shows a 
deviation of less than 0.5% of the theoretically calculated value. 
General Procedures (GP) 
GP1 Asymmetric Synthesis of tetracyclic indole derivatives through a sequential organo-/ 
Au(I) catalyzed double Friedel-Crafts type reaction 
 
To a Schlenk tube containing a solution of Seidel's precatalyst ent-37' (0.08 mmol, 0.1 equiv.) 
in chloroform (4 mL) was added trifluomethanesulfonic acid (0.08 mmol, 0.1 equiv., 7.1 µL). 
The bright reddish-orange solution was stirred for 5 min. NaBArF24[116] (71 mg, 0.08 mmol, 
0.1 equiv.) was added into the reaction mixture and allowed to stir for 10 min until a light 
orange solution is observed. The corresponding ortho-alkynyl substituted nitrostyrene 147a-c 
(0.8 mmol, 1 equiv.) was dissolved in chloroform (4 mL) and added into the reaction mixture. 
This reaction mixture was then cooled to −30°C. The corresponding indole 148a-d (1.2 mmol, 
1.5 equiv.) was dissolved in chloroform (2 mL) and transferred into the cooled reaction 
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mixture. The reaction was monitored by TLC until full conversion of the first tandem step 
was observed (between 1 to 2 days). 
The reaction mixture was then allowed to warm to RT over 30 min, p-toluenesulfonic acid 
hydrate (0.6 mmol, 0.75 equiv.) was first added and allowed to stir for a further 5 min. 
PPh3AuNTf2 (0.08 mmol, 0.1 equiv., usually preactivated by reacting 0.08 mmol of PPh3AuCl 
and 0.08 mmol of AgNTf2 in 1 mL chloroform in a separate vial or using commercially 
available PPh3AuNTf2 directly) was transferred to the reaction mixture. The Schlenk tube was 
subsequently sealed under air and transferred to a 80°C oil bath and allowed to stir at this 
refluxing temperature till no further changes are observed on TLC.  Silica gel was added to 
the reaction mixture, rotary evaporated and dry loaded onto a flash column for purification.  
GP2 Asymmetric Synthesis of tetrahydrocarbazoles through an organo-catalyzed Friedel-
Crafts type Michael/ Ag(I) mediated Ciamician-Plancher rearrangement sequence 
 
 
To a Schlenk tube  containing a solution of Seidel's precatalyst ent-37' (0.06 mmol, 0.1 equiv.) 
in chlorobenzene (3 mL) was added trifluomethanesulfonic acid (0.06 mmol, 0.1 equiv., 5.4 
µL). The bright reddish-orange solution was stirred for 5 min. NaBArF24[116] (53 mg, 0.06 
mmol, 0.1 equiv.) was added into the reaction mixture and allowed to stir for 10 min until a 
light orange solution was observed. Iodo-nitroalkene 192 (145 mg, 0.6 mmol, 1 equiv.) was 
dissolved in chlorobenzene (2 mL) and added into the reaction mixture. This reaction mixture 
was then cooled to −37°C. The corresponding indole 195a-k (0.90 mmol, 1.5 equiv., for 196c, 
g and h, 3.0 equiv indole was used) was then transferred into the cooled reaction mixture. The 
reaction was monitored by TLC until full conversion of the first tandem step was observed. 
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The reaction mixture was then allowed to warm to RT over 15 min, AgSbF6 (309 mg, 0.90 
mmol, 1.5 equiv.) was added and reaction was heated to 80°C for 2-2.5 h. 2 mL of distilled 
MeOH was added, sonicated and directly loaded onto a flash column for purification.  
 
GP3 Asymmetric kinetically controlled organocatalytic Michael/Henry reaction through 
hydrogen bonding activation 
 
 
To a vial containing a solution of ent-37' (16 mg, 0.05 mmol, 0.1 equiv.) in analytic grade 
CHCl3 stabilized with amylenes (3 mL, Fisher Scientific) was added trifluomethanesulfonic 
acid (0.05 mmol, 0.1 equiv., 4.5 µL). The bright reddish-orange solution was stirred for 5 min. 
NaBArF24 [116](44 mg, 0.05 mmol, 0.1 equiv.) was added into the reaction mixture and 
allowed to stir for 10 min until a light orange solution was observed. 200 mg of activated 3Å 
powdered molecular sieves (freshly activated in a Schlenk flask under high vacuum with 
heating from a heat gun for 3-4 h before cooling to RT)  was then added. 
o-Benzaldehyde nitroolefin 225a-c (0.5 mmol, 1 equiv.) was dissolved in CHCl3 (3 mL) and 
added into the reaction mixture. This reaction mixture was then cooled to 0°C. The 
corresponding indole 226a-j (0.60 mmol, 1.2 equiv.) was then transferred into the cooled 
reaction mixture and stirred at 0°C until starting materials were consumed. 
Upon completion of the reaction, the reaction mixture was directly loaded on a flash column 
for purification.   
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GP4 Asymmetric Domino Synthesis of indanes bearing four contiguous stereogenic centres 
catalyzed by sub-mol% loadings of squaramide 
 
 
To a vial containing the o-benzaldehyde nitroolefin 225a-d (0.50 mmol, 1 equiv.), Boc-
protected oxindole 245a-n (0.55 mmol, 1 equiv.) and squaramide catalyst 198 (2.50 µmol, 
0.005 equiv., 0.5 mol%) was added analytical reagent grade CHCl3 stabilized with amylenes 
(0.3 mL, Fisher Scientific) and allowed to stir at room temperature for 45 min at ambient 
conditions (RT, no protective gas). The crude mixture was then transferred to a flash column 
and purified by flash column chromatography to yield the pure products. 
Analytical data of synthesized compounds 
(1R,2S)-1-(3-(3,5-bis(trifluoromethyl)phenyl)thioureido)-2,3-dihydro-1H-inden-2-yl 
diethyl phosphate (151) 
 
Ricci's thiourea catalyst 150[68a, 68b] (0.500g, 1.19 mmol, 1 equiv.) was dissolved in 10 mL 
DCM and cooled to 0°C under argon. 1-methyl-1H-imidazole (0.19 mL, 2.38 mmol, 2 equiv.) 
was added and stirred for 20 min. Diethylchlorophosphate (0.344 mL, 2.38 mmol, 2 equiv.) 
was then added and the reaction was stirred for a further 15 min at 0°C. After warming to RT 
over 2h, the reaction was quenched with saturated ammonium chloride solution and the 
aqueous phase was extracted three times with DCM. The combined organic phases are 
washed with brine and concentrated in vacuo to give a colourless crude solid. Flash column 
chromatography (4:1 Et2O: pentane) yields a colourless solid. 
Experimental Part 
96 
 
Yield: 0.57g, 86% 
Melting point: 193 °C 
Optical rotation: [ ]27Dα = + 12.0 (c = 1.00, CHCl3) 
1H NMR(300 MHz, DMSO-d6):  
δ = 10.45 (bs, 1H, NH), 8.52 (d, J = 8.4 Hz, 1H, CHAr), 8.38 (s, 2H, CHAr), 7.80 (s, 1H, NH), 
7.26-7.40 (m, 4H, CHAr), 6.09 (bs, 1H, CH), 5.24 (m, 1H, CH), 3.88-4.10 (m, 4H, 2xOCH2), 
3.10-3.33 (m, 2H, CH2Ph), 1.14-1.24 (m, 6H, 2xCH3). 
13C NMR (75 MHz, DMSO-d6):  
δ = 181.9 (C=S), 141.7 (CAr), 139.6 (CAr), 139.2 (CAr), 130.5 (CAr), 130.0 (CAr), 128.2 (CHAr), 
126.9 (CHAr), 125.1 (d, J = 27.6 Hz, CHAr), 123.5 (CHAr), 122.1 (CHAr), 121.4 (CHAr), 116.6 
(m, CHAr), 79.5 (d, J = 22.2 Hz, CH), 63.4 (t, J = 25.5 Hz, CH2), 60.8 (d, J = 27.3 Hz, CH), 
37.9 (CH2), 15.9 (m, CH3). 
31P NMR (121 MHz, CDCl3): 
δ = −1.713 ppm. 
MS (EI, 70 eV): 
m/z (%) 556.2 (4) [M+], 403.2 (32), 402.2 (100), 174.2 (81), 148.2 (11), 131.2 (26), 115.2 (51), 
99.2 (20). 
IR (Capillary): 
3309, 1543, 1470, 1385, 1337, 1273, 1226, 1175, 1119, 1025, 984, 880, 845, 807, 778, 699, 
678 cm-1. 
Elemental Analysis: 
Calcd. for C22H23F6N2O4PS:   C, 47.49; H, 4.17; N, 5.03; found: C, 47.32; H, 4.10; N, 4.92. 
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N-((1R,2S)-2-Hydroxy-2,3-dihydro-1H-inden-1-yl)quinoline-2-carbothioamide (ent-37') 
 
A literature procedure was adopted.[22a] 
A mixture of quinoline-2-carbothioic acid methyl ester (0.5 g, 2.28 mmol, 1 equiv) and 
(1R,2S)-1-amino-2,3-dihydro-1H-inden-2-ol (0.34 g, 2.28 mmol, 1 equiv) was stirred in 10 
mL of absolute CH2Cl2 overnight.  
The reaction mixture was dry loaded on silica and purified by flash column chromatography 
(2:1 pentane: Et2O) to provide a yellowish-green solid. 
Yield: 0.605 g, 83% 
TLC: Rf = 0.65 (2:1 Pentane:Et2O) 
Optical rotation: [ ]27Dα = + 66.3 (c = 1.00, CHCl3) 
1H NMR(600 MHz, CDCl3): 
δ = 10.87 (d, J = 7.2 Hz, 1H, NH), 8.86 (d, J = 8.4 Hz, 1H, CHAr), 8.27 (d, J = 9.0 Hz, 1H, 
CHAr), 8.03 (d, J = 8.4 Hz, 1H, CHAr), 7.85 (d, J = 7.8 Hz, 1H, CHAr), 7.71 (t, J = 8.4 Hz, 1H, 
CHAr), 7.59 (t, J = 7.2 Hz, 1H, CHAr), 7.40 (d, J = 7.2 Hz, 1H, CHAr), 7.27-7.35 (m, 2H, 
CHAr), 7.22-7.26 (m, 1H, CHAr), 6.26 (dd, J = 8.4, 5.4 Hz, 1H, CH), 5.01 (t, J = 4.8 Hz, 1H, 
CH), 3.32 (dd, J = 16.8, 5.4 Hz, 1H, PhCH2), 3.09 (d, J = 16.2 Hz, 1H, PhCH2), 2.47 (bs, 1H, 
OH) ppm. 
13C NMR (151 MHz, CDCl3):  
δ = 192.5 (C=S), 150.3 (CAr), 145.6 (CAr), 140.6 (CAr), 139.7 (CAr), 137.2 (CHAr), 130.5 
(CHAr), 130.2 (CHAr), 129.4 (CAr), 128.8 (CHAr), 128.3 (CHAr), 127.8 (CHAr), 127.5 (CHAr), 
125.7 (CHAr), 125.0 (CHAr), 121.8 (CHAr), 73.8 (CH), 63.6 (CH), 40.3 (PhCH2) ppm. 
The analytical data is in agreement with those reported in the literature.[22a]  
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2-(Phenylethynyl)benzaldehyde (146a) 
 
A dry round bottom flask was charged with 2-bromobenzaldehyde 144a (10.0g, 54.0 mmol, 1 
equiv.), CuI (0.206g, 1.08 mmol, 0.02 equiv.) and Pd(PPh3)4 (0.625g, 0.540 mmol, 0.01 
equiv.). This mixture was then subjected to three purge cycles of vacuum and argon gas. 60 
mL of NEt3 and phenylacetylene (5.52g, 54.0 mmol, 1 equiv.) were added to the reaction 
mixture and allowed to stir at RT overnight. The reaction mixture was then diluted with ether 
and water. The aqueous phase was extracted three times with ether. The concentrated organic 
phases were dried with MgSO4 and concentrated in vacuo.  
146a was obtained by flash column chromatography of the crude product (pure pentane to 
10:1 pentane: Et2O) to yield a yellow liquid. 
Yield: 7.08g, 64% 
1H NMR(600 MHz, CDCl3): 
δ = 10.66 (s, 1H, CHaldehyde), 7.95 (d, J = 7.8 Hz, 1H, CHAr), 7.65 (d, J = 7.8 Hz, 1H, CHAr), 
7.54-7.61 (m, 3H, CHAr), 7.45 (t, J = 7.8 Hz, 1H, CHAr), 7.36-7.41 (m, 3H, CHAr) ppm. 
13C NMR (151 MHz, CDCl3): 
δ = 191.9 (CHaldehyde), 136.1 (CAr), 134.0 (CHAr), 133.4 (CHAr), 131.9 (CHAr), 129.3 (CHAr), 
128.8 (CHAr), 128.7 (CHAr), 127.5 (CHAr), 127.1 (CAr), 122.5 (CAr), 96.5 (Calkyne), 
85.1(Calkyne)ppm. 
The analytical data are in agreement with those reported in the literature.[117] 
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5-Fluoro-2-(phenylethynyl)benzaldehyde (146b) 
 
A dry round bottom flask was charged with 2-bromo-5-fluorobenzaldehyde (3.00 g, 16.2 
mmol, 1 equiv.), CuI (0.0620 g, 0.324 mmol, 0.02 equiv.) and Pd(PPh3)4 (0.187 g, 0.162 
mmol, 0.01 equiv.). This mixture was then subjected to three purge cycles of vacuum and 
argon gas. 20 mL of NEt3 and phenylacetylene (1.95 g, 16.2 mmol, 1 equiv.) were added to 
the reaction mixture and allowed to stir at RT overnight. The reaction mixture was then 
diluted with ether and water. The aqueous phase was extracted three times with ether. The 
concentrated organic phases were dried with MgSO4 and concentrated in vacuo.  
146b was obtained by flash column chromatography of the crude product (pure pentane to 
30:1 pentane:diethylether) to yield a yellow liquid  
Yield: 2.41g, 66% 
1H NMR(400 MHz, CDCl3): 
δ = 10.60 (d, J = 3.2 Hz, 1H, CHaldehyde), 7.60-7.67 (m, 2H, CHAr), 7.52-7.58 (m, 2H, CHAr), 
7.35-7.42 (m, 3H, CHAr), 7.29 (td, J = 8.0, 2.8 Hz, 1H, CHAr) ppm. 
13C NMR (100 MHz, CDCl3): 
δ = 190.6 (CHaldehyde), 162.4 (d, J = 250 Hz, CAr), 138.0 (d, J = 6.6 Hz, CAr), 135.4 (d, J = 7.6 
Hz, CAr), 131.9 (CHAr), 129.4 (CHAr), 128.8 (CHAr), 123.2 (d,  J = 3.3 Hz, CHAr), 122.3 
(CHAr), 121.6 (d, J = 20.0 Hz, CHAr), 114.0 (CHAr), 113.8 (CAr), 96.3 (Calkyne), 84.0 (Calkyne) 
ppm. 
The analytical data are in agreement with those reported in the literature.[118] 
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2-(m-Tolylethynyl)benzaldehyde (146c) 
 
To a dry round bottom flask was charged with 2-bromobenzaldehyde (3.09 g, 16.7 mmol, 1 
equiv.), CuI (0.064g, 0.334 mmol, 0.02 equiv.) and Pd(PPh3)4 (0.193 g, 0.167 mmol, 0.01 
equiv.). This mixture was then subjected to three purge cycles of vacuum and argon gas. 20 
mL of NEt3 and m-tolylacetylene (2.00 g, 16.7 mmol, 1 equiv.) were added to the reaction 
mixture allowed to stir at RT overnight. The reaction was then diluted with ether and water. 
The aqueous phase was extracted three times with ether. The concentrated organic phases 
were dried with MgSO4 and concentrated in vacuo.  
146c was obtained by flash column chromatography of the crude product (pure pentane to 
30:1 Pentane:Et2O) to yield a yellow liquid. 
Yield: 2.91g, 79% 
1H NMR(400 MHz, CDCl3): 
δ = 10.66 (s, 1H, CHaldehyde), 7.95 (dd, J = 7.6, 1.2 Hz, 1H, CAr), 7.64 (dd, J = 7.2, 0.8 Hz, 1H, 
CHAr), 7.58 (td, J = 7.6, 1.6 Hz, 1H, CHAr), 7.44 (t, J = 8.0 Hz, 1H, CHAr), 7.35-7.41 (m, 2H, 
CHAr), 7.27 (t, J = 7.6 Hz, 1H, CHAr), 7.20 (d, J = 7.6 Hz, 1H, CHAr), 2.37 (s, 3H, CH3). 
13C NMR (100 MHz, CDCl3): 
δ = 192.0 (CHaldehyde), 138.5 (CAr), 136.0 (CAr), 134.0 (CHAr), 133.4 (CHAr), 132.4 (CHAr), 
130.2 (CHAr),129.0 (CHAr), 128.7 (CHAr), 128.6 (CHAr), 127.4 (CHAr), 127.2 (CAr), 122.3 
(CAr), 96.8 (Calkyne), 84.8 (Calkyne), 21.4 (CH3) ppm. 
The analytical data are in agreement with those reported in the literature.[119] 
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(E)-1-(2-Nitrovinyl)-2-(phenylethynyl)benzene (147a) 
 
146a (6.60 g, 32.0 mmol, 1 equiv.) and nitromethane (2.62 mL, 48.0 mmol, 1.5 equiv.) were 
dissolved in 40 mL of distilled MeOH and cooled in a 0°C ice bath. KOH (1.80 g, 32.0 mmol, 
1 equiv.) was dissolved in 20 mL distilled MeOH and slowly added into the reaction over 10 
min and subsequently stirred for 15 min at 0 °C. The reaction was then added to a large 
excess of 4M HCL and allowed to stir for 1.5 h. The product was extracted 3 times with ether, 
the concentrated organic phases are then dried over MgSO4 and concentrated in vacuo. To the 
crude product obtained was then added mesyl chloride (2.97 mL, 38.4 mmol, 1.2 equiv.) and 
dissolved in 80 mL of distilled DCM. NEt3 (8.93 mL, 64.0 mmol, 2 equiv.) was added and the 
reaction was stirred for 1h at RT. Distilled water was added and the product was extracted 
three times with DCM, the concentrated organic phases are dried over MgSO4 and 
concentrated in vacuo. 
147a was isolated by flash column chromatography (20:1 pentane: Et2O) to yield a yellow 
solid. 
Yield: 4.48 g, 56% 
TLC: Rf = 0.40 (10:1 Pentane:Et2O) 
Melting point: 52 °C 
1H NMR(300 MHz, CDCl3): 
δ = 8.56 (d, J = 13.8 Hz, 1H, CHNO2), 7.81 (d, J = 13.8 Hz, 1H, PhCH), 7.64 (dd, J = 7.8, 1.5 
Hz, 1H, CHAr), 7.56-7.64 (m, 3H, CHAr), 7.48 (dd, J = 7.5, 1.5 Hz, 1H, CHAr), 7.36-7.45 (m, 
4H, CHAr). 
13C NMR (75 MHz, CDCl3): 
δ = 138.5 (CHAlkene), 137.4 (CHAlkene), 133.6 (CHAr), 131.9 (CHAr), 131.7 (CHAr), 131.4 (CAr), 
129.4 (CHAr), 129.1 (CHAr), 129.0 (CHAr), 128.8 (CHAr), 128.0 (CHAr), 125.5 (CAr), 122.5 
(CAr), 97.2 (Calkyne), 86.6 (Calkyne) ppm. 
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MS (EI, 70 eV):  
m/z (%) 249.1 (9) [M+], 204.1 (12), 203.1 (71), 202.1 (100), 191.1 (65), 101.2 (28), 100.2 (10), 
88.2 (13). 
IR (Capillary): 
3107, 2297, 2210, 2109, 1628, 1593, 1501, 1441, 1381, 1331, 1280, 1194, 1130, 1063, 962, 
909, 841, 745, 685 cm-1. 
Elemental Analysis: 
Calcd. for C16H11NO2:   C, 77.10; H, 4.45; N, 5.62; found: C, 77.15; H, 4.36; N, 5.55. 
(E)-4-Fluoro-2-(2-nitrovinyl)-1-(phenylethynyl)benzene (147b) 
NO2
147b
F
 
147b (4.11g, 18.3 mmol, 1 equiv.), ammonium acetate (0.706g, 9.16 mmol, 0.5 equiv.) and 35 
mL nitromethane were charged in a flask and heated to 110 °C for 3.5h. The contents were 
dry loaded on silica gel. 4b was then isolated by flash column chromatography (30:1 to 20:1 
pentane: Et2O). The concentrated fractions were then triturated with a solution of 10:1 
pentane: Et2O for 1 h, filtered and dried in vacuo to yield a yellow solid. 
Yield: 2.55g, 52% 
Melting point: 91°C 
TLC: Rf =  0.47 (10:1 Pentane:Et2O) 
1H NMR(400 MHz, CDCl3): 
δ = 8.50 (d, J = 13.6 Hz, 1H, CHNO2), 7.74 (d, J = 13.6 Hz, 1H, PhCH), 7.63 (dd, J = 8.4, 5.6 
Hz, 1H, CHAr), 7.55-7.61 (m, 2H, CHAr), 7.35-7.43 (m, 3H, CHAr), 7.28 (dd, J = 8.8, 2.4 Hz, 
1H, CHAr), 7.19 (td, J = 8.0 Hz, 2.8 Hz, 1H, CHAr). 
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13C NMR (100 MHz, CDCl3): 
δ = 163.6 (CAr), 161.1 (CAr), 139.3 (CHAlkene), 136.2 (CHAlkene), 135.4 (J = 8.3 Hz, CHAr), 
133.5 (J = 7.9 Hz, CHAr), 131.8 (CHAr), 129.4 (CHAr), 128.8 (CHAr), 122.3 (CAr), 121.7 (J = 
3.2 Hz, CAr), 119.3 (J =22.2 Hz, CHAr), 114.5 (J =23.3 Hz, CHAr), 96.9 (Calkyne), 85.6 (Calkyne) 
ppm. 
19F NMR (376 MHz, CDCl3): 
δ = − 109.3 ppm. 
MS (EI, 70 eV):  
m/z (%) 267.2 (24) [M+], 221.2 (78), 220.2 (100), 209.2 (70), 110.3 (36), 97.3 (15), 77.4 (12), 
51.6 (11). 
IR (Capillary): 
3377, 3302, 2313, 2211, 2097, 1909, 1637, 1600, 1566, 1485, 1339, 1275, 1209, 1160, 1079, 
1027, 967, 919, 839, 751, 720, 685 cm-1. 
Elemental Analysis: 
Calcd. for C16H10FNO2 :   C, 71.91; H, 3.77; N, 5.24; found: C, 71.87; H, 3.637; N, 5.20. 
(E)-1-(2-Nitrovinyl)-2-(m-tolylethynyl)benzene (147c) 
 
147c (2.90g, 13.17 mmol, 1 equiv.), ammonium acetate (0.507g, 6.58 mmol, 0.5 equiv.) and 
30 mL of nitromethane were charged in a flask and heated to 110 °C for 1h. The contents 
were dry loaded on silica gel. 4c was then isolated by flash column chromatography (30:1 to 
20:1 pentane: Et2O). The concentrated fractions were then triturated with a solution of 10:1 
pentane:Et2O for 1 h, filtered and dried in vacuo to yield a yellow solid. 
Yield: 2.34g, 68% 
TLC: Rf = 0.42 (10:1 Pentane:Et2O) 
Experimental Part 
104 
 
Melting point: 94 °C 
1H NMR(300 MHz, CDCl3): 
δ = 8.55 (d, J = 13.8 Hz, 1H, CHNO2), 7.81 (d, J = 13.8 Hz, 1H, PhCH), 7.63 (dd, J = 7.8, 1.5 
Hz, 1H, CHAr), 7.59 (dd, J = 7.8, 1.5 Hz, 1H, CHAr), 7.47 (dd, J = 7.5, 1.5 Hz, 1H, CHAr), 
7.35-7.43 (m, 3H, CHAr), 7.29 (td, J = 7.5, 0.6 Hz, 1H, CHAr), 7.21 (d, J = 7.8 Hz, 1H, CHAr), 
2.38 (s, 3H, CH3). 
13C NMR (75 MHz, CDCl3): 
δ = 138.6 (CHAr), 138.5 (CHAlkene), 137.4 (CHAlkene), 133.5 (CHAr), 132.4 (CHAr), 131.7 
(CHAr), 131.4 (CAr), 130.3 (CHAr), 129.0 (CHAr),128.7 (CHAr), 128.0 (CHAr), 125.6 (CAr), 
122.3 (CAr), 97.5 (Calkyne), 86.3 (Calkyne), 21.5 (CH3) ppm. 
MS (EI, 70 eV): 
m/z (%) 263.2 (14) [M+], 217.2 (29), 205.2 (57), 202.2 (100), 189.2 (14), 107.7 (11), 101.3 
(18), 94.7 (18), 91.3 (11). 
IR (Capillary):  
3110, 3061, 2920, 2304, 2204, 2089, 1951, 1704, 1631, 1594, 1508, 1482, 1383, 1335, 1283, 
1196, 1166, 1093, 1043, 964, 917, 847, 786, 757, 687 cm-1. 
Elemental Analysis: 
Calcd. for C17H13NO2:  C, 77.55; H, 4.98; N, 5.32; found: C, 77.67; H, 5.117; N, 5.26. 
(R)-5-Methoxy-3-(2-nitro-1-(2-(phenylethynyl)phenyl)ethyl)-1H-indole (149) 
 
To a solution of Seidel's precatalyst ent-37' (6.4 mg, 0.02 mmol, 0.1 equiv.) in 1 mL CHCl3 
was added trifluomethanesulfonic acid (1.8 µL, 0.02 mmol, 0.1 equiv.). The bright reddish-
orange solution was stirred for 5 min. NaBArF24 (18 mg, 0.02 mmol, 0.1 equiv.) was added 
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into the reaction mixture and allowed to stir for 10 min until a light orange solution was 
observed. This reaction was then cooled to − 30°C. 147a (50 mg, 0.2 mmol, 1 equiv.) in 1 mL 
CHCl3 was added. Subsequently, 148a (44 mg, 0.3 mmol, 1.5 equiv.) was added and allowed 
to stir at −30 °C for 24 h. Silica gel was added to the reaction mixture, rotary evaporated and 
dry loaded onto a flash column for purification. 149 was isolated by flash column 
chromatography (2:1 pentane: diethylether) to yield a brown solid. 
Yield: 72 mg, 91% 
TLC: Rf =  0.13 (2:1 Pentane:Et2O) 
Melting point: 65°C (decomp.) 
Optical rotation: [ ]25Dα = − 35.7 (c = 1.02, CHCl3) 
ee: 95% 
anal. chiral HPLC: tR 10.47 min (major) 11.63 (minor); elution solvent: n-
heptane/isopropanol, 70:30, 0.7 mL/min, Daicel-AD column.  
1H NMR (300 MHz, CDCl3):  
δ = 8.02 (s, 1H, NH), 7.53-7.69 (m, 3H, CHAr), 7.30-7.42 (m, 3H, CHAr), 7.17-7.29 (m, 4H, 
CHAr), 7.13 (s, 1H, CHAr), 6.92 (s, 1H, CHAr), 6.82 (d, J = 8.7 Hz, 1H, CHAr), 5.89 (m, 1H, 
CH), 4.97-5.12 (m, 2H, CH2NO2), 3.66 (m, 3H, OCH3). 
13C NMR (75 MHz, CDCl3):  
δ = 154.4 (CAr), 140.9 (CAr), 132.9 (CHAr), 131.9 (CHAr), 131.7(CAr), 129.1 (CHAr), 128.9 
(CHAr), 128.7 (CHAr), 127.8 (CHAr), 127.6 (CHAr), 127.1 (CHAr), 123.0 (CAr), 122.3 (CHAr), 
113.9 (CAr), 113.1 (CHAr), 112.2(CHAr), 101.1 (CHAr), 95.4 (Calkyne), 87.2 (Calkyne), 78.7 
(CH2NO2), 55.9 (CH), 39.5 (OCH3) ppm. 
MS (EI, 70 eV): 
m/z (%) 396.3 (100) [M+], 350.3 (32), 336.3 (72), 334.3 (29), 318.3 (16), 77.4 (10). 
IR (Capillary) 
3420, 3062, 2928, 2832, 2325, 2113, 1896, 1702, 1593, 1548, 1487, 1435, 1375, 1291, 1211, 
1174, 1098, 1027, 918, 831, 801, 755, 688 cm-1. 
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HRMS (ESI):  
calcd. for C25H21O3N2 397.1552 found 397.1547. 
(R)-2-Methoxy-12-(nitromethyl)-6-phenyl-5,12-dihydrobenzo[4,5]cyclohepta[1,2-b] 
indole (154a) 
 
154a was synthesized according to GP1 and isolated by flash column chromatography (3:1 
pentane: Et2O) to yield a yellow foam. 
Yield: 248 mg, 78% 
TLC: Rf =  0.40 (2:1 Pentane:Et2O) 
Melting point: 115 °C 
Optical rotation: [ ]27Dα = + 66.8 (c = 1.00, CHCl3) 
ee: 97% 
anal. chiral HPLC: tR 6.59 min (major), 8.00 (minor); elution solvent: n-heptane/ethanol, 
90:10, 1.3 mL/min, Daicel-OD column. 
1H NMR(300 MHz, CDCl3): 
δ = 7.82 (bs, 1H, NH), 7.56-7.63 (m, 2H, CHAr), 7.44-7.55 (m, 5H, CHAr), 7.29-7.43 (m, 2H, 
CHAr), 7.25 (s, 1H, PhCH), 7.08-7.15 (m, 2H, CHAr), 6.87 (dd, J = 8.7, 1.8 Hz, 1H, CHAr), 
5.34 (t, J= 8.4 Hz, 1H, CH), 4.63 (d, J= 8.4 Hz , 2H, CH2NO2), 3.94 (s, 3H, OCH3). 
13C NMR (75 MHz, CDCl3): 
δ = 154.8 (CAr), 140.0 (CAr), 135.3 (C), 134.6 (CAr), 134.0 (CAr), 132.7 (CAr), 132.3 (CAr), 
131.5 (CHAr), 130.1 (CHAr), 130.0 (CHAr), 129.8 (CHAr), 129.7 (CHAr), 129.4 (CHAr), 129.2 
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(CHAr), 129.1 (CHAr), 128.9 (CHAr), 127.5 (CHAr), 126.9 (CAr), 114.4 (CHAr), 112.8 (CAr), 
112.1 (CHAr), 99.6 (CH), 75.3 (CH2NO2), 56.2 (CH), 41.7 (OCH3) ppm. 
MS (EI, 70 eV): 
m/z (%) 396 (27) [M+], 336 (98). 
IR (Capillary):  
3420, 3056 , 3021, 2929, 2831, 2323, 2105, 1713, 1625, 1600, 1546, 1488, 1449, 1375, 1336, 
1285, 1216, 1174, 1113, 1029, 983, 886, 829, 799, 765, 701 cm-1. 
HRMS (ESI):  
calcd. for C25H21O3N2: 397.1547 found: 397.1549. 
(R)-2-Methyl-12-(nitromethyl)-6-phenyl-5,12-dihydrobenzo[4,5]cyclohepta[1,2-b]indole 
(154b) 
 
154b was synthesized according to GP1 and isolated by flash column chromatography (2:1 
pentane: Et2O) to yield a yellow foam.  
Yield: 282 mg, 92 % 
TLC: Rf =  0.55 (2:1 Pentane:Et2O) 
Melting point: 116 °C 
Optical rotation: [ ]27Dα = + 63.5 (c = 1.00, CHCl3) 
ee: 97%  
anal. chiral HPLC: tR 17.83 min (major), 20.15 min (minor); elution solvent: n-
heptane/ethanol, 95:5, 0.7 mL/min, Daicel-OD column. 
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1H NMR(400 MHz, CDCl3):  
δ = 7.79 (bs, 1H, NH), 7.63 (s, 1H, CHAr), 7.57-7.61 (m, 2H, CHAr), 7.42-7.53 (m, 5H, CHAr), 
7.38 (td, J= 7.2, 1.2 Hz, CHAr), 7.13 (s, 1H, CH), 7.11 (d, J= 8.4 Hz, 1H, CHAr), 7.02 (dd, J= 
8.0, 1.6 Hz, 1H, CHAr), 5.36 (t, J= 8.4 Hz, 1H, CH), 4.62 (d, J= 8.0 Hz, 2H, CH2NO2), 2.50 (s, 
3H, OCH3) ppm. 
13C NMR (100 MHz, CDCl3): 
δ = 140.0 (CAr), 135.4 (C), 135.3 (CAr), 134.6 (CAr), 134.1 (CAr), 132.2 (CHAr), 131.5 (CHAr), 
130.1 (CHAr), 129.9 (CHAr), 129.8 (CHAr), 129.7 (CHAr), 129.2 (CHAr), 129.1 (CAr), 128.9 
(CAr), 127.4 (CHAr), 126.7 (CAr), 125.5 (CHAr), 117.9 (CHAr), 112.7 (CAr), 110.9 (CH), 75.3 
(CH2NO2), 41.7 (CH), 21.8 (CH3)ppm. 
MS (EI, 70 eV): 
m/z (%) 380.4 (17) [M+], 320.3 (99), 159.9 (16). 
IR (Capillary):  
3422, 3023, 2916, 1722, 1599, 1546, 1488, 1429, 1375, 1331, 1303, 1221, 1180, 1115, 1075, 
1005, 862, 798, 761, 699 cm-1. 
HRMS (ESI):  
calcd. for C25H20O2N2Na: 403.1417 found: 403.1418 
(R)-12-(Nitromethyl)-6-phenyl-5,12-dihydrobenzo[4,5]cyclohepta[1,2-b]indole (154c) 
 
154c was synthesized according to GP1 and isolated by flash column chromatography (3:1 
pentane: Et2O) to yield a yellow foam. 
Yield: 151 mg, 51 % 
TLC: Rf =  0.48 (2:1 Pentane:Et2O) 
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Melting point: 108 °C 
Optical rotation: [ ]27Dα = + 33.6 (c = 1.00, CHCl3) 
ee: 97 % 
anal. chiral HPLC: tR 15.75 min (major), 20.86 min (minor); elution solvent: n-
heptane/isopropanol, 90:10, 1.0 mL/min, (S,S)-Whelk O1 column. 
1H NMR(300 MHz, CDCl3):  
δ =7.89 (bs, 1H, NH), 7.82-7.88 (m, 1H, CHAr), 7.56-7.63 (m, 2H, CHAr), 7.43-7.55 (m, 5H, 
CHAr), 7.38 (td, J= 7.2, 1.5 Hz ,1H, CHAr), 7.32 (td, J= 7.2, 1.5 Hz, 1H, CHAr), 7.17-7.23 (m, 
3H, CHAr), 7.16 (s, 1H, CH), 5.40 (t, J= 8.1 Hz, 1H, CH), 4.63 (d, J= 7.8 Hz, 2H, CH2NO2). 
13C NMR (75 MHz, CDCl3):  
δ = 139.9 (CAr), 136.9 (CAr), 135.3 (C), 134.5 (CAr), 134.0 (CAr), 132.0 (CAr), 131.6 (CHAr), 
130.1 (CHAr), 130.0 (CHAr), 129.8 (CHAr), 129.3 (CHAr), 129.1 (CHAr), 129.0 (CHAr), 127.5 
(CHAr), 126.5 (CAr), 123.7 (CHAr), 120.5 (CHAr), 118.4 (CHAr), 113.1 (CAr), 111.2 (CH), 75.2 
(CH2NO2), 41.6 (CH) ppm. 
MS (EI, 70 eV):  
m/z (%) 366.5 (21) [M+], 307.5 (28), 306.4 (98), 304.4 (15). 
IR (Capillary):  
3417, 3057, 2322, 2202, 2113, 1547, 1489, 1440, 1375, 1338, 1275, 1130, 1007, 922, 885, 
747, 701 cm-1. 
HRMS (ESI):  
calcd. for C24H18O2N2K 405.1000 found: 405.0998 
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(R)-4-Methyl-12-(nitromethyl)-6-phenyl-5,12-dihydrobenzo[4,5]cyclohepta[1,2-b]indole 
(154d) 
 
154d was synthesized according to GP1 and isolated by flash column chromatography (2:1 
pentane:CH2Cl2) to yield a yellow foam. 
Yield:  214 mg, 70 % 
TLC: Rf =  0.43 (2:1 Pentane:Et2O) 
Melting point: 207 °C 
Optical rotation: [ ]27Dα = + 11.0 (c = 1.01, CHCl3) 
ee: 98 % 
anal. chiral HPLC: tR 10.38 min (major), 11.98 min (minor); elution solvent: n-
heptane/ethanol, 80:20, 0.50 mL/min, Daicel-OD column.… 
1H NMR(300 MHz, CDCl3):  
δ = 7.76 (bs, 1H, NH), 7.72 (d, J= 8.1 Hz, 1H, CHAr), 7.60-7.66 (m, 2H, CHAr), 7.46-7.56 (m, 
4H, CHAr), 7.27-7.46 (m, 3H, CHAr), 7.17 (s, 1H, CH), 7.14 (t, J= 7.5 Hz, 1H, CHAr), 7.02 (d, 
J= 7.2 Hz, 1H, CHAr), 5.38 (t, J= 8.4 Hz , 1H, CH), 4.63 (d, J= 8.1 Hz, 2H, CH2NO2), 2.33 (s, 
3H, CH3). 
13C NMR (75 MHz, CDCl3):  
δ = 140.0 (CAr), 136.7 (CAr), 135.4 (C), 134.5 (CAr), 134.0 (CAr), 131.6 (CAr), 131.5 (CHAr), 
130.1 (CHAr), 130.0 (CHAr), 129.8 (CHAr), 129.3 (CHAr), 129.0 (CHAr), 127.4 (CHAr), 126.1 
(CAr), 124.3 (CHAr), 120.8 (CHAr), 120.5 (CAr), 116.1 (CH), 113.9 (CAr), 75.1 (CH2NO2), 41.8 
(CH), 16.8 (CH3) ppm. 
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MS (EI, 70 eV):  
m/z (%) 380.2 (26) [M+], 321.2 (37), 320.2 (99), 318.2 (11). 
IR (Capillary):  
3424, 3055, 2919, 2855, 1725, 1599, 1547, 1490, 1443, 1376, 1339, 1306, 1248, 1186, 1142, 
1076, 1031, 978, 948, 885, 860, 762, 701 cm-1. 
HRMS (ESI):  
calcd. for C25H21O2N2 381.1597 found 381.1600 
(R)-10-Fluoro-2-methoxy-12-(nitromethyl)-6-phenyl-5,12-dihydrobenzo [4,5]cyclohepta- 
[1,2-b]indole (154e) 
 
154e was synthesized according to GP1 and isolated by flash column chromatography (1:1 
pentane: CH2Cl2) to yield a yellow foam.  
Yield: 221 mg, 67 % 
TLC: Rf =  0.36 (2:1 Pentane:Et2O) 
Melting point: 230 °C 
Optical rotation: [ ]26Dα = + 71.8 (c = 1.01, CHCl3) 
ee: 98% 
anal. chiral HPLC: tR 6.09 min (major), 10.94 min (minor); elution solvent: n-
heptane/isopropanol, 70:30, 1.00 mL/min, Daicel-AD column. 
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1H NMR(600 MHz, CDCl3):  
δ = 7.81 (bs, 1H, NH), 7.55-7.59 (m, 2H, CHAr), 7.43-7.52 (m, 4H, CHAr), 7.22 (d, J= 1.8 Hz, 
1H, CHAr), 7.1 (dd, J= 9.0, 3.0 Hz, 1H, CHAr), 7.13 (d, J= 8.4 Hz, 1H, CHAr), 7.08 (s, 1H, 
CH), 7.03 (td, J= 8.4, 3.0 Hz, 1H, CHAr), 6.88 (dd, J= 8.4, 2.4 Hz, 1H, CHAr), 5.27 (t, J= 8.4, 
1H, CH), 4.58-4.68 (m, 2H, CH2NO2), 3.94 (s, 3H, OCH3) ppm. 
13C NMR (151 MHz, CDCl3):  
δ = 164.6 (CAr), 162.9 (CAr), 154.9 (CAr), 139.8 (C), 137.3 (d, J= 7.2 Hz, CAr), 133.6 (CHAr), 
133.3 (d, J= 8.4 Hz, CHAr), 132.7 (CHAr), 132.3 (CAr), 131.0 (CAr), 130.9 (d, J= 3.0 Hz, CAr), 
129.3 (CHAr), 129.0 (CHAr), 128.6 (CHAr), 126.7 (CAr), 116.8 (CHAr), 116.6 (CHAr), 114.8 
(CHAr), 114.6 (CHAr), 112.2 (CHAr), 111.9 (CAr), 99.4 (CH), 74.9 (CH2NO2), 56.2 (OCH3), 
41.4 (CH) ppm. 
19F NMR (564 MHz, CDCl3):  
δ = −112.4 ppm. 
MS (EI, 70 eV):  
m/z (%) 414.2 (15) [M+], 354.2 (100). 
IR (Capillary):  
3280, 3069, 3030, 2951, 2833, 2693, 2325, 2082, 1749, 1605, 1543, 1489, 1449, 1374, 1334, 
1282, 1243, 1208, 1111, 1012, 985, 920, 874, 834, 802, 760, 696 cm-1. 
HRMS (ESI):  
calcd. for C25H20O3N2F 415.1453 found 415.1453. 
(R)-10-Fluoro-2-methyl-12-(nitromethyl)-6-phenyl-5,12-dihydrobenzo[4,5] cyclohepta [1, 
2-b]indole (154f) 
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154f was synthesized according to GP1 and was isolated by flash column chromatography 
(6:1 pentane: Et2O) to yield a yellow foam. 
Yield: 305 mg, 96 % 
TLC: Rf =  0.48 (2:1 Pentane:Et2O) 
Melting point: 220 °C 
Optical rotation: [ ]26Dα = + 55.5 (c = 1.01,  CHCl3) 
ee: 95 % 
anal. chiral HPLC: tR 8.69 min (minor), 11.31 min (major); elution solvent: n-heptane/ 
isopropanol, 80:20, 1.00 mL/min, Daicel-OD column.  
1H NMR(400 MHz, CDCl3):  
δ = 7.81 (bs, 1H, NH), 7.61 (s, 1H, CHAr), 7.54-7.59 (m, 2H, CHAr), 7.42-7.53 (m, 4H, CHAr), 
7.16 (dd, J= 8.8, 2.4 Hz, 1H, CHAr), 7.12 (d, 1H, J= 8.4 Hz, CHAr), 7.09 (s, 1H, CH), 6.98-
7.06 (m, 2H, CHAr), 5.29 (t, J= 7.6 Hz, 1H, CH), 4.55-4.68 (m, 2H, CH2NO2), 2.50 (s, 3H) 
ppm. 
13C NMR (100 MHz, CDCl3):  
δ = 165.0 (CAr), 162.5 (CAr), 139.8 (CAr), 137.3 (d, J = 7.1 Hz, CAr), 135.4 (C), 133.6 (d, J = 
1.6 Hz, CHAr), 133.4 (CHAr), 133.3 (CHAr), 132.1 (CAr), 130.9 (d, J = 3.1 Hz, CAr), 130.0 
(CAr), 129.3 (CHAr), 129.0 (CHAr), 128.7 (CHAr), 126.5 (CAr), 125.6 (CHAr), 117.8 (CHAr), 
116.7 (d, J = 21.7 Hz, CHAr), 114.6 (d, J = 21.3 Hz, CHAr), 111.8 (CAr), 111.0 (CH), 74.9 
(CH2NO2), 41.3 (CH), 21.8 (CH3) ppm. 
19F NMR (376 MHz, CDCl3):  
δ = −112.4 ppm. 
MS (EI, 70 eV):  
m/z (%) 398.2 (20) [M+], 338.2 (99), 336.2 (10), 168.9 (15). 
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IR (Capillary):  
3456, 3051, 2915, 2331, 2174, 2122, 1954, 1877, 1734, 1596, 1541, 1490, 1442, 1417, 1371, 
1321, 1224, 1151, 1104, 1071, 100, 970, 912, 879, 847, 796, 764, 724, 696 cm-1. 
HRMS (ESI):  
calcd. for C25H20O2N2F 399.1503 found 399.1502. 
(R)-10-Fluoro-12-(nitromethyl)-6-phenyl-5,12-dihydrobenzo[4,5]cyclohepta[1,2-b]indole 
(154g) 
 
154g was synthesized according to GP1 and was isolated by flash column chromatography 
(6:1 pentane: Et2O) to yield a yellow foam. 
Yield: 248 mg, 81 % 
TLC: Rf =  0.43 (2:1 Pentane:Et2O) 
Melting point: 113°C 
Optical rotation: [ ]27Dα = + 26.6 (c  = 0.99, CHCl3) 
ee: 98% 
anal. chiral HPLC: tR 8.31 min (minor), 11.41 min (major); elution solvent: n-
heptane/isopropanol, 80:20, 1.00 mL/min, Daicel-OD column. 
1H NMR(300 MHz, CDCl3):  
δ = 7.91 (bs, 1H, NH), 7.80-7.87 (m, 1H, CHAr), 7.55-7.61 (m, 2H, CHAr), 7.43-7.54 (m, 4H, 
CHAr), 7.19-7.25 (m, 3H, CHAr), 7.17 (dd, J= 8.7, 2.7 Hz, 1H, CHAr), 7.12 (s, 1H, CH), 7.03 
(td, J= 7.8, 2.4 Hz, 1H, CHAr), 5.33 (t, J= 8.1 Hz, 1H, CH), 4.55-4.70 (m, 2H, CH2NO2) ppm. 
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13C NMR (75 MHz, CDCl3):  
δ = 165.5 (CAr), 162.1 (CAr), 139.7 (CAr), 137.3 (d, J = 7.1 Hz, CAr), 136.9 (C), 133.5 (CHAr), 
133.4 (CHAr), 133.3 (CHAr), 132.0 (CAr), 130.8 (d, J = 2.9 Hz, CAr), 129.3 (CHAr), 129.0 
(CHAr), 128.9 (CHAr), 126.3 (CAr), 123.9 (CHAr), 120.7 (CHAr), 118.3 (CHAr), 116.7 (d, J = 
21.7 Hz, CHAr), 114.7 (d, J = 21.3 Hz, CHAr) , 112.2 (CAr), 111.3 (CH), 74.8 (CH2NO2), 41.3 
(CH) ppm. 
19F NMR (282 MHz, CDCl3):  
δ = −112.3 ppm. 
MS (EI, 70 eV):  
m/z (%) 384.2 (20) [M+], 325.2 (30), 324.2 (100), 322.2 (15), 161.2 (10). 
IR (Capillary):  
3414, 3053, 2921, 2325, 2101, 1719, 1602, 1546, 1493, 1442, 1374, 1333, 1250, 1146, 1007, 
968, 922, 875, 811, 746, 702, 577 cm-1. 
HRMS (ESI):  
calcd. for C24H18O2N2F 385.1347 found 385.1349. 
(R)-10-Fluoro-4-methyl-12-(nitromethyl)-6-phenyl-5,12-dihydrobenzo[4,5]cyclohepta 
[1,2-b] indole (154h) 
 
154h was synthesized according to GP1 and was isolated by flash column chromatography 
(6:1 pentane: Et2O) to yield a yellow foam.  
Yield:  248 mg, 78 % 
TLC: Rf =  0.43 (2:1 Pentane:Et2O) 
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Melting point:  115 °C 
Optical rotation: [ ]26Dα = + 8.08 (c = 1.02, CHCl3) 
ee: 99% 
anal. chiral HPLC: tR 10.17 min (minor) 11.74 (major); elution solvent: n-
heptane/isopropanol, 80:20, 0.70 mL/min, Daicel-OD column. 
1H NMR (400 MHz, CDCl3):  
δ = 7.75 (bs, 1H, NH), 7.69 (d, J= 8.0 Hz, 1H, CHAr), 7.61 (dd, 2H, J= 8.0, 1.6 Hz, CHAr), 
7.43-7.55 (m, 4H, CHAr), 7.11-7.18 (m, 3H, CH and CHAr), 6.99-7.05 (m, 2H, CHAr), 5.31 (t, 
J= 8.4 Hz, 1H, CH), 4.56-4.69 (m, 2H, CH2NO2), 2.34 (s, 3H, CH3) ppm. 
13C NMR (100 MHz, CDCl3):  
δ = 165.0 (CAr), 162.5 (CAr), 139.8 (CAr), 137.4 (d, J = 7.2 Hz, CAr), 136.7 (C), 133.6 (CHAr), 
133.3 (d, J = 8.4 Hz, CHAr), 131.6 (CAr), 130.8 (d, J = 3.2 Hz, CAr), 129.3 (CHAr), 129.1 
(CHAr), 128.9 (CHAr), 125.9 (CAr), 124.5 (CHAr), 120.9 (CHAr), 120.5 (CAr), 116.7 (d, J = 21.7 
Hz, CHAr), 116.0 (CHAr), 114.7 (d, J = 21.4 Hz, CHAr), 113.0 (CAr), 74.8 (CH2), 41.5 (CH), 
16.8 (CH3) ppm. 
19F NMR (376 MHz, CDCl3):  
δ = −112.4 ppm. 
MS (EI, 70 eV):  
m/z (%) 398.3 (18) [M+], 339.2 (24), 338.2 (100). 
IR (Capillary):  
3454, 3055, 2854, 2323, 2108, 1897, 1603, 1547,1493, 1443, 1421, 1375, 1337, 1309, 1248, 
1190, 1141, 1103, 1076, 1030, 969, 917, 874, 816, 781, 744, 700, 655, 574 cm-1. 
HRMS (ESI):   
calcd. for C25H20O2N2F 399.1503 found 399.1505. 
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(R)-2-Methoxy-12-(nitromethyl)-6-(m-tolyl)-5,12-dihydrobenzo[4,5]cyclohepta[1,2-b]    
indole (154i) 
 
154i was synthesized according to GP1 and was isolated by flash column chromatography 
(6:1 pentane: Et2O) to yield a yellow foam. 
Yield: 262 mg, 80% 
TLC: Rf =  0.36 (2:1 Pentane:Et2O) 
Melting point:  189 °C 
Optical rotation: [ ]27Dα = + 63.5 (c = 1.00, CHCl3) 
ee: 97%  
anal. chiral HPLC: tR 7.28 min (major) 8.34 min (minor), elution solvent: n-heptane/ethanol, 
80:20, 0.70 mL/min, Daicel-OD column. 
1H NMR(300 MHz, CDCl3):  
δ = 7.80 (bs, 1H, NH), 7.49 (dd, J= 7.2, 1.5 Hz, 1H, CHAr), 7.45 (dd, J= 7.5, 1.5 Hz, 1H, 
CHAr), 7.35-7.42 (m, 4H, CHAr), 7.33 (dd, J= 7.5, 1.8 Hz, 1H, CHAr), 7.23-7.30 (m, 2H, CHAr), 
7.09-7.14 (m, 2H, CH and CHAr), 6.86 (dd, 1H, CHAr), 5.33 (t, 1H, CH), 4.63 (d, J= 8.1 Hz, 
2H, CH2NO2), 3.93 (s, 3H, OCH3), 2.44 (s, 3H, CH3) ppm. 
13C NMR (75 MHz, CDCl3):  
δ = 154.8 (CAr), 140.0 (CAr), 139.0 (CAr), 135.3 (C), 134.6 (CAr), 134.2 (CAr), 132.9 (CAr), 
132.3 (CAr), 131.6 (CHAr), 130.0 (CHAr), 129.7 (CHAr), 129.1 (CHAr), 127.4 (CHAr), 126.9 
(CAr), 126.2 (CHAr), 114.4 (CHAr), 112.7 (CAr), 112.1 (CHAr), 99.6 (CH), 75.3 (CH2NO2), 
56.2 (OCH3), 41.8 (CH), 21.7 (CH3) ppm. 
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MS (EI, 70 eV):  
m/z (%) 380.2 (27) [M+], 321.2 (37), 320.2 (100), 318.2 (11). 
IR (Capillary):  
3422, 3056, 2919, 2854, 2080,1726, 1601, 1547, 1488, 1443, 1375, 1339, 1301, 1252, 1215, 
1189, 1143, 1112, 1079, 1027, 979, 947, 887, 832, 751, 702, 661 cm-1. 
HRMS (ESI):   
calcd. for C25H21O2N2 381.1597 found 381.1600. 
(R)-2-Methyl-12-(nitromethyl)-6-(m-tolyl)-5,12-dihydrobenzo[4,5]cyclohepta[1,2-b]       
indole (154j) 
 
154j was synthesized according to GP1 and was isolated by flash column chromatography 
(6:1 pentane: Et2O) to yield a yellow foam  
Yield: 297 mg, 94 % 
TLC: Rf =  0.62 (2:1 Pentane:Et2O) 
Melting point:  113 °C 
Optical rotation: [ ]27Dα = + 74.0 (c = 1.00, CHCl3) 
ee: 98% 
anal. chiral HPLC: tR 9.05 min (major) 19.47 min (minor), elution solvent: n-
heptane/ethanol, 70:30, 1.0 mL/min, Daicel-IA column.  
1H NMR(300 MHz, CDCl3):  
δ = 7.82 (bs, 1H, NH), 7.64 (s, 1H, CHAr), 7.49 (d, J= 7.5 Hz, 1H, CHAr), 7.44 (d, J= 7.5 Hz, 
1H, CHAr), 7.22-7.41 (m, 6H, CHAr), 7.13 (1H, s, CH), 7.12 (d, J= 8.1 Hz, 1H,CHAr), 7.02 (d,  
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J= 8.4 Hz, 1H, CHAr), 5.36 (t, J= 8.4 Hz , 1H, CH), 4.54-4.68 (m, 2H, CH2NO2), 2.50 (s, 3H, 
OCH3), 2.44 (s, 3H, CH3) ppm. 
13C NMR (75 MHz, CDCl3):  
δ = 140.0 (CAr), 138.9 (CAr), 135.4 (CAr), 135.3 (C), 134.6 (CAr), 134.2 (CAr), 132.3 (CAr), 
131.5 (CHAr), 130.0 (CHAr), 129.8 (CHAr), 129.7 (CAr), 129.1 (CHAr), 127.4 (CHAr), 126.7 
(CAr), 126.1 (CHAr), 125.4 (CHAr), 117.9 (CHAr), 112.5 (CAr), 110.9 (CH), 75.3 (CH2NO2), 
41.7 (CH), 21.8 (CH3), 21.7 (CH3) ppm. 
MS (EI, 70 eV):  
m/z (%) 394.3 (23) [M+], 335.3 (38), 334.3 (100). 
IR (Capillary):  
3417, 3023, 2916, 2858, 2322, 2083, 1719, 1602, 1546, 1483, 1431, 1374, 1329, 1302, 1226, 
1191, 1115, 1039, 875, 792, 751, 705 cm-1. 
HRMS (ESI):   
calcd. for C26H23O2N2 395.1754 found 395.1754. 
(R)-12-(Nitromethyl)-6-(m-tolyl)-5,12-dihydrobenzo[4,5]cyclohepta[1,2-b]indole (154k) 
 
154k was synthesized according to GP1 and was isolated by flash column chromatography 
(6:1 pentane: Et2O) to yield a yellow foam.  
Yield: 241 mg, 79 % 
TLC: Rf =  0.55 (2:1 Pentane:Et2O) 
Melting point: 184 °C 
Optical rotation: [ ]27Dα = + 33.5 (c = 1.00, CHCl3) 
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ee: 97%  
anal. chiral HPLC: tR 12.35 min (major) 27.85 min (minor), elution solvent: n-
heptane/isopropanol, 70:30, 1.00 mL/min, Daicel-AD column. 
1H NMR(300 MHz, CDCl3):  
δ = 7.90 (bs, 1H, NH), 7.86 (m, 1H, CHAr), 7.49 (dd, J= 7.5, 1.5 Hz, 1H, CHAr), 7.43 (dd, J= 
7.5, 1.5 Hz, 1H, CHAr), 7.16-7.41 (m, 9H, CHAr), 7.14 (s, 1H, CH), 5.39 (t, 1H, CH), 4.62 (d, 
J= 8.1 Hz, 2H, CH2NO2), 2.44 (s, 3H, CH3) ppm. 
13C NMR (75 MHz, CDCl3):  
δ = 139.9 (CAr), 139.0 (CAr), 136.9 (CAr), 135.3 (C), 134.6 (CAr), 134.1 (CAr), 132.2 (CAr), 
131.5 (CHAr), 130.0 (CHAr), 129.9 (CHAr), 129.8 (CHAr), 129.7 (CHAr), 129.6 (CHAr), 129.1 
(CHAr), 127.4 (CHAr), 126.5 (CAr), 126.1 (CHAr), 123.7 (CHAr), 120.5 (CHAr), 118.4 (CHAr), 
112.9 (CAr), 111.2 (CH), 75.2 (CH2NO2), 41.6 (CH), 21.7 (CH3) ppm. 
MS (EI, 70 eV):  
m/z (%) 380.3 (16) [M+], 321.3 (29), 320.3 (100) 
IR (Capillary):  
3416, 3055, 2918, 2112, 1725, 1603, 1546, 1487, 1446, 1424, 1375, 1334, 1308, 1273, 1243, 
1222, 1190, 1134, 1093, 1042, 1008, 882, 792, 744, 704 cm-1. 
HRMS (ESI):   
calcd. for C25H21O2N2 381.1597 found 381.1597 
(R)-4-Methyl-12-(nitromethyl)-6-(m-tolyl)-5,12-dihydrobenzo[4,5]cyclohepta[1,2-b] 
indole (154l) 
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154l was synthesized according to GP1 and was isolated by two consecutive flash column 
chromatography (firstly 6:1 pentane: Et2O and 2:1 pentane:CH2Cl2) to yield an off-white 
foam. 
Yield: 189 mg, 60% 
TLC: Rf =  0.55 (2:1 Pentane:Et2O) 
Melting point:  221°C 
Optical rotation: [ ]27Dα =  + 18.5 (c = 1.00, CHCl3)  
ee: 98%  
anal. chiral HPLC: tR 4.89 min (major) 12.56 (minor), elution solvent: n-heptane/ethanol, 
85:15, 1.00 mL/min, Daicel-AD column. 
1H NMR(300 MHz, CDCl3): 
 δ = 7.77 (bs, 1H, NH), 7.71 (d, J= 8.1 Hz, 1H, CHAr), 7.49 (dd, J= 7.5, 1.5 Hz, 1H, CHAr), 
7.25-7.46 (m, 7H, CHAr), 7.16 (s, 1H, CH), 7.13 (t, J= 7.2 Hz, 1H, CHAr), 7.02 (dd, J= 6.9 Hz, 
0.9 Hz, 1H, CHAr), 5.37 (t, J= 8.1 Hz, 1H, CH), 4.63 (d, J= 8.4 Hz, 2H, CH2NO2), 2.46 (s, 3H, 
CH3), 2.33 (s, 3H, CH3) ppm. 
13C NMR (75 MHz, CDCl3):  
δ = 140.0 (CAr), 139.1 (CAr), 136.6 (CAr), 135.4 (C), 134.6 (CAr), 134.1 (CAr), 131.8 (CAr), 
131.5 (CHAr), 130.0 (CAr), 129.9 (CHAr), 129.7 (CHAr), 129.6 (CHAr), 129.1 (CHAr), 127.4 
(CHAr), 126.1 (CHAr), 124.3 (CHAr), 120.8 (CHAr), 120.5 (CAr), 116.1 (CH), 113.8 (CAr), 75.2 
(CH2NO2), 41.8 (CH), 21.7 (CH3), 16.8 (CH3) ppm. 
MS (EI, 70 eV):  
m/z (%) 394.2 (25) [M+], 335.3 (43), 334.2 (100) 
HRMS (ESI):  
calcd. for C26H23O2N2 395.1754 found 395.1756 
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(R)-(2-Methyl-6-phenyl-5,12-dihydrobenzo[4,5]cyclohepta[1,2-b]indol-12-yl) 
methanamine (155) 
 
To a suspension of 154b (1.00g, 2.63 mmol, 1 equiv.), NiCl2.6H2O (0.338g, 2.63 mmol, 0.62 
equiv.) in 30 mL distilled MeOH was added NaBH4 (0.497 g, 13.14 mmol, 5 equiv.) at 0°C 
for 0.5 h. 
The reaction mixture was then quenched at 0°C with saturated NH4Cl solution and extracted 
with DCM. The combined organic phases was washed with brine and dried over MgSO4. The 
concentrated organic fractions was then purified by flash column chromatography (5:95 
MeOH:CH2Cl2 to 10:90 MeOH: CH2Cl2) to yield a yellow solid.  
Yield: 0.729 g, 86 % 
TLC: Rf =  0.18 (95:5 CH2Cl2:MeOH) 
Melting point:   134 °C 
Optical rotation: [ ]23Dα = + 71.4 (c = 0.63, CHCl3) 
1H NMR(300 MHz, CDCl3):  
δ = 7.92 (bs, 1H, NH), 7.60 (s, 1H, CHAr), 7.53-7.59 (m, 2H, CHAr), 7.33-7.49 (m, 6H, CHAr), 
7.23-7.32 (m, 1H, CHAr), 7.09 (d, J= 8.4 Hz, 1H, CHAr), 6.95-7.01 (m, 2H, CH and CHAr), 
4.44 (t, J= 7.8 Hz, 1H, CH), 2.94 (d, J= 7.8 Hz, 2H, CH2NO2), 2.48 (s, 3H, CH3), 1.67 (bs, 2H, 
NH2) ppm. 
13C NMR (75 MHz, CDCl3):  
δ = 140.7 (CAr), 139.1 (CAr), 135.5 (CAr), 134.7 (CAr), 133.7 (CAr), 131.5 (CHAr), 130.5 (CHAr), 
130.0 (CHAr), 129.2 (CAr), 129.1 (CAr), 129.0 (2xCHAr), 128.5 (CHAr), 127.9 (CAr), 126.5 
(CHAr), 124.8 (CHAr), 118.0 (CHAr), 116.1 (CAr), 110.8 (CH), 47.0 (CH), 43.4 (CH2NH2), 
21.8 (CH3) ppm. 
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MS (EI, 70 eV):  
m/z (%) 350.2 (2) [M+], 321.2 (33), 320.2 (100), 318.2 (13) 
IR (Capillary):  
3428, 3016, 2914, 2859, 2685, 2328, 2086, 1918, 1731, 1594, 1546, 1487, 1441, 1374, 1336, 
1304,1266, 1223, 1179, 1111, 1073, 1008, 972, 890, 851, 795, 760, 697, 665 cm-1. 
HRMS (ESI):   
calcd. for C25H23N2 351.1856 found 351.1855. 
(1S,4R)-4,7,7-Trimethyl-N-(((R)-2-methyl-6-phenyl-5,12-dihydrobenzo[4,5] cyclohepta 
[1, 2-b]indol-12-yl)methyl)-3-oxo-2-oxabicyclo[2.2.1]heptane-1-carboxamide (156) 
 
To a stirring solution of 155 (0.300 g, 0.856 mmol, 1 equiv.) in 6 mL of absolute CH2Cl2 was 
added (−)-camphanic chloride (0.371 g, 1.71 mmol, 2 equiv.) at 0°C. NEt3 (0.12 mL, 0.856 
mmol, 1 equiv.) was added and reaction was allowed to stir for 1.5 h at 0°C. The reaction 
mixture was then quenched with 5 mL saturated NH4Cl solution and extracted five times with 
ethyl acetate. The combined organic phases were washed with brine and dried over MgSO4. 
The concentrated organic fractions was then purified by flash column chromatography (2:1 
pentane: Et2O) to yield an off-white solid.  
Yield: 0.390 g, 86 %  
TLC: Rf =  0.20 (2:1 Pentane:Et2O) 
Melting point: 149 °C 
Optical rotation: [ ]24Dα = −3.31 (c= 0.605, CHCl3) 
d.r.= 96:4  
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anal. chiral HPLC (diastereomeric separation): tR 8.83 min (major) 10.49 (minor), elution 
solvent: n-heptane/ethanol, 70:30, 0.7 mL/min, Daicel-IA column. 
1H NMR(400 MHz, CDCl3):  
δ = 7.75 (s, 1H, NH), 7.60-7.65 (m, 2H, CHAr), 7.58 (s, 1H, CHAr), 7.41-7.52 (m, 4H, CHAr), 
7.26-7.37 (m, 3H, CHAr), 7.11 (d, J = 8.0 Hz, 1H, CHAr), 7.07 (s, 1H, CH), 6.99 (dd, J = 8.4, 
1.2 Hz, 1H, CHAr), 6.26 (t,  J = 5.6 Hz, 1H, CONH), 4.80 (t, J = 8.4 Hz, 1H, CH), 3.50-3.67 
(m, 2H, CH2NH), 2.46 (s, 3H, CH3), 2.40 (m, 1H, CH2), 1.86 (m, 1H, CH2), 1.53-1.67 (m, 2H, 
CH2), 1.03 (s, 3H, CH3), 1.02 (s, 3H, CH3), 0.61 (s, 3H, CH3) ppm.  
13C NMR (100 MHz, CDCl3):  
δ = 178.4 (C=O), 167.2 (C=O), 140.5 (CAr), 138.1 (CAr), 135.4 (C), 134.6 (CAr), 133.8 (CAr), 
131.7 (CAr), 131.5 (CHAr), 130.3 (CHAr), 129.9 (CHAr), 129.2 , 129.1 (CHAr), 129.0 (CHAr), 
128.6 (CHAr), 127.5 (CAr), 126.8 (CHAr), 125.0 (CHAr), 118.1 (CHAr), 115.3 (CAr), 110.8 (CH), 
92.7 (C), 55.4 (C), 53.8, 42.4 (CH), 40.1 (CH2NH), 30.5 (CH2), 29.2 (CH2), 21.7 (CH3), 16.9 
(CH3), 16.4 (CH3), 9.8 (CH3) ppm. 
MS (EI, 70 eV):  
m/z (%) 559.4 (6) [M+], 532.4 (18), 531.4 (55), 320.3 (11), 85.3 (25), 75.5 (14) 
IR (Capillary):  
3414, 2968, 2325, 1785, 1669, 1531, 1489, 1441, 1377, 1318, 1268, 1222, 1168, 1120, 1061, 
1020, 985, 954, 921, 889, 859, 798, 764, 699, 663 cm-1. 
HRMS (ESI):   
calcd. for C35H35O3N2 531.2642 found 531.2643. 
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(R)-4-Bromo-N-((2-methyl-6-phenyl-5,12-dihydrobenzo[4,5]cyclohepta[1,2-b]indol-12-
yl)methyl)benzamide (157) 
 
To a stirring solution of 155 (0.200 g, 0.571 mmol, 1 equiv.) in 5 mL absolute CH2Cl2 was 
added p-bromobenzoyl chloride (0.250 g, 1.141 mmol, 2 equiv.) at 0°C. NEt3 (0.08 mL, 0.571 
mmol, 1 equiv.) was added and the reaction was allowed to stir for 1.5 h at 0°C. The reaction 
mixture was then quenched with 5 mL saturated NH4Cl solution and extracted five times with 
ethyl acetate. The combined organic phases were washed with brine and dried over MgSO4. 
The concentrated organic fractions was then purified by flash column chromatography (2:1 
pentane: Et2O) to yield an off-white solid.  
Yield: 0.161 g, 53 % 
TLC: Rf =  0.24 (2:1 Pentane:Et2O) 
Melting point:  136 °C 
Optical rotation: [ ]24Dα = + 8.33 (c= 0.6, CHCl3) 
ee: 91 %  
anal. chiral HPLC: tR 11.03 min (minor) 15.08 min (major), elution solvent: n-
heptane/isopropanol, 70:30, 1.00 mL/min, Daicel-OD column. 
1H NMR(400 MHz, CDCl3):  
δ = 7.78 (bs, 1H, NH), 7.55-7.62 (m, 3H, CHAr), 7.26-7.52 (m, 11H, CHAr), 7.13 (d, J = 8.0 
Hz, 1H, CHAr), 7.02 (d, J = 8.0 Hz, 2H, CH and CHAr), 5.86 (t, J = 5.6 Hz, 1H, CONH), 4.83 
(t, J = 8.0 Hz, 1H, CH), 3.78 (m, 1H, CH2NH), 3.65 (m, 1H, CH2NH), 2.45 (s, 3H, CH3) ppm. 
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13C NMR (100 MHz, CDCl3):  
δ = 166.8 (C=O), 140.5 (CAr), 138.1 (CAr), 135.3 (CAr), 134.8 (CAr), 133.9 (CAr), 133.8 (CHAr), 
131.8 (CHAr), 131.7 (CHAr), 130.6 (CHAr), 130.1 (CHAr), 129.6 (CAr), 129.5 (CAr), 129.1 (CAr), 
128.7 (CHAr), 128.6 (CHAr), 127.8 (CAr), 126.9 (CHAr), 126.0 (CAr), 125.2 (CHAr), 118.0 
(CHAr), 115.4 (CAr), 110.9 (CH), 42.7 (CH), 41.5 (CH2), 21.7 (CH3) ppm 
MS (EI, 70 eV): 
 m/z (%) 532.2 (1) [M+], 321.3 (24), 320.2 (100), 318.2 (16) 
IR (Capillary):  
3635, 3428, 3285, 2920, 2854, 2660, 2323, 2107, 1644, 1589, 1525, 1480, 1435, 1382, 1303, 
1221, 1179, 1151, 1112, 1070, 1009, 842, 797, 755, 699, 662 cm-1. 
HRMS (ESI):  
calcd. for C32H26ON2Br 533.1150 found 533.1209. 
5-Methoxy-2-methyl-1'-(nitromethyl)-3'-phenyl-1'H-spiro[indole-3,2'-naphthalene (164) 
 
To a Schlenk tube (under open flask condition) containing a solution (26 mg, 0.08 mmol, 0.1 
equiv.) of quinolinyl thioamide catalyst precursor ent-37' in CHCl3 (4 mL) was added 
trifluomethanesulfonic acid (7.1 µL, 0.08 mmol, 0.1 equiv.). The bright reddish-orange 
solution was stirred for 5 min. NaBArF24 (71 mg, 0.08 mmol, 0.1 equiv.) was added into the 
reaction mixture and allowed to stir for 10 min until a light orange solution is observed. 5a 
(0.200 g ,0.8 mmol, 1 equiv.) was dissolved in CHCl3 (4 mL) and added into the reaction 
mixture. This reaction was then cooled to −30°C. 17 (0.194 g ,1.2 mmol, 1.5 equiv.) was 
dissolved in CHCl3 (2 mL) and transferred into the cooled reaction mixture. The reaction was 
monitored by TLC until full conversion of the first tandem step is observed (9.5 h). 
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The reaction mixture was then allowed to warm to RT over 30 min, p-toluenesulfonic acid 
hydrate (0.114g, 0.6 mmol, 0.75 equiv.) was first added and allowed to stir for a further 5 min. 
PPh3AuNTf2 (0.08 mmol, 0.1 equiv., (preactivated by reacting 0.08 mmol of PPh3AuCl and 
0.08 mmol of AgNTf2 in 1 mL chloroform in a separate vial) was transferred to the reaction 
mixture. The Schlenk tube was subsequently sealed under air and transferred to a 80°C oil 
bath and allowed to stir at this refluxing temperature till no further changes are observed on 
TLC (37 h). Silica gel was added to the reaction mixture, rotary evaporated and dry loaded 
onto a flash column for purification (2:1 pentane: Et2O to 1:1 pentane: Et2O) to yield a brown 
solid. 
Yield: 27 mg, 8.2% 
TLC: Rf =  0.16 (2:1 Pentane:Et2O) 
Melting point:  76 °C 
1H NMR(300 MHz, CDCl3, mixture of diastereomers):  
δ = 7.54 (d, J = 8.4 Hz, 0.14 H, CHAr), 7.43 (d, J = 8.4 Hz, 0.98 H, CHAr), 7.25-7.35 (m, 3H, 
CHAr), 7.01-7.12 (m, 4H, CHAr), 6.96 (s, 0.96 H, CH), 6.93 (s, 0.07 H, CH), 6.72-6.86 (m, 3H, 
CHAr), 6.70 (d, J = 2.7 Hz, 0.90 H, CHAr), 6.28 (d, J = 2.4 Hz, 0.04 H, CHAr), 4.61 (m, 1.94 H, 
CH2NO2), 4.34 (m, 0.07 H, CH2NO2), 3.66 (s, 3H, OCH3), 3.58-3.64 (m, 1H, CH), 2.12 (s, 
0.13 H, CH), 1.98 (s, 2.85 H, CH3) ppm.  
13C NMR (75 MHz, CDCl3):  
δ = 179.8 (N=C), 159.1 (CAr-OMe), 148.9 (CAr), 144.0 (CAr), 140.1 (CAr), 139.3 (CAr), 133.6 
(CAr), 132.0 (CAr), 130.7 (CHAr), 128.9 (CHAr), 128.6 (CHAr), 128.4 (CHAr), 127.9 (CHAr), 
127.8 (CHAr), 125.9 (CHAr), 125.0 (CHAr), 121.0 (CHAr), 114.3 (CHAr), 109.6 (CH), 74.4 
(CH2NO2), 64.8 (Cquartenary), 55.9 (CH3), 43.9 (CH), 18.3 (OCH3) ppm 
MS (EI, 70 eV): 
 m/z (%) 410.2 (15) [M+], 351.2 (26), 350.3 (100), 85.3 (47), 83.3 (75) 
IR (Capillary):  
3060, 3027, 2920, 2838, 2076, 1689, 1617, 1596, 1552, 1472, 1429, 1375, 1339, 1279, 1213, 
1160, 1112, 1028, 946, 896, 819, 757, 697, 632, 608, 571, 525 cm-1. 
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HRMS (EI):   
calcd. for C26H22O3N2 410.1625 found 410.1632 
(E)-5-Bromo-1-nitropent-1-ene (194) 
 
To a solution of bromoaldehyde 193 (16.0 g, 106 mmol, 1 equiv.) and nitromethane (57.1 mL, 
1060 mmol, 10 equiv.) in THF (100 mL) was added NEt3 (14.8 mL, 106 mmol, 1 equiv.) at 
RT. The reaction mixture was allowed to stir at RT for 24 h. 1 N HCL was then added to 
quench the reaction. The aqueous phase was extracted three times with Et2O (3 x 250 mL) and 
the combined organic phases are then washed successively with saturated NaHCO3, brine and 
dried over MgSO4. The organic phases were then concentrated in vacuo and the crude product 
concentrated product was dissolved in dry CH2Cl2 (31 mL) and cooled in a salt ice bath. 
TFAA (4.75 mL, 33.6 mmol, 1.1 equiv.) was then added using a syringe under argon. After 
stirring for 5 min, NEt3 (8.94 mL, 64.2 mmol, 2.1 equiv.) was added dropwise over 10 min 
and the reaction was allowed to stir for a further 15 min at salt ice bath temperature.  
The reaction was subsequently diluted with CH2Cl2 and quenched with saturated NH4Cl. The 
aqueous phase was extracted three times with CH2Cl2 (3 x 250 mL) and the concentrated 
organic phases are dried over MgSO4. The organic phases was then concentrated in vacuo and 
purified by flash column chromatography (30:1 Pentane: Et2O) to yield a yellow oil. 
Yield: 3.05 g, 15% over two steps 
1H NMR(300 MHz, CDCl3):  
 
δ = 7.25 (dt, J = 12.6, 8.4 Hz, 1H, =CHNO2), 7.03 (d, J = 13.5 Hz, 1H, CH=C), 3.44 (t, J = 
6.3 Hz, 2H, CH2), 2.48 (q, J = 7.2 Hz, 2H, CH2), 2.08 (q, J = 6.3 Hz, 2H, CH2) ppm. 
13C NMR (75 MHz, CDCl3): 
δ = 140.6 (CH x 2), 32.2 (CH2), 30.5 (CH2), 27.0 (CH2) ppm. 
The analytical data are in agreement with those reported in the literature.[99] 
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(E)-5-Iodo-1-nitropent-1-ene (192) 
 
To a solution of (E)-5-bromo-1-nitropent-1-ene (3.00 g, 15.5 mmol, 1 equiv.) in 30 mL of 
distilled acetone was added NaI (6.95 g, 46.4 mmol, 3 equiv.) and stirred under reflux for 3h 
and then cooled to RT. The solvent was evaporated in vacuo and the resulting residue was 
redissolved in ether and washed with water. The aqueous layer was then extracted with ether 
(3 x 300 mL). The concentrated organic phases were dried with MgSO4 and concentrated in 
vacuo.  
192 was obtained by flash column chromatography of the crude product (10:1 Pentane:Et2O) 
to yield a yellow oil. 
 
Yield: 3.26 g, 87% 
 
1H NMR(300 MHz, CDCl3):  
δ = 7.17-7.29 (dt, J = 13.5 ,7.5 Hz, 1H, =CHNO2), 7.04 (dt, J = 13.5, 1.2 Hz, 1H, CH=C), 
3.21 (t, J = 6.6 Hz, 2H, CH2), 2.43 (qd, J = 7.2, 1.5 Hz, 2H, CH2), 2.03 (q, J = 7.8 Hz, 2H, 
CH2) ppm. 
 
13C NMR (75 MHz, CDCl3): 
δ = 140.6 (CH), 140.4 (CH), 31.0 (CH2), 29.3 (CH2), 4.8 (CH2) ppm. 
 
The analytical data are in agreement with those reported in the literature.[99] 
(R)-4-(Nitromethyl)-2,3,4,9-tetrahydro-1H-carbazole (196a) 
 
196a was synthesized by GP2 and isolated by flash column chromatography (3:1 pentane: 
Et2O) to yield a brown solid.  
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Yield: 0.093 g, 68%  
TLC: Rf =  0.28 (2:1 Pentane:Et2O) 
Melting point: 93 °C 
Optical rotation: [ ]27Dα = − 13.7 (c = 0.53, CHCl3) 
ee: 90%  
anal. chiral HPLC: tR 9.09 min (minor) 10.27 min (major), elution solvent: n-
heptane/isopropanol, 90:10, 1.00 mL/min, Daicel-IA column. 
 
1H NMR(400 MHz, CDCl3):  
δ = 7.83 (bs, 1H, NH), 7.51 (d, J = 7.6 Hz, 1H, CHAr), 7.30 (d, J = 7.6 Hz, 1H, CHAr), 7.10-
7.18 (m, 2H, CHAr), 4.87 (dd, J = 12, 4 Hz, 1H, CH2NO2), 4.42 (t, J = 10.8 Hz, 1H, CH2NO2), 
3.90 (m, 1H, CH), 2.75 (m, 2H, CH2), 1.90-2.00 (m, 4H, 2x CH2) ppm.  
13C NMR (100 MHz, CDCl3):  
δ = 135.9 (CAr), 135.8 (CAr), 126.5 (CAr), 121.9 (CHAr), 120.1 (CHAr), 117.6 (CHAr), 111.1 
(CHAr), 107.6 (CAr), 78.9 (CH2NO2), 32.0 (CH), 26.0 (CH2), 23.2 (CH2), 19.0 (CH2) ppm.  
MS (EI, 70 eV):  
m/z (%) 230.2 (66) [M+], 183.2 (100), 170.2 (76), 161.8 (35), 154.1 (21), 143.2 (16), 130.2 
(15). 
IR (Capillary):  
3398, 3060, 2932, 2860, 2080, 1585, 1536, 1452, 1379, 1326, 129, 1232, 1212, 1158, 1078, 
1013, 968, 919, 846, 787, 738, 688, 658 cm-1. 
Elemental Analysis: 
Calcd. for C13H14N2O2: C, 67.81; H, 6.13; N, 12.17; found: C, 67.99; H, 5.91; N, 11.74 
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(R)-6-Methoxy-4-(nitromethyl)-2,3,4,9-tetrahydro-1H-carbazole (196b) 
 
196b was synthesized by GP2 and was isolated by flash column chromatography (3:1 pentane: 
Et2O) to yield an off-white solid. 
Yield: 0.104 g, 66%  
TLC: Rf =  0.21 (2:1 Pentane:Et2O) 
Melting point:  143 °C; 
Optical rotation:  [ ]27Dα = −10.9 (c = 0.46, CHCl3),  
ee: 87% before recrystallization, 98% after recrystallization over methanol 
anal. chiral HPLC:  tR 12.16 min (minor)  14.30 min (major), elution solvent: n-
heptane/isopropanol, 90:10, 1.00 mL/min, Daicel-IA column. 
 
1H NMR(400 MHz, CDCl3):  
δ = 7.73 (bs, 1H, NH), 7.18 (d, J = 8.8 Hz, 1H, CHAr), 6.94 (s, J = 2.4 Hz, 1H, CHAr), 6.80 (dd, 
J = 8.4, 2.4 Hz, 1H, CHAr), 4.81(dd, J = 12, 4 Hz, 1H, CH2NO2), 4.41 (t, J = 10.8 Hz, 1H, 
CH2NO2), 3.85 (s, 3H, OCH3), 3.81-3.88 (m, 1H, CH), 2.69-2.76 (m, 2H, CH2), 1.84-1.98 (m, 
4H, 2 x CH2) ppm. 
13C NMR (100 MHz, CDCl3):  
δ = 154.5 (CAr), 136.8 (CAr), 130.9 (CAr), 127.0 (CAr), 111.7 (CHAr), 111.4 (CHAr), 107.5 (CAr), 
100.2 (CHAr), 78.7 (CH2NO2), 56.3 (OCH3), 32.0 (CH), 26.0 (CH2), 23.3 (CH2), 18.9 (CH2) 
ppm. 
MS (EI, 70 eV):  
m/z (%) 260.1 (100) [M+], 213.2 (95), 200.1 (90), 170.1 (12), 154.1 (11), 143.1 (10). 
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IR (Capillary):  
3336, 2933, 2858, 2835, 2333, 2080, 1627, 1591, 1541, 1481, 1454, 1430, 1377, 1324, 1296, 
1209, 1180, 1134, 1115, 1081, 1022, 973, 935, 826, 798, 762, 683 cm-1. 
Elemental Analysis: 
Calcd. For C14H16N2O3: C, 64.60; H, 6.20; N, 10.76; found: C, 64.35; H, 6.36; N, 10.46 
(R)-6-Bromo-4-(nitromethyl)-2,3,4,9-tetrahydro-1H-carbazole (196c) 
 
196c was synthesized by GP2 and was isolated by two successive flash column 
chromatography (first 3:1 pentane: Et2O, then 2:1 pentane: CH2Cl2) to yield a brown solid.  
Yield: 61 mg, 33% 
TLC: Rf =  0.13 (2:1 Pentane:Et2O) 
Melting point:  106  °C 
Optical rotation: [ ]27Dα = − 9.8 (c = 0.51, CHCl3) 
ee: 90%  
anal. chiral HPLC:  tR 13.28 min (minor) 14.69 min (major), elution solvent: n-
heptane/isopropanol, 90:10, 0.70 mL/min, Daicel-AD column. 
 
1H NMR(400 MHz, CDCl3):  
δ = 7.89 (bs, 1H, NH), 7.61 (s, J = 2 Hz, 1H, CHAr), 7.23 (dd, J = 8.4, 1.6 Hz, 1H, CHAr), 7.17 
(d, J = 8.8 Hz, 1H, CHAr), 4.80 (dd, J = 12, 4 Hz, 1H, CH2NO2), 4.41 (t, J = 11.2 Hz, 1H, 
CH2NO2), 3.80-3.90 (m, 1H, CH), 2.70-2.80 (m, 2H, CH2), 1.80-2.00 (m, 4H, 2 x CH2) ppm. 
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13C NMR (100 MHz, CDCl3):  
δ = 137.4 (CAr), 134.5 (CAr), 128.3 (CAr), 124.7 (CHAr), 120.2 (CHAr), 113.3 (CAr), 112.4 
(CHAr), 107.4 (CAr), 78.6 (CH2NO2), 31.7 (CH), 25.9 (CH2), 23.2 (CH2), 18.8 (CH2) ppm. 
MS (EI, 70 eV):  
m/z (%)  310.1 (67) [M+], 263.1 (90), 261.1 (100), 248.1 (50), 183.2 (28), 182.2 (31), 168.2 
(45), 167.2 (35), 154.2 (23), 91.2 (13), 90.4 (23), 83.7 (28), 77.4 (23). 
IR (Capillary):  
3403, 3230, 2935, 2063, 1705, 1626, 1540, 1459, 1370, 1203, 1120, 1066, 995, 918, 841, 781, 
712 cm-1. 
HRMS (ESI):  
calcd. for C13H14O2N2Br: 309.0233 found 309.0228 
(R)-6-Methyl-4-(nitromethyl)-2,3,4,9-tetrahydro-1H-carbazole (196d) 
 
196d was synthesized by GP2 and isolated by flash column chromatography (3:1 pentane: 
Et2O) to yield a biege solid.  
Yield: 119 mg, 81% 
TLC: Rf =  0.31 (2:1 Pentane:Et2O) 
Melting point:  145 °C  
Optical rotation: [ ]27Dα = − 11.9 (c = 0.67, CHCl3) 
ee: 89% ee before recrystallization, 97% ee after recrystallization over methanol 
anal. chiral HPLC: tR 10.58 min (minor) 11.32 min (major), elution solvent: n-
heptane/ethanol, 70:30, 0.40 mL/min, Daicel-IA column. 
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1H NMR(400 MHz, CDCl3):  
δ = 7.73 (bs, 1H, NH), 7.29 (s, 1H, CHAr), 7.19 (d, J = 8 Hz, 1H, CHAr), 6.98 (d, J = 8 Hz, 1H, 
CHAr), 4.87 (dd, J = 12, 3.6 Hz, 1H, CH2NO2), 4.41 (t, J = 11.2 Hz, 1H, CH2NO2), 3.81-3.92 
(m, 1H, CH), 2.69-2.79 (m, 2H, CH2), 2.45 (s, 3H, CH3), 1.86-2.01 (m, 4H, 2 x CH2) ppm. 
13C NMR (100 MHz, CDCl3):  
δ = 136.1 (CAr), 134.2 (CAr), 129.4 (CAr), 126.7 (CAr), 123.4 (CHAr), 117.4 (CHAr), 110.7 
(CHAr), 107.1 (CAr), 78.8 (CH2NO2), 32.0 (CH), 26.0 (CH2), 23.2 (CH2), 21.7 (CH3), 19.0 
(CH2) ppm. 
MS (EI, 70 eV):  
m/z (%) 244.3 (85) [M+], 197.3 (93), 184.3 (100), 168.2 (27), 154.2 (19), 144.3 (13) 
IR (Capillary):  
3378, 2937, 2860, 1589, 1544, 1458, 1430, 1377, 1314, 1284, 1228, 1194, 1130, 1013, 869, 
803, 763, 686 cm-1. 
Elemental Analysis: 
Calcd. For C14H16N2O2: C, 68.83; H, 6.60; N, 11.47; found: C, 68.86; H, 6.63; N, 11.35. 
(R)-7-Methyl-4-(nitromethyl)-2,3,4,9-tetrahydro-1H-carbazole (196e) 
 
196e was synthesized by GP2 and isolated by flash column chromatography (3:1 pentane: 
Et2O) to yield a yellow syrup. 
Yield: 116 mg, 79% 
TLC: Rf =  0.29 (2:1 Pentane:Et2O) 
Optical rotation: [ ]27Dα = − 14.5 (c = 0.51, CHCl3) 
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ee: 86%  
anal. chiral HPLC: tR 18.85 min (minor) 22.32 min (major), elution solvent: n-
heptane/ethanol, 90:10, 0.50 mL/min, Daicel-AD column. 
 
1H NMR(400 MHz, CDCl3):  
δ = 7.70 (bs, 1H, NH), 7.38 (d, J = 8 Hz, 1H, CHAr), 7.10 (s, 1H, CHAr), 6.95 (d, J = 8 Hz, 1H, 
CHAr), 4.86 (dd, J = 11.6, 4 Hz, 1H, CH2NO2), 4.41 (t, J = 11.2 Hz, 1H, CH2NO2), 3.81-3.93 
(m, 1H, CH), 2.69-2.76 (m, 2H, CH2), 2.44 (s, 3H, CH3), 1.86-1.99 (m, 4H, 2 x CH2) ppm. 
13C NMR (100 MHz, CDCl3):  
δ = 136.4 (CAr), 135.2 (CAr), 131.8 (CAr), 124.3 (CAr), 121.7 (CHAr), 117.3 (CHAr), 111.1 
(CHAr), 107.4 (CAr), 79.0 (CH2NO2), 32.1 (CH), 26.1 (CH2), 23.2 (CH2), 21.9 (CH3), 19.0 
(CH2) ppm. 
MS (EI, 70 eV):  
m/z (%) 244.2 (81) [M+], 197.2 (100), 184.2 (92), 182.2 (28), 168.1 (24), 154.1 (17), 144.1 
(13), 128.1 (10), 115.1 (10), 90.2 (12), 77.3 (15) 
IR (Capillary):  
3925, 3637, 3436, 3219, 3022, 2919, 2736, 2669, 2436, 2367, 2250, 1872, 1720, 1623, 1460, 
1380, 1326, 1213, 1161, 1078, 999, 921, 859, 802, 741, 669, 622, 541 cm-1. 
HRMS (ESI):  
calcd. for C14H17O2N2: 245.1285, found 245.1285 
(R)-8-Methyl-4-(nitromethyl)-2,3,4,9-tetrahydro-1H-carbazole (196f) 
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196f was synthesized by GP2 and isolated by flash column chromatography (3:1 pentane: 
Et2O) to yield a light yellow solid  
Yield: 75 mg, 51% 
TLC: Rf =  0.31 (2:1 Pentane:Et2O) 
Melting point:  161 °C; 
Optical rotation: [ ]27Dα = − 8.2 (c = 0.55, CHCl3) 
ee: 93%  
anal. chiral HPLC: tR 20.35 min (minor) 22.76 min (major), elution solvent: n-
heptane/isopropanol, 95:5, 1.00 mL/min, Daicel-AS column. 
1H NMR(400 MHz, CDCl3):  
δ = 7.77 (bs, 1H, NH), 7.37 (d, J = 7.6 Hz, 1H, CHAr), 7.05 (t, J = 7.6 Hz, 1H, CHAr), 6.97 (d, 
J = 7.2 Hz, 1H, CHAr), 4.87 (dd, J = 12, 4 Hz, 1H, CH2NO2), 4.41 (t, J = 11.2 Hz, 1H, 
CH2NO2), 3.85-3.94 (m, 1H, CH), 2.73-2.82 (m, 2H, CH2), 2.46 (s, 3H, CH3), 1.87-2.02 (m, 
4H, 2 x CH2) ppm. 
13C NMR (100 MHz, CDCl3):  
δ = 135.6 (CAr), 135.3 (CAr), 126.0 (CAr), 122.7 (CHAr), 120.3 (CAr), 120.2 (CHAr), 115.4 
(CHAr), 108.1 (CAr), 78.9 (CH2NO2), 32.1 (CH), 26.1 (CH2), 23.2 (CH2), 19.0 (CH2), 16.8 
(CH3) ppm. 
MS (EI, 70 eV):  
m/z (%) 244.2 (77) [M+], 197.2 (100), 184.1 (98), 168.2 (23), 154.1 (18), 144.1 (12), 128.1 
(19), 90.4 (14), 77.3 (13). 
IR (Capillary):  
3404, 3054, 2929, 2858, 1620, 1583, 1537, 1461, 1428, 1379, 1327, 1215, 1156, 1080, 971, 
906, 856, 773, 744, 688 cm-1. 
Elemental Analysis: 
Calcd. For C14H16N2O2: C, 68.83; H, 6.60; N, 11.47; found: C, 68.60; H, 6.53; N, 11.09 
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(R)-6-Fluoro-4-(nitromethyl)-2,3,4,9-tetrahydro-1H-carbazole (196g) 
 
196g was synthesized by GP2 and isolated by flash column chromatography (3:1 pentane: 
Et2O) to yield a pale yellow solid.  
Yield: 87 mg, 58% 
TLC: Rf =  0.17 (2:1 Pentane:Et2O) 
Melting point:   97 °C 
Optical rotation: [ ]27Dα = − 6.1 (c = 0.58,  CHCl3) 
ee: 87%  
anal. chiral HPLC: tR 23.73 min (major) 30.35 min (minor), elution solvent: n-
heptane/isopropanol, 90:10, 0.70 mL/min, Daicel-OD column. 
 
1H NMR(400 MHz, CDCl3): 
 δ = 7.86 (bs, 1H, NH), 7.21 (dd, J = 8.8, 4.4 Hz, 1H, CHAr), 7.15 (dd, J = 9.6, 2.4 Hz, 1H, 
CHAr), 6.89 (td, J = 9.2, 2.4 Hz, 1H, CHAr), 4.78 (dd, J =12, 4 Hz, 1H, CH2NO2), 4.42 (t, J = 
10.8 Hz, 1H, CH2NO2), 3.78-3.88 (m, 1H, CH), 2.70-2.80 (m, 2H, CH2), 1.88-2.00 (m, 4H, 2 
x CH2) ppm. 
13C NMR (100 MHz, CDCl3):  
δ = 157.9 (d, J = 233 Hz, CAr), 137.9 (CAr), 132.3 (CAr), 126.9 (d, J = 9.4 Hz, CAr), 111.6 (d, J 
= 9.4 Hz, CHAr), 109.9 (d, J = 25.7 Hz, CHAr), 107.9 (d, J = 4.2 Hz, CAr), 102.9 (d, J = 23.8 
Hz, CHAr), 78.6 (CH2NO2), 31.9 (CH), 26.0 (CH2), 23.3 (CH2), 18.8 (CH2) ppm. 
19F(376 MHz, CDCl3):  
δ = 123.9 ppm. 
Experimental Part 
138 
 
MS (EI, 70 eV): 
 m/z (%) 248.4 (69) [M+], 201.3 (100), 188.3 (48), 172.2 (15), 161.3 (12), 148.2 (11). 
IR (Capillary):  
3401, 2935, 2334, 2043, 1734, 1630, 1584, 1539, 1446, 1379, 1317, 1218, 1170, 1124, 1002, 
938, 843, 796, 763, 686 cm-1. 
Elemental Analysis: 
Calcd. for C13H13FN2O2: C, 62.90; H, 5.28; N, 11.28; found: C, 62.84; H, 5.02; N, 10.91 
(R)-6-Chloro-4-(nitromethyl)-2,3,4,9-tetrahydro-1H-carbazole (196h) 
 
196h was synthesized by GP2 and isolated by flash column chromatography (3:1 pentane: 
Et2O) to yield a biege solid.  
Yield: 111 mg, 70% 
TLC: Rf =  0.19 (2:1 Pentane:Et2O) 
Melting point:  119 °C;  
Optical rotation: [ ]27Dα = − 8.73 (c = 0.63, CHCl3) 
ee: 91% ee before recrystallization, 95% ee after recrystallization over benzene  
anal. chiral HPLC: tR 19.44 min (minor) 22.67 min (major), elution solvent: n-
heptane/isopropanol, 95:5, 1.00 mL/min, Daicel-AD column. 
 
1H NMR(400 MHz, CDCl3):  
δ = 7.88 (bs, 1H, NH), 7.46(s, J = 2 Hz, 1H, CHAr), 7.21 (d, J = 8.8 Hz, 1H, CHAr), 7.10 (dd, J 
= 8.4, 1.6 Hz, 1H, CHAr), 4.80 (dd, J = 12, 4 Hz, 1H, CH2NO2), 4.41 (t, J = 10.8 Hz, 1H, 
CH2NO2), 3.80-3.88 (m, 1H, CH), 2.70-2.79 (m, 2H, CH2), 1.85-2.02 (m, 4H, 2 x CH2) ppm. 
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13C NMR (100 MHz, CDCl3):  
δ = 137.5 (CAr), 134.3 (CAr), 127.6 (CAr), 125.8 (CAr), 122.1 (CHAr), 117.2 (CHAr), 112.0 
(CHAr), 107.5 (CAr), 78.6 (CH2NO2), 31.7 (CH), 25.9 (CH2), 23.2 (CH2), 18.8 (CH2) ppm. 
MS (EI, 70 eV):  
m/z (%) 264.2 (81) [M+], 217.2 (100), 204.3 (63), 183.3 (18), 168.2 (20), 154.2 (15), 90.4 (10), 
77.4 (11). 
IR (Capillary):  
3406, 3266, 2939, 2854, 2247, 2196, 2115, 1855, 1704, 1578, 1534, 1466, 1434, 1377, 1313, 
1283, 1235, 1207, 1176, 1126, 1062, 994, 971, 927, 851, 799, 719, 671 cm-1. 
Elemental Analysis: 
Calcd. for C13H13ClN2O2: C, 58.99; H, 4.95; N, 10.58; found: C, 58.86; H, 5.13; N, 10.39 
(R)-7-Chloro-4-(nitromethyl)-2,3,4,9-tetrahydro-1H-carbazole (196i) 
 
196i was synthesized by GP2 and isolated by flash column chromatography (3:1 pentane: 
Et2O) to yield a brown solid.  
Yield: 92 mg, 58% 
TLC: Rf =  0.21 (2:1 Pentane:Et2O) 
Melting point: 86 °C 
Optical rotation: [ ]22Dα = −7.55 (c = 0.53, CHCl3) 
ee: 87%  
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anal. chiral HPLC: tR 9.75 min (minor) 22.98 min (major), elution solvent: n-
heptane/ethanol, 70:30, 1.00 mL/min, Daicel-OJ column. 
1H NMR(600 MHz, CDCl3):  
δ = 7.83 (bs, 1H, NH), 7.39 (d, J = 8.4 Hz, 1H, CHAr), 7.27 (s, J = 1.2 Hz, 1H, CHAr), 7.08 (dd, 
J = 8.4, 1.8 Hz, 1H, CHAr), 4.79 (dd, J = 12, 4.2 Hz, 1H, CH2NO2), 4.42 (t, J = 10.8 Hz, 1H, 
CH2NO2), 3.83-3.92 (m, 1H, CH), 2.71-2.76 (m, 2H, CH2), 1.87-1.99 (m, 4H, 2 x CH2) ppm. 
13C NMR (150 MHz, CDCl3):  
δ = 136.7 (CAr), 136.3 (CAr), 127.8 (CAr), 125.2 (CAr), 120.7 (CHAr), 118.4 (CHAr), 111.1 
(CHAr), 111.0 (CHAr), 107.9 (CAr), 78.9 (CH2NO2), 31.9 (CH), 26.0 (CH2), 23.1 (CH2), 18.8 
(CH2) ppm;   
MS (EI, 70 eV):  
m/z (%) 264.2 (79) [M+], 217.2 (100), 204.2 (56), 183.2 (18), 168.2 (24), 154.2 (21) 
IR (Capillary):  
3410, 2935, 2864, 1619, 1543, 1463, 1379, 1325, 1235, 1211, 1152, 1063, 986, 913, 893, 848 
803, 717 cm-1. 
Elemental Analysis: 
Calcd. for C13H13ClN2O2: C, 58.99; H, 4.95; N, 10.58; found: C, 59.31; H, 4.77; N, 10.21 
(R)-4-(Nitromethyl)-6-phenyl-2,3,4,9-tetrahydro-1H-carbazole (196j) 
 
196j was synthesized by GP2 and isolated by two consecutive flash column chromatography 
(first 3:1 pentane: Et2O then 2:1 pentane: Et2O) to yield an off-white foam.  
Yield: 135 mg, 74%. 
TLC: Rf =  0.21 (2:1 Pentane:Et2O) 
Experimental Part 
141 
 
Melting point:  63 °C 
Optical rotation: [ ]22Dα = −13.3 (c = 0.57, CHCl3) 
ee:  88%  
anal. chiral HPLC: tR 11.38 min (major) 15.16 min (minor), elution solvent: n-
heptane/isopropanol, 70:30, 0.50 mL/min, Daicel-OD column. 
 
1H NMR(400 MHz, CDCl3):  
δ = 7.86 (bs, 1H, NH), 7.67 (s, 1H, CHAr), 7.63 (dd, J = 8, 1.2 Hz, 2H, CHAr), 7.44 (t, J = 7.6 
Hz, 2H, CHAr), 7.40 (dd, J = 8.4, 1.6 Hz, 1H, CHAr), 7.35 (dd, J = 8.4, 0.4 Hz, 1H, CHAr), 
7.31 (tt, J = 7.6, 2 Hz, 1H, CHAr), 4.89 (dd, J = 11.6, 3.6 Hz, 1H, CH2NO2), 4.44 (t, J = 11.2 
Hz, 1H, CH2NO2), 3.89-3.98 (m, 1H, CH), 2.70-2.80 (m, 2H, CH2), 1.85-2.05 (m, 4H, 2 x 
CH2) ppm. 
13C NMR (100 MHz, CDCl3):  
δ = 142.5 (CAr), 136.7 (CAr), 135.4 (CAr), 133.9 (CAr), 128.9, 127.6 (CAr), 127.0 (CHAr), 126.7 
(CHAr), 121.8 (CHAr), 116.2 (CHAr), 111.3 (CHAr), 108.0 (CAr), 78.8 (CH2NO2), 31.9 (CH), 
26.0 (CH2), 23.3 (CH2), 18.9 (CH2) ppm. 
MS (EI, 70 eV):  
m/z (%) 306.2 (86) [M+],, 259.2 (99), 246.1 (70), 230.1 (14), 219.2 (12), 129.7 (13). 
IR (Capillary):  
3406, 3054, 2931, 2863, 1597, 1542, 1465, 137, 1316, 1232, 120, 1145, 1078, 992, 917, 875, 
811, 758, 696 cm-1. 
HRMS (ESI):  
calcd. for C19H19O2N2: 307.1441, found: 307.1440 
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(R)-7-(Nitromethyl)-8,9,10,11-tetrahydro-7H-benzo[a]carbazole (196k) 
 
196k was was synthesized by GP2 and isolated by flash column chromatography (3:1 pentane: 
Et2O) to yield a greenish-brown solid. 
Yield: 67 mg, 40% 
TLC: Rf =  0.28 (2:1 Pentane:Et2O) 
Melting point:   58 °C (decomposition) 
Optical rotation: [ ]22Dα = + 19.1 (c = 0.53, CHCl3) 
ee: 96%  
anal. chiral HPLC: tR 14.52 min (minor) 18.84 min (major), elution solvent: n-
heptane/isopropanol, 90:10, 1.00 mL/min, Daicel-IA column. 
 
1H NMR(400 MHz, CDCl3):  
 
δ = 8.58 (bs, 1H, NH), 7.92 (t, J = 7.6 Hz, 2H, CHAr), 7.61 (d, J = 8.4 Hz, 1H, CHAr), 7.53 (d, 
J = 8.4 Hz, 1H, CHAr), 7.49 (d, J = 8.0 Hz, 1H, CHAr), 7.40 (t, J = 8.4 Hz, 1H, CHAr), 4.88 (dd, 
J = 12, 4 Hz, 1H, CH2NO2), 4.47 (t, J = 11.2 Hz, 1H, CH2NO2), 3.92-4.02 (m, 1H, CH), 2.76-
2.93 (m, 2H, CH2), 1.90-2.05 (m, 4H, 2 x CH2) ppm. 
 
13C NMR (100 MHz, CDCl3):  
 
δ = 133.9 (CAr), 130.3 (CAr), 130.2 (CAr), 129.2 (CHAr), 125.8 (CHAr), 124.0 (CHAr), 122.1 
(CAr), 121.6 (CAr), 120.9 (CHAr), 119.3 (CHAr), 117.8 (CHAr), 109.5 (CAr), 79.2 (CH2NO2), 
32.0 (CH), 26.1 (CH2), 23.2 (CH2), 19.0 (CH2) ppm. 
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MS (EI, 70 eV):  
 
m/z (%) 280.5 (22) [M+], 233.5 (43), 220.5 (53), 204.4 (50), 193.5 (29), 180.5 (15), 116.8 (51), 
108.9 (100), 102.5 (55), 94.7 (11), 88.4 (10) 
 
HRMS (ESI):  
calcd. for C17H17O2N2: 281.1285, found: 281.1285 
(R)-1-(6-Methoxy-9-(phenylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-4-yl)-N,N-
dimethylmethanamine (169) 
MeO
N
H
NO2
1. NaBH4,
NiCl2.6H2O
2. HCHO,
NaCNBH3
3. NaH,
PhSO2Cl
43% in 3 steps
DMF, RT
MeO
N
N
H3C
CH3
SO2Ph
96% ee No intermediate
purification
97% ee
MeOH, 3h MeOH, AcOH,
RT
196b (R)-169
 
To a suspension of 196b (179 mg, 0.688 mmol, 1 equiv.) and NiCl2.6H2O (236 mg, 0.825 
mmol, 1.2 equiv.) in 5 mL of distilled MeOH in a round bottom flask was added NaBH4 (130 
mg, 3.44 mmol, 5 equiv.) at 0°C under argon. The reaction was stirred for 3h at 0°C and 
quenched with saturated NH4Cl solution and added CH2Cl2. The aqueous layer was extracted 
with CH2Cl2 (5x50 mL), the organic phase was dried over MgSO4 and the product was 
concentrated in vacuo to yield an off white foam.   
The crude product was directly dissolved in 10 mL distilled MeOH  and glacial acetic acid 
(0.158 mL, 2.75 mmol, 4 equiv.) was added at RT. The reaction mixure was cooled in an ice 
bath and NaCNBH3 (86 mg, 1.38 mmol, 2 equiv.) was added in portions under argon. An 
aqueous solution of formaldehyde (37% solution in water) (0.140 g, 1.72 mmol, 2.5 equiv.) 
dissolved in 5 mL distilled MeOH was transferred into the reaction dropwise by syringe and 
the reaction was allowed to stir overnight at RT. 2M aqueous Na2CO3 was added to change 
the pH of the solution to 8-9 and the reaction mixture was concentrated in vacuo to remove 
MeOH. The residue was then partitioned between CH2Cl2 and water. The aqueous phase was 
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extracted with CH2Cl2 (5 x 50 mL), the organic phase was then dried over MgSO4 and 
concentrated in vacuo to yield a yellow oil.  
To the crude product from the previous step was added 60% NaH in paraffin (41 mg, 1.032 
mmol, 1.5 equiv.) and heated neat to 100°C for 1h until all bubbling stops. The reaction was 
allowed to cool to RT, 3 mL of anhydrous DMF was then added. The reaction mixture was 
cooled in an ice bath and PhSO2Cl (0.132 mL, 1.032 mmol, 1.5 equiv.) was added dropwise 
and the reaction was allowed to stir at RT overnight. Saturated NaHCO3 solution was added 
to quench the reaction and the aqueous phase was extracted with CH2Cl2 (5 x 50 mL). The 
combined organic phases was dried over MgSO4 and concentrated in vacuo. Toluene was then 
added to the obtained residue and concentrated again in vacuo to azeotropically remove traces 
of DMF present.   
(R)-169 was isolated by flash column chromatography (3% MeOH in CH2Cl2) to yield a 
brown oil.  
Yield: 118 mg, 43% yield over 3 steps. 
TLC: Rf =  0.56 (9:1CH2Cl2: MeOH) 
Optical rotation: [ ]26Dα = − 62 (c = 0.62, CHCl3) 
ee:  97% 
anal. chiral HPLC: tR 13.38 min (minor) 14.75 min (major), elution solvent: n-
heptane/ethanol, 97:3, 0.70 mL/min, Daicel-IA column. 
 
1H NMR(400 MHz, CDCl3):  
δ = 8.05 (d, J = 8.8 Hz, 1H, CHAr), 7.72 (d, J = 7.2 Hz, 2H, CHAr), 7.50 (t, J = 7.6 Hz, 1H, 
CHAr), 7.39 (t, J = 7.6 Hz, 2H, CHAr), 6.94 (s, 1H, CHAr), 6.86 (d, J = 8.4 Hz, 1H, CHAr), 3.83 
(s, 3H, OCH3), 2.96-3.20 (m, 2H, CH2NR2), 2.70-2.88 (m, 1H, CH), 2.40-2.48 (m, 2H, CH2), 
2.33 (s, 6H, 2 x CH3), 1.99-2.08 (m, 1H, CH2), 1.62-1.91 (m, 3H, CH2) ppm. 
13C NMR (100 MHz, CDCl3):  
δ = 155.5 (CAr), 139.2 (CAr), 137.3 (CAr), 133.6 (CHAr), 131.2 (CAr), 131.0 (CAr), 129.3 (CHAr), 
126.4 (CHAr), 120.7 (CAr), 115.6 (CHAr), 111.7 (CHAr), 102.5 (CHAr), 62.7 (CH2NR2), 55.8 
(OCH3), 46.1 (N(CH3)2), 30.4 (CH), 25.1 (CH2), 25.0 (CH2), 19.1 (CH2) ppm. 
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MS (CI, 100 eV):  
399.3 (100) [M+H+], 284.4 (34), 257.4 (33) 
IR (Capillary):  
3782, 3438, 3070, 2934, 2857, 2772, 2627, 1728, 1607, 1464, 1373, 1281, 1212, 1162, 1088, 
1035, 981, 911, 853, 803, 734, 684, 576 cm-1. 
HRMS (ESI):  
calcd. for C22H27O3N2S: 399.1737, found: 399.1737 
(E)-2-(2-Nitrovinyl)benzaldehyde (225a) 
 
To a solution of 224a[105] (7.65g, 34.6 mmol, 1 equiv.) dissolved in 200 mL of acetone was 
added 2N HCl (70 mL, 138 mmol, 4 equiv.) and the solution was stirred at RT for 2h.  
Upon completion of the reaction, excess distilled water was added to the flask and the 
precipitated solid was filtered, washed with pentane and dried under high vacuum to yield a 
pale yellow solid.  
Yield: 4.69g, 76% 
TLC: Rf =  0.38 (1:1 Pentane:Et2O) 
1H NMR(600 MHz, CDCl3):  
δ = 10.21(s, 1H, CHaldehyde), 8.95 (d, J = 13.8 Hz, 1H, =CHNO2), 7.94 (d, J = 7.2 Hz, 1H, 
CHAr), 7.72 (t, J = 7.2 Hz, 1H, CHAr), 7.69 (t, J = 7.2 Hz, 1H, CHAr), 7.62 (d, J = 7.2 Hz, 1H, 
CHAr), 7.48 (d, J = 13.2 Hz, 1H, PhCH=) ppm. 
13C NMR (151 MHz, CDCl3):  
δ = 192.3 (CHaldehyde), 140.0 (CHAlkene), 136.9 (CHAlkene), 135.0 (CHAr), 134.7 (CAr), 134.3 
(CHAr), 131.8 (CHAr), 131.3 (CAr), 128.8 (CHAr) ppm. 
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The analytical data are in agreement with those reported in the literature.[105b] 
 
(E)-5-Methoxy-2-(2-Nitrovinyl)benzaldehyde (225b) 
 
To a solution of 224b[105] (18.0 g, 71.6 mmol, 1 equiv.) dissolved in 300 mL of acetone was 
added 2N HCl (143 mL, 287 mmol, 4 equiv.) and the solution was stirred at RT for 2h.  
Upon completion of the reaction, excess distilled water was added to the flask and the 
precipitated solid was filtered, washed with pentane and dried under high vacuum to yield a 
bright yellow solid.  
Yield: 13.72 g, 92% 
TLC: Rf =  0.50 (1:1 Pentane:Et2O) 
Melting point: 144 °C 
1H NMR(300 MHz, CDCl3):  
δ = 10.22 (s, 1H, CHaldehyde), 8.91 (d, J = 13.5 Hz, 1H, =CHNO2), 7.61 (d, J = 8.7 Hz, 1H, 
CHAr), 7.49 (d, J = 13.5 Hz, 1H, PhCH=), 7.42 (d, J = 2.7 Hz, 1H, CHAr), 7.18 (dd, J = 8.7, 
2.7 Hz, 1H, CHAr), 3.94 (s, 3H, OCH3) ppm. 
13C NMR (75 MHz, CDCl3):  
δ = 191.5 (CHaldehyde), 162.7 (CAr), 138.5 (CHAlkene), 136.2 (CAr), 135.7 (CHAlkene), 130.3 
(CHAr), 123.5 (CAr), 120.1 (CHAr), 118.9 (CHAr), 56.1(OCH3) ppm.  
MS (CI, 100 eV):  
m/z (%) 208.1 (90) [M+H+], 162.1 (100) 
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IR (Capillary):  
3099, 2847, 2291, 1687, 1592, 1560, 1499, 1328, 1253, 1182, 1104, 1030, 965, 921, 874, 825, 
773, 720, 683 cm-1 ;  
Elemental Analysis: 
Calcd. for C10H9NO4: C, 57.97; H, 4.38; N, 6.76; found: C, 57.65; H, 4.11; N, 6.62. 
(E)-5-Chloro-2-(2-Nitrovinyl)benzaldehyde (225c) 
 
To a solution of 224c[105] (1.23g, 4.81 mmol, 1 equiv.) dissolved in 50 mL acetone was added 
2N HCl (9.7 mL, 19.2 mmol, 4 equiv.) and the solution was stirred at RT for 24h. 2N HCL 
(4.8 mL, 9.62 mmol, 2 equiv.) was added again and allowed to stir at RT overnight. Upon 
completion of the reaction, excess distilled water was added to the flask and the precipitated 
solid was filtered, washed with pentane and dried under high vacuum to yield a pale yellow 
solid.  
Yield: 0.589g, 58%.  
TLC: Rf =  0.71 (1:1 Pentane:Et2O) 
Melting point:  132 °C 
1H NMR(600 MHz, CDCl3):  
δ = 10.17 (s, 1H, CHaldehyde), 8.86 (d, J = 13.2 Hz, 1H, =CHNO2), 7.91 (d, J = 2.4 Hz, 1H, 
CHAr), 7.66 (dd, J = 8.4, 2.4 Hz, 1H, CHAr), 7.58 (d, J = 8.4 Hz, 1H, CHAr), 7.47 (d, J = 13.2 
Hz, 1H, PhCH=) ppm. 
13C NMR (151 MHz, CDCl3):  
δ = 190.6 (CHaldehyde), 140.3 (CH), 138.4 (CAr), 135.7 (CAr), 135.4 (CH), 134.4 (CHAr), 134.3 
(CHAr), 130.0 (CHAr), 129.6 (CAr) ppm. 
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MS (CI, 100 eV):  
m/z (%) 214.0 (29) [M+H+], 212.0 (100) [M+H+]. 
IR (Capillary):  
3093, 3026, 2861, 2759, 1690, 1630, 1587, 1511, 1383, 1341, 1284, 1196, 1105, 959, 899, 
833, 743, 716 cm-1.  
HRMS (ESI):  
calcd. for C9H6O3NClNa: 233.9928, found 233.9929. 
(1S,2R,3R)-3-(1H-Indol-3-yl)-2-nitro-2,3-dihydro-1H-inden-1-ol (227a) 
NO2
OH
NH
227a
 
227a was synthesized by GP3 and isolated as a diastereomeric mixture (10:1 d.r.) by two 
successive flash column chromatography (first 1% MeOH in CH2Cl2 then 1:1 Pentane:Et2O) 
to yield a yellow solid.  
 
Yield: 141 mg, 96%.  
TLC: Rf =  0.56 (2:1 Et2O:Pentane) 
Melting point: 148 °C 
Optical rotation: [ ]24Dα = + 39.6 (c = 0.55, CHCl3) 
ee: 93% ee (major diastereomer) 
anal. chiral HPLC (major diastereomer): tR 30.46 min (minor) 41.58 min (major), elution 
solvent: n-heptane/ethanol, 90:10, 1.00 mL/min, Daicel-AD column. 
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1H NMR(600 MHz, CDCl3):  
δ = 8.05-8.19 (bs, 1H, both diastereomers, NH), 7.54 (d, J = 7.2 Hz, 1H, major, CHAr), 7.51 (d, 
J = 7.2 Hz, 1H, minor, CHAr), 7.37-7.43 (m, 2H, both diastereomers, CHAr), 7.35 (td, J = 7.2, 
0.6 Hz, 1H, major, CHAr), 7.30 (t, J = 7.8 Hz, 1H, minor, CHAr), 7.20 (t, J = 7.8 Hz, 1H, 
major, CHAr), 7.17 (d, J = 2.4 Hz, 1H, minor, CHAr), 7.06-7.14 (m, 3H, major, CHAr), 7.04 (d, 
J = 7.8 Hz, 1H, minor, CHAr), 7.01 (t, J = 7.8 Hz, 1H, major, CHAr), 5.83 (t, J = 6.6 Hz, 1H, 
minor), 5.65 (t, J = 7.2 Hz, 1H, major, C(OH)H), 5.56 (d, J = 7.2 Hz, 1H, major, C(indolyl)H), 
5.44 (t, J = 6 Hz, 1H, major, C(NO2)H), 5.26 (t, J = 9 Hz, 1H, minor), 5.19 (d, J = 9 Hz, 1H, 
minor), 2.87 (d, J = 6.6 Hz, 1H, minor, OH), 2.47 (d, J = 7.8 Hz, 1H, major, OH) ppm. 
13C NMR (151 MHz, CDCl3):  
δ = 142.1 (CAr), 140.1 (minor), 139.0 (CAr), 137.0 (CAr), 130.7 (CHAr), 129.9 (minor), 128.8 
(CHAr), 125.9 (CAr), 125.8 (CHAr), 125.4 (CHAr), 125.3 (minor), 124.2 (minor), 123.9 (CHAr), 
123.8 (minor), 122.7 (CHAr), 120.1 (minor), 120.1 (CHAr), 119.4 (minor), 119.3 (CHAr), 113.7 
(CAr), 111.8 (CHAr), 100.2 (minor), 94.1 (C(NO2)H), 78.8 (minor), 74.8 (C(OH)H), 45.3 
(minor), 44.3 (C(indolyl)H) ppm. 
MS (EI, 70 eV):  
m/z (%) 294.1 (100) [M+], 276.1 (27), 247.1 (90), 230.1 (41), 218.1 (29), 202.1 (12), 130.1 
(18), 117.1 (70). 
IR (Capillary):  
3411, 2919, 1615, 1544, 1458, 1422, 1371, 1222, 1166, 1098, 1031, 882, 835, 743 cm-1  
HRMS (ESI):  
calcd. for C17H14O3N2Na: 317.0897, found: 317.0898. 
(1S,2R,3R)-3-(5-Methoxy-1H-indol-3-yl)-2-nitro-2,3-dihydro-1H-inden-1-ol (227b) 
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227b was synthesized by GP3 and isolated as a diastereomeric mixture (9:1 d.r.) by two 
successive flash column chromatography (first 1% MeOH in CH2Cl2 then 1:1 Pentane:Et2O) 
to yield a yellow solid. 
Yield: 153 mg, 94% 
TLC: Rf =  0.56 (2:1 Et2O:Pentane) 
Melting point:  78°C 
Optical rotation: [ ]24Dα = + 18.1 (c = 0.81, CHCl3) 
ee: 91% ee (major diastereomer) 
anal. chiral HPLC (major diastereomer): tR 19.04 min (minor) 37.91 min (major), elution 
solvent: n-heptane/ethanol, 80:20, 0.70 mL/min, Daicel-AD column. 
1H NMR(600 MHz, CDCl3):  
δ = 8.07 (bs, 1H, minor, NH), 8.04 (bs, 1H, major, NH), 7.54 (d, J = 7.2 Hz, 1H, major, CHAr), 
7.51 (d, J = 7.8 Hz, 1H, minor, CHAr), 7.40 (t, J = 7.2 Hz, 1H, both, CHAr), 7.36 (t, J = 7.8 Hz, 
1H, major, CHAr), 7.31 (t, J = 7.8 Hz, 1H, minor, CHAr), 7.28 (d, J = 9 Hz, 1H, major, CHAr), 
7.16 (d, J = 7.8 Hz, 1H, major, CHAr), 7.12 (d, J = 1.8 Hz, 1H, minor, CHAr), 7.07 (d, J = 7.2 
Hz, 1H, minor, CHAr), 7.01 (d, J = 2.4 Hz, 1H, major, CHAr), 6.87 (dd, J = 9, 2.4 Hz, 1H, both, 
CHAr), 6.81-6.82 (m, 1H, minor, CHAr), 6.59 (s, J = 1.8 Hz, 1H, both, CHAr), 5.60-5.69 (m, 
1H, major, C(OH)H), 5.53 (d, J = 7.2 Hz, 1H, major, C(indolyl)H), 5.40 (t, J = 6 Hz, 1H, 
major, C(NO2)H), 5.21-5.25 (m, 1H, minor), 5.17 (d, J = 8.4 Hz, 1H, minor), 3.71 (s, 3H, 
major, OCH3), 3.68 (s, 3H, minor, OCH3), 2.90 (bs, 1H, minor, OH), 2.51 (m, 1H, major, OH) 
ppm. 
13C NMR (151 MHz, CDCl3):  
δ = 154.3 (CAr), 141.9 (CAr), 139.2 (CAr), 132.1 (CAr), 131.9 (minor), 130.6 (CHAr), 129.8 
(minor), 128.8 (CHAr), 128.7 (minor), 126.5 (minor), 126.4 (minor), 125.9 (CHAr), 125.4 
(CHAr), 124.4 (CHAr), 124,3 (minor), 124.2 (2C, minor), 113.6 (minor), 112.8 (minor), 112.7 
(CHAr), 112.5 (CAr), 112.4 (minor), 101.4 (minor), 101.3 (CAr), 100.2 (minor), 94.1 
(C(NO2)H), 78.9 (minor), 74.8 (C(OH)H), 56.0 (OCH3), 45.3 (minor), 44.3 (C(indolyl)H), 
29.9 (minor) ppm. 
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MS (EI, 70 eV):  
m/z (%) 324.1 (100) [M+], 306.1 (70), 277.2 (46), 260.1 (48), 248.2 (25), 234.1 (16), 217.2 
(17), 204.1 (11), 189.1 (12), 160.1 (12), 147.1 (85), 132.1 (10), 108.7 (11), 103.0 (10);  
IR (Capillary):  
3411, 2929, 2834, 2156, 2065, 1710, 1625, 1583, 1545, 1482, 1372, 1281, 1211, 1170, 1108, 
1029, 926, 885, 836, 799, 759 cm-1. 
HRMS (ESI):  
calcd. for C18H17O4N2: 325.1183, found: 325.1183 
(1S,2R,3R)-3-(5-Chloro-1H-indol-3-yl)-2-nitro-2,3-dihydro-1H-inden-1-ol (227c) 
 
227c was synthesized by GP3 and isolated as a diastereomeric mixture (7:1 d.r.) by two 
successive flash column chromatography (first 1% MeOH in CH2Cl2 then 1:1 Pentane:Et2O) 
to yield a light orange solid. 
Yield: 101 mg, 61%  
TLC: Rf =  0.47 (2:1 Et2O:Pentane) 
Melting point:  80 °C 
Optical rotation: [ ]24Dα = + 39.1 (c = 0.57, CHCl3) 
ee: 92% (major diastereomer) 
anal. chiral HPLC (major diastereomer):  
tR 23.76 min (minor) 46.22 min (major), elution solvent: n-heptane/ethanol, 90:10, 1.00 
mL/min, Daicel-AD column. 
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1H NMR(600 MHz, CDCl3):  
δ = 8.11-8.23 (bs, 1H, both, NH), 7.55 (d,  J = 7.8 Hz, 1H, major, CHAr), 7.53 (d, J = 7.2 Hz, 
1H, minor, CHAr), 7.42 (t, J = 7.2 Hz, 1H, both, CHAr), 7.37 (t,  J = 7.2 Hz, 1H, major, CHAr), 
7.31 (d, J = 9 Hz, 1H, both, CHAr), 7.21 (d, J = 2.4 Hz, 1H, minor, CHAr), 7.13-7.18 (m, 2H, 
major, CHAr), 7.08 (d, J = 7.2 Hz, 1H, both, CHAr), 7.01 (d, J = 1.8 Hz, 1H, both, CHAr), 5.83 
(d, J = 6.6 Hz, 1H, minor), 5.66 (d, J = 5.4 Hz, 1H, major, C(OH)H), 5.53 (d, J = 7.8 Hz, 1H, 
major, C(indolyl)H), 5.38 (dd, J = 7.8, 6 Hz, 1H, major, C(NO2)H), 5.20 (dd, J = 9, 6.6 Hz, 
1H, minor), 5.14 (d, J = 8.4 Hz, 1H, minor), 2.88 (bs, 1H, minor, OH), 2.45 (bs, 1H, major, 
OH) ppm.  
13C NMR (151 MHz, CDCl3):  
δ = 141.6 (CAr), 139.4 (minor), 139.0 (minor), 138.8 (CAr), 135.4 (CAr), 130.9 (CHAr), 130.0 
(minor), 129.0 (CHAr), 126.9 (CAr), 125.8 (CAr), 125.7 (CHAr), 125.6 (CHAr), 125.4 (CHAr), 
125.3 (minor), 125.2 (minor), 125.1 (minor), 124.3 (minor), 123.2 (minor), 123.1 (CHAr), 
118.8 (minor), 118.7 (CHAr), 113.4 (CAr), 112.8 (CHAr), 100.1 (minor), 93.8 (C(NO2)H), 78.7 
(minor), 74.6 (C(OH)H), 45.0 (minor), 43.8 (C(indolyl)H)ppm. 
MS (EI, 70 eV):  
m/z (%) 330.0 (20) [M+], 328.0 (60) [M+], 310.0 (25), 281.0 (99), 264.0 (48), 252.0 (20), 
246.1 (13), 229.1 (17), 217.1 (24), 202.1 (13), 166.1 (12), 164.0 (17), 153.0 (30), 151.0 (97), 
131.0 (14), 122.8 (14), 108.6 (20), 103.1 (16). 
IR (Capillary):  
3423, 2920, 1711, 1610, 1546, 1460, 1373, 1319, 1285, 1220, 1168, 1101, 1035, 949, 890, 
798, 758, 681 cm-1. 
HRMS (ESI):  
calcd. for C17H13O3N2ClNa: 351.0507, found: 351.0507. 
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(1S,2R,3R)-3-(5-Bromo-1H-indol-3-yl)-2-nitro-2,3-dihydro-1H-inden-1-ol (227d) 
 
227d was synthesized by GP3 and isolated as a diastereomeric mixture (9:1 d.r.) by two 
successive flash column chromatography (first 1% MeOH in CH2Cl2 then 1:1 Pentane:Et2O) 
to yield a light orange solid. 
Yield: 120 mg, 64%.  
TLC: Rf =  0.44 (2:1 Et2O:Pentane) 
Melting point: 88 °C 
Optical rotation: [ ]24Dα = + 30.8 (c = 0.57, CHCl3),  
ee: 90%  (major diastereomer) 
anal. chiral HPLC (major diastereomer): tR 23.67 min (minor) 41.05 min (major), elution 
solvent: n-heptane/ethanol, 90:10, 1.00 mL/min, Daicel-AD column. 
1H NMR(600 MHz, CDCl3):  
δ = 8.10-8.26 (bs, 1H, both, NH), 7.56 (d, J = 7.2 Hz, 1H, major, CHAr), 7.53 (d, J = 7.8 Hz, 
1H, minor, CHAr), 7.42 (t, J = 7.2 Hz, 1H, both, CHAr), 7.38 (t, J = 7.2 Hz, 1H, major, CHAr), 
7.33 (t, J = 7.8 Hz, 1H, minor, CHAr), 7.27-7.30 (m, 2H, major, CHAr), 7.19 (d, J = 3 Hz, 1H, 
minor, CHAr), 7.18 (s, 1H, major, CHAr), 7.15 (d, J = 2.4 Hz, 1H, major, CHAr), 7.09 (d, J = 
7.2 Hz, 1H, major, CHAr), 7.01 (d, J = 7.8 Hz, 1H, minor, CHAr), 5.84 (t, J = 6.6 Hz, 1H, 
minor), 5.67 (t, J = 6.6 Hz, 1H, major, C(OH)H), 5.53 (d, J = 7.2 Hz, 1H, major, C(indolyl)H), 
5.38 (dd, J = 7.8, 5.4 Hz, 1H, major, C(NO2)H), 5.20 (dd, J = 9, 7.2 Hz, 1H, minor), 5.14 (d, J 
= 8.4 Hz, 1H, minor) 2.85 (d, J = 6.6 Hz, 1H, minor, OH), 2.42 (d, J = 7.2 Hz, 1H, major, OH) 
ppm. 
 
Experimental Part 
154 
 
13C NMR (151 MHz, CDCl3):  
δ = 141.4 (CAr), 138.6 (CAr), 135.4 (CAr), 130.6 (CHAr), 129.8 (minor), 128.8 (CHAr), 127.3 
(CAr), 125.6 (minor), 125.5 (CHAr), 125.4 (2C,CHAr), 125.0 (CHAr), 121.6 (CHAr), 113.2 (CAr), 
113.1 (CAr), 113.0 (CHAr), 99.8 (minor), 93.6 (C(NO2)H), 78.5 (minor), 74.4 (C(OH)H), 44.7 
(minor), 43.6 (C(indolyl)H) ppm. 
MS (EI, 70 eV):  
m/z (%) 374.0 (58) [M+], 372.0 (56) [M+], 356.0 (51), 354.0 (54), 327.0 (99), 325.0 (95), 
308.0 (60), 298.1 (23), 246.1 (26), 229.1 (51), 217.1 (47), 202.1 (26), 197.0 (61), 189.2 (16), 
144.1 (11), 122.7 (19), 114.1 (25), 108.7 (28), 100.2 (18), 95.5 (10). 
IR (Capillary):  
3542, 3421, 2917, 2107, 1545, 1457, 1373, 1320, 1283, 1220, 1167, 1100, 1034, 948, 882, 
796, 757, 667 cm-1.  
HRMS (ESI):  
calcd. for C17H13O3N2BrNa: 395.0002, found: 395.0002 
(1S,2R,3R)-3-(5-Methyl-1H-indol-3-yl)-2-nitro-2,3-dihydro-1H-inden-1-ol (227e) 
 
227e was synthesized by GP3 and isolated as a diastereomeric mixture (10:1 d.r.) by two 
successive flash column chromatography (first 1% MeOH in CH2Cl2 then 1:1 Pentane:Et2O) 
to yield a light orange solid.  
Yield: 154 mg, > 99% 
TLC: Rf =  0.58 (2:1 Et2O:Pentane) 
Melting point:  80 °C;  
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Optical rotation: [ ]24Dα = + 34.5 (c = 0.66, CHCl3) 
ee: 90% (major diastereomer) 
anal. chiral HPLC (major diastereomer): tR 8.26 min (minor) 11.74 min (major), elution 
solvent: n-heptane/ethanol, 70:30, 0.70 mL/min, Daicel-AD column. 
IR (Capillary):  
3409, 2915, 2860, 2020, 1546, 1477, 1425, 1373, 1315, 1228, 1167, 1101, 1033, 881, 840, 
798, 759, 697 cm-1. 
1H NMR(600 MHz, CDCl3):  
δ = 7.95-8.09 (bs, 1H, both, NH), 7.54 (d, J = 7.8 Hz, 1H, major, CHAr), 7.52 (d, J = 7.8 Hz, 
1H, minor, CHAr), 7.40 (t, J = 7.8 Hz, 1H, both, CHAr), 7.35 (td, J = 7.8, 1.2 Hz, 1H, major, 
CHAr), 7.31 (d, J = 7.8 Hz, 1H, minor, CHAr), 7.29 (d, J = 8.4 Hz, 1H, minor, CHAr), 7.28 (d, J 
= 8.4 Hz, 1H, major, CHAr), 7.13 (d, J = 7.8 Hz, 1H, major, CHAr), 7.12 (d, J = 2.4 Hz, 1H, 
minor, CHAr), 7.03 (dd, J = 8.4, 1.2 Hz, 1H, both, CHAr), 7.00 (d, J = 2.4 Hz, 1H, major, 
CHAr), 6.91 (s, 1H, both, CHAr), 5.82 (d, J = 6.6 Hz, 1H, minor), 5.62-5.68 (m, 1H, major, 
C(OH)H), 5.52 (d, J = 6.6 Hz, 1H, major, C(indolyl)H), 5.44 (t, J = 6 Hz, 1H, major, 
C(NO2)H), 5.26 (dd, J = 9, 7.2 Hz, 1H, minor), 5.16 (d, J = 8.4 Hz, 1H, minor), 2.85 (bs, 1H, 
minor, OH), 2.45 (m, 1H, major, OH), 2.35 (s, 3H, major, CH3), 2.33 (s, 3H, minor, CH3) 
ppm. 
13C NMR (151 MHz, CDCl3):  
δ = 142.1 (CAr), 139.1 (CAr), 135.3 (CAr), 130.7 (CHAr), 129.9 (minor), 129.5 (CAr), 128.7 
(CHAr), 126.1 (CAr), 125.9 (CHAr), 125.4 (CHAr), 125.3 (minor), 124.4 (minor), 124.3 (CHAr), 
124.1 (minor), 123.9 (CHAr), 123.8 (minor), 119.0 (minor), 118.8 (CHAr), 113.3 (CAr), 111.5 
(CHAr), 111.4 (minor), 100.1 (minor), 94.0 (C(NO2)H), 78.9 (minor), 74.8 (C(OH)H), 45.3 
(minor), 44.4 (C(indolyl)H), 21.7 (CH3) ppm. 
MS (EI, 70 eV):  
m/z (%) 308.1 (95) [M+], 290.1 (33), 261.1 (74), 244.1 (45), 232.1 (29), 217.1 (17), 202.1 (10), 
144.1 (18), 131.1 (100). 
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HRMS (ESI):  
calcd. for C18H16O3N2Na: 331.1053, found: 331.1053 
(1S,2R,3R)-3-(7-Methyl-1H-indol-3-yl)-2-nitro-2,3-dihydro-1H-inden-1-ol (227f) 
 
227f was synthesized by GP3 and isolated as a diastereomeric mixture (11:1 d.r.) by two 
successive flash column chromatography (first 1% MeOH in CH2Cl2 then 1:1 Pentane:Et2O) 
to yield a pale yellow solid. 
Yield: 147 mg, 95%.  
TLC: Rf =  0.56 (2:1 Et2O:Pentane) 
Melting point:  82 °C 
Optical rotation: [ ]24Dα = + 51.8 (c = 0.56, CHCl3) 
ee: 97% ee (major diastereomer) 
anal. chiral HPLC (major diastereomer): tR 32.62 min (minor) 38.63 min (major), elution 
solvent: n-heptane/ethanol, 90:10, 0.70 mL/min, Daicel-IA column. 
1H NMR(600 MHz, CDCl3):  
δ = 7.98-8.13 (bs, 1H, both, NH), 7.54 (d, J = 7.2 Hz, 1H, major, CHAr), 7.52 (d, J = 7.8 Hz, 
1H, minor, CHAr), 7.40 (t, J = 7.2 Hz, 1H, both, CHAr), 7.35 (td, J = 7.8, 1.2 Hz, 1H, major, 
CHAr), 7.29 (t, J = 7.8 Hz, 1H, minor, CHAr), 7.20 (d, J = 2.4 Hz, 1H, minor, CHAr), 7.10-7.15 
(m, 2H, both, CHAr), 6.99-7.05 (m, 1H, both, CHAr), 6.91-6.98 (m, 2H, both, CHAr), 5.84 (t, J 
= 6.6 Hz, 1H, minor), 5.65 (dd, J = 7.8, 6 Hz, 1H, major, C(OH)H), 5.55 (d, J = 7.2 Hz, 1H, 
major, C(indolyl)H), 5.45 (dd, J = 7.2, 6 Hz, 1H, major, C(NO2)H), 5.27 (dd, J = 9, 7.2 Hz, 
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1H, minor), 5.18 (d, J = 8.4 Hz, 1H, minor), 2.81 (d, J = 6 Hz, 1H, minor), 2.50 (s, 3H, both, 
CH3), 2.43 (d, J = 7.2 Hz, 1H, major, OH) ppm.  
13C NMR (151 MHz, CDCl3):  
δ = 141.9 (CAr), 138.8 (CAr), 136.4 (CAr), 130.5 (CHAr), 129.6 (minor), 128.5 (CHAr), 125.6 
(CHAr), 125.2 (CHAr), 125.1 (CAr), 123.9 (minor), 123.4 (CHAr), 123.2 (minor), 123.0 (CHAr), 
120.8 (CAr), 120.1 (CHAr), 117.0 (minor), 116.8 (CHAr), 114.0 (CAr), 100.0 (minor), 93.8 
(C(NO2)H), 78.6 (minor), 74.5 (C(OH)H), 74.4 (minor), 45.2 (minor), 44.2 (C(indolyl)H), 
16.6 (CH3)ppm.  
MS (EI, 70 eV):  
m/z (%) 308.1 (100) [M+], 290.1 (46), 261.1 (72), 244.1 (48), 232.1 (23), 217.1 (12), 144.0 
(16), 131.0 (86).  
IR (Capillary):  
3414, 3050, 2914, 1615, 1546, 1439, 1372, 1223, 1167, 1105, 1036, 952, 884, 835, 751 cm-1  
HRMS (ESI):  
calcd. for C18H16O3N2Na: 331.1053, found: 331.1053 
(1S,2R,3R)-3-(5-Fluoro-1H-indol-3-yl)-2-nitro-2,3-dihydro-1H-inden-1-ol (227g) 
 
227g was synthesized by GP3 and isolated as a diastereomeric mixture (9:1 d.r.) by two 
successive flash column chromatography (first 1% MeOH in CH2Cl2 then 1:1 Pentane:Et2O) 
to yield a yellow solid.  
Yield: 142 mg, 91%  
TLC: Rf =  0.47 (2:1 Et2O:Pentane) 
Melting point: 69 °C;  
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Optical rotation: [ ]24Dα = + 48.7 (c = 0.62, CHCl3) 
ee: 91% ee (major diastereomer) 
anal. chiral HPLC (major diastereomer):  tR 6.34 min (major) 6.99 min (minor), elution 
solvent: n-heptane/ethanol, 90:10, 1.00 mL/min, Daicel-IC column. 
IR (Capillary):  
3424, 2919, 1706, 1630, 1581, 1546, 1483, 1457, 1373, 1302, 1273, 1239, 1167, 1104, 1037, 
937, 887, 846, 799, 758, 699 cm-1. 
1H NMR(600 MHz, CDCl3):  
δ = 8.06-8.24 (bs, 1H, both, NH), 7.54 (d, J = 7.2 Hz, 1H, major, CHAr), 7.52 (d, J = 7.8 Hz, 
1H, minor, CHAr), 7.41 (t, J = 7.8 Hz, 1H, both, CHAr), 7.37 (t, J = 7.2 Hz, 1H, major, CHAr), 
7.31 (dd, J = 9, 4.8 Hz, 1H, both, CHAr), 7.23 (d, J = 2.4 Hz, 1H, minor, CHAr), 7.18 (d, J = 
2.4 Hz, 1H, major, CHAr), 7.10 (d, J = 7.2 Hz, 1H, major, CHAr), 7.02 (d, J = 7.8 Hz, 1H, 
minor, CHAr), 6.94 (dd, J = 9, 2.4 Hz, 1H, both, CHAr), 6.74 (dd, J = 9.6, 2.4 Hz, 1H, minor, 
CHAr), 6.68 (dd, J = 9.6, 2.4 Hz, 1H, major, CHAr), 5.83 (m, 1H, minor), 5.65 (t, J = 4.8 Hz, 
1H, major, C(OH)H), 5.53 (d, J = 7.2 Hz, 1H, major, C(indolyl)H), 5.37 (dd, J = 7.2, 6 Hz, 
1H, major, C(NO2)H), 5.20 (dd, J = 8.4, 6.6 Hz, 1H, minor), 5.14 (d, J = 8.4 Hz, 1H, minor), 
2.89 (bs, 1H, minor, OH), 2.47 (m, 1H, major, OH) ppm. 
13C NMR (151 MHz, CDCl3):  
δ = 158.4 (CAr), 156.8 (CAr), 141.4 (CAr), 138.7 (CAr), 133.3 (CAr), 130.6 (CHAr), 129.7 
(minor), 128.7 (CHAr), 125.9 (d, J =9.9 Hz, minor), 125.6 (CHAr), 125.5 (CHAr), 125.4 (CHAr), 
125.3 (minor), 124.9 (minor), 124.0 (minor), 113.5 (d, J = 4.7 Hz, minor), 112.3 (d, J = 9.8 
Hz, CHAr), 111.0 (d, J = 26.3 Hz, CHAr), 104.1 (J = 24 Hz, CHAr), 99.9 (minor), 93.6 
(C(NO2)H), 78.5 (minor), 74.4 (C(OH)H), 44.9 (minor), 43.7  (C(indolyl)H) ppm. 
19F NMR (564 MHz, CDCl3):  
123.44 (m, major), 123.38 ppm (m, minor). 
MS (EI, 70 eV):  
m/z (%) 312.1 (48) [M+], 294.1 (10), 265.1 (82), 248.1 (38), 236.1 (33), 220.1 (10), 148.1 (18), 
135.0 (100), 131.1 (12), 103.1 (15). 
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HRMS (ESI):  
calcd. for C17H13O3N2FNa: 335.0802, found: 335.0802  
(1S,2R,3R)-3-(6-Methyl-1H-indol-3-yl)-2-nitro-2,3-dihydro-1H-inden-1-ol (227h) 
 
227h was synthesized by GP3 and isolated as a diastereomeric mixture (11:1 d.r.) by two 
successive flash column chromatography (first 1% MeOH in CH2Cl2 then 1:1 Pentane:Et2O) 
to yield a yellow solid. 
Yield: 152 mg, 98%  
TLC: Rf =  0.60 (2:1 Et2O:Pentane) 
Melting point:  77 °C;  
Optical rotation: [ ]24Dα = + 45.8 (c = 0.57, CHCl3). 
ee: 91% (major diastereomer) 
anal. chiral HPLC (major diastereomer):  tR 24.84 min (major) 26.81 min (minor), elution 
solvent: n-heptane/ethanol, 95:5, 1.00 mL/min, Daicel-IC column. 
1H NMR(600 MHz, CDCl3):  
δ = 7.92-8.05 (bs, 1H, both, NH), 7.54 (d, J = 7.2 Hz, 1H, major, CHAr), 7.52 (d, J = 7.2 Hz, 
1H, minor, CHAr), 7.40 (t, J = 7.2 Hz, 1H, both, CHAr), 7.35 (td, J = 7.8, 1.2 Hz, 1H, major, 
CHAr), 7.30 (t, J = 7.2 Hz, 1H, minor, CHAr), 7.19 (s, major, CHAr), 7.13 (d, J = 7.2 Hz, 1H, 
major, CHAr), 7.11 (d, J = 2.4 Hz, 1H, minor, CHAr), 7.04 (d, J = 7.8 Hz, 1H, minor, CHAr), 
7.02 (d, J = 2.4 Hz, 1H, major, CHAr), 6.98 (d, J = 8.4 Hz, 1H, minor, CHAr), 6.96 (d, J = 8.4 
Hz, 1H, major, CHAr), 6.85 (d, J = 7.2 Hz, 1H, both, CHAr), 5.83( m, 1H, minor), 5.65 (t, J = 
5.4 Hz, 1H, major, C(OH)H), 5.53 (d, J = 7.2 Hz, 1H, major, C(indolyl)H), 5.43 (dd, J = 7.2, 
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6 Hz, 1H, major, C(NO2)H), 5.25 (dd, J = 8.4, 7.2 Hz, 1H, minor), 5.16 (d, J = 8.4 Hz, 1H, 
minor), 2.44 (s, 3H, both, CH3), 2.41-2.43 (bs, 1H, major, OH), 2.40 (bs, 1H, minor, OH) ppm. 
13C NMR (151 MHz, CDCl3):  
δ = 142.2 (CAr), 139.1 (CAr), 137.5 (CAr), 132.7 (CAr), 130.7, 129.9 (minor), 128.7 (CHAr), 
125.9 (CHAr), 125.4 (CHAr), 125.3 (minor), 124.1 (minor), 123.6 (CAr), 123.3 (CHAr), 123.1 
(minor), 121.8 (CHAr), 119.1 (minor), 118.9 (CHAr), 113.6 (CAr), 111.7 (CHAr), 111.6 (minor), 
100.2 (minor), 94.0 (C(NO2)H), 84.6 (minor), 78.9 (minor), 74.8 (C(OH)H), 45.4 (minor), 
44.4 (C(indolyl)H), 21.9 (CH3) ppm. 
MS (EI, 70 eV): 
m/z (%) 308.1 (38) [M+], 261.1 (31), 244.1 (20), 232.1 (16), 217.1 (10), 144.0 (17), 131.0 
(100), 115.1 (11), 103.0 (13), 77.1 (11). 
IR (Capillary):  
3410, 3029, 2917, 2315, 2079, 1625, 1545, 1456, 1372, 1227, 1156, 1097, 1035, 801, 755cm-1  
HRMS (ESI):  
calcd. for C18H17O3N2: 309.1234, found: 309.1232. 
(1S,2R,3R)-3-(6-Chloro-1H-indol-3-yl)-2-nitro-2,3-dihydro-1H-inden-1-ol (227i) 
 
227i was synthesized by GP3 and isolated as a diastereomeric mixture (11:1 d.r.) by two 
successive flash column chromatography (first 1% MeOH in CH2Cl2 then 1:1 Pentane:Et2O) 
to yield a yellow solid. 
Yield: 148 mg, 90%.  
TLC: Rf =  0.53 (2:1 Et2O:Pentane) 
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Melting point:   82 °C 
Optical rotation: [ ]24Dα = + 47.0 (c = 0.53, CHCl3),  
ee: 90% (major diastereomer) 
anal. chiral HPLC (major diastereomer):  tR 29.24 min (minor) 38.74 min (major), elution 
solvent: n-heptane/ethanol, 90:10, 1.00 mL/min, Daicel-IA column. 
1H NMR(600 MHz, CDCl3):  
δ = 8.07-8.19 (bs, 1H, both, NH), 7.55 (d, J = 7.8 Hz, 1H, major, CHAr), 7.52 (d, J = 7.8 Hz, 
1H, minor, CHAr), 7.41 (t, J = 7.2 Hz, 1H, both, CHAr), 7.39 (t, J = 1.2 Hz, 1H, major, CHAr), 
7.36 (td, J = 7.8, 1.2 Hz, 1H, major, CHAr), 7.31 (t, J = 7.8 Hz, 1H, minor, CHAr), 7.19 (d, J = 
2.4 Hz, 1H, minor, CHAr), 7.12 (d, J = 2.4 Hz, 1H, major, CHAr), 7.10 (d, J = 7.8 Hz, 1H, 
major, CHAr), 6.99-7.03 (m, 2H, minor, CHAr), 6.96-6.99 (m, 2H, major, CHAr), 5.84 (t, J = 
6.6 Hz, 1H, minor), 5.65 (t, J = 6.6 Hz, 1H, major, C(OH)H), 5.55 (d, J = 7.2 Hz, 1H, major, 
C(indolyl)H), 5.37 (dd, J = 7.8, 6 Hz, 1H, major, C(NO2)H), 5.21 (dd, J = 8.4, 6.6 Hz, 1H, 
minor), 5.16 (d, J = 8.4, 1H, minor), 2.86 (d, J = 6.6 Hz, 1H, minor), 2.43 (d, J = 7.8 Hz, 1H, 
major, OH) ppm. 
13C NMR (151 MHz, CDCl3):  
δ = 141.8 (CAr), 139.0 (CAr), 137.4 (CAr), 130.8 (CHAr), 130.0 (minor), 128.9 (CHAr), 128.8 
(CAr), 125.8 (CHAr), 125.6 (CHAr), 125.2 (minor), 124.6 (CHAr), 124.5 (minor), 124.4 (minor), 
124.3 (minor), 121.0 (minor), 120.9 (CHAr), 120.3 (minor), 120.2 (CHAr), 114.0 (CAr), 111.8 
(CHAr), 100.2 (minor), 94.0 (C(NO2)H), 78.7 (minor), 74.7 (C(OH)H), 45.1 (minor), 43.9 
(C(indolyl)H) ppm;  
MS (EI, 70 eV):  
m/z (%) 328.1 (70) [M+], 310.2 (32), 281.1 (91), 264.1 (57), 252.1 (25), 246.2 (13), 228.2 (19), 
217.2 (30), 202.2 (18), 164.1 (20), 151.1 (100), 131.1 (15), 114.1 (13), 108.7 (15), 103.2 (20).  
IR (Capillary): 
3545, 3425, 1617, 1545, 1454, 1374, 1330, 1226, 1103, 1060, 1032, 905, 846, 802, 759 cm-1  
HRMS (ESI):  
calcd. for C17H13O3N2ClNa: 351.0507, found: 351.0505 
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(1S,2R,3R)-3-(1H-Benzo[g]indol-3-yl)-2-nitro-2,3-dihydro-1H-inden-1-ol (227j) 
 
227j was synthesized by GP3 and isolated as a diastereomeric mixture (9:1 d.r.) by two 
successive flash column chromatography (first 1% MeOH in CH2Cl2 then 1:1 Pentane:Et2O) 
to yield a light brown solid.  
Yield: 128 mg, 74%  
TLC: Rf = 0.49 (2:1 Et2O:Pentane) 
Melting point: 196 °C (decomposition);  
Optical rotation: [ ]24Dα = + 31.1  (c = 0.91, CHCl3) 
ee: 95% ee (major diastereomer) 
anal. chiral HPLC (major diastereomer):  tR 6.94 min (major) 7.85 min (minor), elution 
solvent: n-heptane/ethanol, 90:10, 1.00 mL/min, Daicel-IC column. 
1H NMR(600 MHz, DMSO-d6):  
δ = 12.11 (bs, 1H, minor, NH), 12.04 (bs, 1H, major, NH), 8.36 (d, J = 8.4 Hz, 1H, both, 
CHAr), 7.90 (d, J = 8.4 Hz, 1H, both, CHAr), 7.54 (t, J = 7.2 Hz, 1H, both, CHAr), 7.49 (d, J = 
7.2 Hz, 1H, both, CHAr), 7.37 -7.44 (m, 4H, both, CHAr), 7.35 (t, J = 7.2 Hz, 1H, major, CHAr), 
7.29 (td, J = 7.8, 1.2 Hz, 1H, major, CHAr), 7.27 (t, J = 7.8 Hz, 1H, minor, CHAr), 7.23 (d, J = 
9 Hz, 1H, minor, CHAr), 6.94 (d, J = 7.8 Hz, 1H, major, CHAr), 6.87 (d, J = 7.2 Hz, 1H, minor, 
CHAr), 6.61 (d, J = 7.2 Hz, 1H, minor, CHAr), 6.21 (d, J = 6.6 Hz, 1H, major, OH), 5.76 (app. 
s, 1H, minor), 5.72 (dd, J = 8.4, 6 Hz, 1H, major, C(OH)H), 5.59 (d, J = 8.4 Hz, 1H, major, 
C(indolyl)H), 5.55 (t, J = 6.6 Hz, 1H, major, C(NO2)H), 5.33 (dd, J = 9, 7.2 Hz, 1H, minor), 
5.18 (d, J = 9.6 Hz, 1H, minor) ppm. 
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13C NMR (151 MHz, DMSO-d6):  
δ = 142.9 (CAr), 140.0 (CAr), 131.1 (CAr), 129.7 (CAr), 129.5 (CHAr), 128.9 (minor), 128.3 
(CHAr), 128.0 (minor), 127.7 (CHAr), 125.4 (CHAr), 125.3 (CHAr), 124.4 (CHAr), 124.2 
(minor), 123.8 (minor), 123.7 (CHAr), 122.5 (minor), 122.1 (CAr), 121.9 (CAr), 121.8 (CHAr), 
121.3 (minor), 120.5 (CHAr), 119.5 (CHAr), 118.9 (CHAr), 118.7 (minor), 114.4 (CAr), 100.9 
(minor), 93.8 (C(NO2)H), 77.6 (minor), 73.5 (C(OH)H), 45.2 (minor), 42.3 (C(indolyl)H) 
ppm. 
MS (EI, 70 eV):  
m/z (%) 344.1 (100) [M+], 326.1 (70), 297.1 (56), 280.1 (50), 268.1 (36), 254.1 (20), 180.1 
(16), 167.0 (82), 148.6 (11), 139.1 (25), 133.6 (21), 127.1 (14);  
IR (Capillary):  
3538, 3437, 2920, 2325, 2106, 1605, 1548, 1471, 1383, 1326, 1296, 1216, 1152, 1103, 1059, 
956, 884, 806, 752 cm-1 ;  
HRMS (ESI):  
calcd. for C21H17O3N2: 345.1234, found: 345.1234 
(1S,2R,3R)-6-Chloro-3-(7-methyl-1H-indol-3-yl)-2-nitro-2,3-dihydro-1H-inden-1-ol 
(227k) 
 
227k was synthesized by GP3 and isolated as a diastereomeric mixture (17:1 d.r.) by two 
successive flash column chromatography (first 1% MeOH in CH2Cl2 then 1:1 Pentane:Et2O) 
to yield a light orange solid. 
Yield: 155 mg, 90% 
TLC: Rf =  0.46 (2:1 Et2O:Pentane) 
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Melting point: 93 °C 
Optical rotation: [ ]24Dα = + 37.7 (c = 0.61, CHCl3) 
ee: 91% (major diastereomer) 
anal. chiral HPLC (major diastereomer): tR 11.91 min (major) 13.11 min (minor), elution 
solvent: n-heptane/ethanol, 80:20, 0.70 mL/min, Daicel-IA column. 
IR (Capillary):  
3415, 2919, 2079, 1547, 1471, 1432, 1371, 1298, 1219, 1167, 1117, 1078, 1037, 904, 880, 
853, 816, 781, 746, 706 cm-1. 
1H NMR(600 MHz, CDCl3):  
δ = 8.06 (bs, 1H, both, NH), 7.53 (d, J = 2.4 Hz, 1H, major, CHAr), 7.51 (m, 1H, minor, CHAr), 
7.32 (dd, 1H, J = 8.4, 2.4 Hz, 1H, major, CHAr), 7.21 (d, J = 2.4 Hz, 1H, minor, CHAr), 7.09 
(d, J = 2.4 Hz, 1H, both, CHAr), 7.06 (d, J = 7.8 Hz, 1H, major, CHAr), 7.02 (d, J = 6.6 Hz, 1H, 
major, CHAr), 6.92-6.99 (m, 2H, both, CHAr), 5.81 (t, J = 6.6 Hz, 1H, minor, CHAr), 5.63 (t, J 
= 7.2 Hz, 1H, major, C(OH)H), 5.48 (d, J = 6.6 Hz, 1H, major, C(indolyl)H), 5.44 (t, J = 6 Hz, 
1H, major, C(NO2)H), 5.28 (dd, J = 9, 7.2 Hz, 1H, minor), 5.12 (d, J = 9 Hz, 1H, minor), 2.88 
(d, J = 6 Hz, 1H, minor, OH), 2.53 (d, J = 7.8 Hz, 1H, major, OH), 2.50 (s, 3H, both, CH3) 
ppm. 
13C NMR (151 MHz, CDCl3):  
δ = 140.8 (CAr), 140.5 (CAr), 136.7 (CAr), 134.5 (CAr), 130.9 (CHAr), 127.2 (CHAr), 125.7 
(CHAr), 125.1 (CAr), 123.7 (CHAr), 123.6 (minor), 123.4 (CHAr), 121.2 (CAr), 120.5 (CHAr), 
116.8 (CHAr), 113.7 (CAr), 93.8 (C(NO2)H), 84.7 (minor), 74.3 (C(OH)H), 44.2 (C(indolyl)H), 
16.8 (CH3) ppm. 
MS (EI, 70 eV):  
m/z (%) 342.1 (71) [M+], 324.1 (15), 295.1 (55), 278.1 (24), 266.1 (18), 260.1 (10), 231.2 (12), 
217.2 (10), 144.2 (16), 131.1 (100), 115.1 (10). 
HRMS (ESI):  
calcd. for C18H15O3N2ClNa: 365.0663, found: 365.0663 
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(1S,2R,3R)-3-(1H-Indol-3-yl)-6-methoxy-2-nitro-2,3-dihydro-1H-inden-1-ol (227l) 
 
 
227l was synthesized by GP3 and isolated as a diastereomeric mixture (11:1 d.r.) by two 
successive flash column chromatography (first 1% MeOH in CH2Cl2 then 1:1 Pentane:Et2O) 
to yield a yellow solid. 
Yield: 152 mg, 94%  
TLC: Rf =  0.31 (2:1 Et2O:Pentane) 
Melting point:  79 °C;  
Optical rotation: [ ]24Dα = + 27.9 (c = 0.59, CHCl3) 
ee: 94% (major diastereomer) 
anal. chiral HPLC (major diastereomer): tR 28.17 min (minor) 34.36 min (major), elution 
solvent: n-heptane/ethanol, 95:5, 1.00 mL/min, Daicel-IC column. 
1H NMR(600 MHz, CDCl3):  
δ = 8.10 (bs, 1H, both, NH), 7.40 (d, J = 7.8 Hz, 1H, both, CHAr), 7.21 (t, J = 8.4 Hz, 1H, both, 
CHAr), 7.18 (d, J = 2.4 Hz, 1H, minor, CHAr), 7.15 (d, J = 8.4 Hz, 1H, both, CHAr), 6.99-7.08 
(m, 4H, both, CHAr), 6.94 (d, J = 8.4 Hz, 1H, minor, CHAr), 6.91 (dd, J = 8.4, 2.4 Hz, 1H, 
major, CHAr), 6.85 (dd, J = 8.4, 2.4 Hz, 1H, minor, CHAr), 5.80 (t, J = 6 Hz, 1H, minor), 5.60 
(t, J = 7.2 Hz, 1H, major, C(OH)H), 5.47 (d, J = 6.6 Hz, 1H, major, C(indolyl)H), 5.43 (dd, J 
= 7.2, 6 Hz, 1H, major, C(NO2)H), 5.24 (dd, J = 8.4, 7.2 Hz, 1H, minor), 5.12 (d, J = 8.4 Hz, 
1H, minor), 3.86 (s, 3H, both, OCH3), 2.81 (d, J = 6 Hz, 1H, minor), 2.47 (d, J = 7.8 Hz, 1H, 
major) ppm. 
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13C NMR (151 MHz, CDCl3):  
δ = 160.4 (CAr), 140.4 (CAr), 137.0 (CAr), 133.7 (CAr), 126.8 (CHAr), 126.3 (minor), 125.8 
(CAr), 123.6 (minor), 122.7 (CHAr), 120.1 (CHAr), 119.5 (minor), 119.3 (CHAr), 117.4 (CHAr), 
116.8 (minor), 114.2 (CAr), 111.8 (CHAr), 111.7 (minor), 109.7 (CHAr), 108.5 (minor), 100.3 
(minor), 94.4 (C(NO2)H), 78.7 (minor), 74.8 (C(OH)H), 55.8 (CH3), 43.9 (C(indolyl)H) ppm. 
MS (EI, 70 eV):  
m/z (%) 324.2 (65) [M+], 306.2 (20), 277.2 (79), 260.2 (42), 248.2 (14), 217.2 (17), 204.1 (10), 
130.1 (21), 117.1 (100). 
IR (Capillary):  
3410, 2940, 2072, 1902, 1613, 1545, 1489, 1456, 1371, 1313, 1249, 1183, 1145, 1107, 1024, 
930, 856, 820, 741 cm-1. 
HRMS (ESI):  
calcd. for C18H17O4N2: 325.1183, found: 325.1183 
(1S,2R,3R)-6-Methoxy-3-(5-methyl-1H-indol-3-yl)-2-nitro-2,3-dihydro-1H-inden-1-ol 
(227m) 
 
227m was synthesized by GP3 and isolated as a diastereomeric mixture (11:1 d.r.) by two 
successive flash column chromatography (first 1% MeOH in CH2Cl2 then 1:1 Pentane:Et2O) 
to yield a brown solid.  
Yield: 169 mg, > 99%  
TLC: Rf =  0.33 (2:1 Et2O:Pentane) 
Melting point: 85 °C 
Optical rotation: [ ]24Dα = + 19.1 (c = 0.96, CHCl3) 
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ee: 93% (major diastereomer) 
anal. chiral HPLC (major diastereomer): tR 27.76 min (minor) 33.41 min (major), n-
heptane/ethanol, 95:5, 1.00 mL/min, Daicel-IC column. 
1H NMR(600 MHz, CDCl3):  
δ = 8.05 (bs, 1H, minor, NH), 8.01 (bs, 1H, major, NH), 7.27 (d, J = 8.4 Hz, 1H, major, CHAr), 
7.09 (d, J = 2.4 Hz, 1H, minor, CHAr), 7.05 (d, J = 2.4 Hz, 1H, major, CHAr), 7.03 (d, J = 7.8 
Hz, 2H, both, CHAr), 6.96 (d, J = 1.8 Hz, 2H, major, CHAr), 6.94 (m, 2H, minor, CHAr), 6.92 
(m, 1H, minor, CHAr), 6.90 (dd, J = 8.4, 3 Hz, 1H, major, CHAr), 6.84 (dd, J = 8.4, 2.4 Hz, 1H, 
minor, CHAr), 5.78 (t, J = 6.6 Hz, 1H, minor), 5.59 (dd, J = 7.8, 5.4 Hz, 1H, major, C(OH)H), 
5.38-5.45 (m, 2H, major, C(indolyl)H and C(NO2)H), 5.23 (dd, J = 8.4, 7.2 Hz, 1H, minor), 
5.08 (d, J = 8.4 Hz, 1H, minor), 3.85 (3H, s, both, OCH3), 2.87 (d, J = 6.6 Hz, 1H, minor, 
OH), 2.52 (d, J = 7.8 Hz, 1H, major, OH), 2.36 (s, 3H, major, CH3), 2.33 (s, 3H, minor, CH3) 
ppm. 
13C NMR (151 MHz, CDCl3):  
δ = 160.3 (CAr), 140.4 (CAr), 135.3 (CAr), 133.8 (CAr), 129.4 (CAr), 126.7 (CHAr), 126.2 
(minor), 126.1 (CAr), 124.4 (CHAr), 123.8 (CHAr), 123.6 (minor), 119.0 (minor), 118.8 (CHAr), 
117.4 (CHAr), 116.7 (minor), 113.7 (CAr), 111.4 (CHAr), 111.3 (minor), 109.7 (CHAr), 108.4 
(minor), 100.2 (minor), 94.3 (C(NO2)H), 78.7 (minor), 74.8 (C(OH)H), 74.7 (minor), 55.8 
(OCH3), 44.7 (minor), 43.9 (C(indolyl)H), 21.7 (CH3) ppm. 
MS (EI, 70 eV):  
m/z (%) 338.2 (77) [M+], 320.2 (25), 291.2 (68), 274.2 (63), 262.2 (15), 231.2 (15), 146.0 (13), 
144.1 (17), 131.1 (100). 
IR (Capillary):  
3408, 2918, 2320, 1613, 1546, 1488, 1431, 1372, 1311, 1250, 1181, 1145, 1108, 1025, 924, 
855, 797, 732 cm-1. 
HRMS (ESI):  
calcd. for C19H18O4N2Na: 361.1159, found: 361.1157 
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(1R,2R,3R)-3-(1H-Indol-3-yl)-2-nitro-2,3-dihydro-1H-inden-1-ol (1-epi-227a) 
 
To a solution of 227a (0.113g, 0.384 mmol, 1 equiv.) in 4 mL of a 1:1 xylene:DCM mixture 
was added a catalytic amount (1 drop) TMG and allowed to stir at RT for 6h. The reaction 
mixture was directly loaded on a flash column and 1-epi-227a was isolated as a 
diastereomeric mixture (6:1 d.r.) by flash column chromatography (2:1 to 1:1 pentane: Et2O) 
to yield a light orange solid. 
Yield: 113 mg, >99% 
TLC: Rf =  0.44 (2:1 Et2O:Pentane) 
Melting point:  69 °C 
Optical rotation: [ ]22Dα = + 65.6 (c = 0.64, CHCl3) 
ee: 93% (major diastereomer) 
anal. chiral HPLC (major diastereomer): tR 17.27 min (minor) 21.71 min (major), n-
heptane/ethanol, 90:10, 1.00 mL/min, Daicel-AD column. 
1H NMR(600 MHz, CDCl3):  
δ = 8.15 (bs, 1H, major, NH), 8.12 (bs, 1H, minor, NH), 7.55 (d, J = 7.2 Hz, 1H, minor, CHAr), 
7.52 (d, J = 7.8 Hz, 1H, major, CHAr), 7.39-7.43 (m, 2H, both, CHAr), 7.36 (td, J = 7.2, 1.2 Hz, 
1H, minor, CHAr), 7.30 (t, J = 7.8 Hz, 1H, major, CHAr), 7.18-7.22 (m, 2H, both, CHAr), 7.12 
(d, J = 7.8 Hz, 1H, both, CHAr), 7.09 (d, J = 1.8 Hz, 2H, minor, CHAr), 7.04 (d, J = 7.8 Hz, 1H, 
major, CHAr), 7.00 (t, J = 7.8 Hz, 1H, both, CHAr), 5.84 (t, J = 6.6 Hz, 1H, major, C(OH)H), 
5.66 (dd, J = 7.2, 6 Hz, 1H, minor), 5.57 (d, J = 7.2 Hz, 1H, minor), 5.44 (dd, J = 7.2, 6 Hz, 
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1H, minor), 5.27 (dd, J = 8.4, 6.6 Hz, 1H, major, C(NO2)H), 5.20 (d, J = 8.4 Hz, 1H, major, 
C(indolyl)H), 2.83 (d, J = 6 Hz, 1H, major, OH), 2.43 (d, J = 7.8 Hz, 1H, minor, OH) ppm. 
13C NMR (151 MHz, CDCl3):  
δ = 139.8 (CAr), 138.8 (CAr), 136.8 (CAr), 130.5 (minor), 129.7 (CHAr), 128.5 (CHAr), 125.6 
(minor), 125.5 (CAr), 125.2 (minor), 125.1 (CHAr), 123.9 (CHAr), 123.7 (minor), 123.5 (CHAr), 
122.5 (CHAr), 119.9, 119.8 (minor), 119.2 (CHAr), 119.1 (minor), 113.6 (CAr), 111.5 (CHAr), 
100.0 (C(NO2)H), 93.8 (minor), 78.6 (C(OH)H), 74.5 (minor), 45.1(C(indolyl)H), 44.1 
(minor) ppm. 
MS (EI, 70 eV):  
m/z (%) 294.1 (67) [M+], 276.1 (11), 247.1 (78), 230.2 (40), 218.2 (38), 202.1 (15), 130.1 (20), 
117.1 (100), 103.1 (16);  
IR (Capillary):  
3413, 3050, 1703, 1544, 1458, 1422, 1368, 1207, 1097, 1046, 843, 743 cm-1. 
HRMS (ESI):  
calcd. for C17H14O3N2Na: 317.0897, found: 317.0897 
N-((1S,2R,3R)-1-Hydroxy-3-(1H-indol-3-yl)-2,3-dihydro-1H-inden-2-yl)quinoline-2-
carbothioamide (229) 
 
To a suspension of recrystallized 227a (0.126 g, 0.426 mmol, 1 equiv.) and NiCl2.6H2O 
(0.102g, 0.426 mmol, 1 equiv.) in 6 mL MeOH was added NaBH4 (0.081g, 2.13 mmol, 5 
equiv.) at 0°C. The reaction mixture was allowed to stir at 0°C under argon for 1h. Upon 
completion of the reaction, saturated NH4Cl solution was added and the product was extracted 
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five times with 25 mL DCM and concentrated under reduced pressure to yield the crude 
amino-indanol.  
The crude amino-indanol was dissolved in 10 mL absolute DCM, and thioester 228 (0.109 g, 
0.498 mmol, 1.1 equiv.) was added. The reaction mixture was allowed to stir at RT under 
argon for 16 h.  The reaction mixture was first dry loaded on silica, and then subjected to flash 
column chromatography (1:1 Pentane: Et2O) to yield 16 as a greenish-yellow solid.  
Yield: 88 mg, 45% over 2 steps, d.r. >20:1  
TLC: Rf =  0.43 (2:1 Pentane:Et2O) 
Melting point: 184 °C 
Optical rotation: [ ]23Dα = + 45.0 (c = 0.56, CHCl3). 
ee: 98%  
anal. chiral HPLC (major diastereomer): tR 23.05 min (minor) 39.40 min (major), n-
heptane/ethanol, 80:20, 0.70 mL/min, Daicel-IA column. 
1H NMR(600 MHz, DMSO-d6):  
δ = 11.03 (d, J = 7.8 Hz, 1H, NH), 10.94 (d, J = 2.4 Hz, 1H, CONH), 8.60 (d, J = 8.4 Hz, 1H, 
CHAr), 8.53 (d, J = 8.4 Hz, 1H, CHAr), 8.17 (d, J = 8.4 Hz, 1H, CHAr), 8.07 (d, J = 7.2 Hz, 1H, 
CHAr), 7.89 (td, J = 8.4, 1.2 Hz, 1H, CHAr), 7.73 (td, J = 8.4, 1.2 Hz, 1H, CHAr), 7.54 (d, J = 
7.2 Hz, 1H, CHAr), 7.31-7.36 (m, 3H, CHAr), 7.25-7.29 (m, 2H, CHAr), 7.04 (td, J = 7.8, 1.2 
Hz, 1H, CHAr), 7.00 (d, J = 7.2 Hz, 1H, CHAr), 6.89 (td, J = 7.8, 0.6 Hz, 1H, CHAr), 5.74 (bs, 
1H, OH), 5.38-5.45 (m, 2H, 2 x CHindane), 5.20-5.25 (m, 1H, CHindane) ppm. 
13C NMR (151 MHz, DMSO-d6):  
δ = 191.0 (C=S), 150.4 (CAr), 144.9 (CAr), 144.4 (CAr), 142.6 (CAr), 137.4 (CHAr), 136.7 (CAr), 
130.8 (CHAr), 129.4 (CHAr), 128.7 (CHAr), 128.6 (CAr), 128.3 (CHAr), 128.0 (CHAr), 127.2 
(CHAr), 126.5 (CAr), 125.5 (CHAr), 124.4 (CHAr), 123.5 (CHAr), 121.0 (CHAr), 119.0 (CHAr), 
118.4 (CHAr), 113.4 (CAr), 111.6 (CHAr), 70.9 (CHindane), 65.6 (CHindane), 44.5 (CHindane) ppm. 
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MS (EI, 70 eV):  
m/z (%) 435.2 (53) [M+], 419.2 (16), 401.2 (52), 384.2 (13), 247.2 (100), 230.2 (22), 218.2 
(44), 204.2 (13), 189.1 (18), 173.1 (23), 155.1 (18), 128.1 (88), 117.1 (72), 101.1 (18), 77.2 
(12). 
IR (Capillary):  
3410, 3282, 3050, 1713, 1589, 1498, 1457, 1425, 1377, 1311, 1222, 1099, 1045, 1003, 937, 
875, 833, 741 cm-1. 
HRMS (ESI):  
calcd. for C27H22ON3S: 436.1478, found: 436.1478 
(E)-5-Fluoro-2-(2-nitrovinyl)benzaldehyde (225d) 
 
To a solution of 224d[105] (3.23 g, 13.5 mmol, 1 equiv.) dissolved in 57 mL of acetone was 
added 2N HCl (27 mL, 54 mmol, 4 equiv.) and the solution was stirred for at RT for 3 h. 
Upon completion of the reaction, excess distilled water was added to the flask and the 
precipitated solid was filtered, washed with pentane and dried under high vacuum to yield a 
yellow solid.  
Yield: 1.67 g, 64% 
TLC: Rf =  0.48 (2:1 Pentane:Et2O) 
Melting point:  68-71 °C 
1H NMR (400 MHz, CDCl3):  
δ = 10.19 (s, 1H, CHaldehyde), 8.85 (d, J = 13.6 Hz, 1H, NO2CH=), 7.66–7.62 (m, 2H, CHAr), 
7.46 (d, J = 13.6 Hz, 1H, PhCH=), 7.39 (ddd, J = 8.6, 7.8, 2.7 Hz, 1H, CHAr)  
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13C NMR (101 MHz, CDCl3):  
δ = 190.3 (C=O), 164.5 (d, J = 256.6 Hz, CAr), 139.9 (d, J = 24.7 Hz, CHNO2), 136.6 (d, J = 
6.0 Hz, CAr), 135.2 (d, J = 20.3 Hz, PhCH), 130.9 (d, J = 8.1 Hz, CHAr), 127.5 (d, J = 3.7 Hz, 
CAr), 121.6 (d, J = 22.0 Hz, CHAr), 120.8 (d, J = 22.5 Hz, CHAr). 
19F NMR (376 MHz, CDCl3):  
δ = − 106.06 ppm  
MS (EI, 70 ev):  
m/z (%) 149.1 (100) [M-NO2]+, 120.1 (20), 101.1 (42).  
IR (Capillary):  
3370, 3102, 3071, 2864, 2753, 2295, 2147, 2109, 1924, 1789, 1692, 1631, 1596, 1555, 1492, 
1378, 1341, 1251, 1194, 1151, 1096, 951, 883, 832, 781, 721, 673 cm-1 
Elemental Analysis: 
Anal. Calcd. for C9H6FNO3: C, 55.39; H, 3.10; N; 7.18. Found: C, 55.39; H, 3.06; N, 7.16. 
tert-Butyl 3-((1S,2S,3R)-3-hydroxy-2-nitro-2,3-dihydro-1H-inden-1-yl)-5-methyl-2-oxo-3-
phenylindoline-1-carboxylate  (246a) 
 
246a was synthesized by GP4 and isolated as a diastereomeric mixture (>20:1 d.r.) by flash 
column chromatography (3:1 Pentane:Et2O) to yield a white solid.  
Yield: 233 mg, 93% 
TLC: Rf =  0.12 (2:1 Pentane:Et2O) 
Melting point: 159 °C 
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Optical rotation: [ ]24Dα = + 190.7 (c = 0.70, CHCl3),  
ee: 93% (major diastereomer) 
anal. chiral HPLC (major diastereomer): tR 17.97 min (major) 22.11 min (minor), n-
heptane/isopropanol, 95:5, 1.00 mL/min, Chiralcel-OD column. 
1H NMR(600 MHz, CDCl3, major diastereomer):  
δ = 7.58 (d, J = 8.4 Hz, 1H, CHAr), 7.32-7.41 (m, 5H, CHAr), 7.20-7.24 (m, 2H, CHAr), 7.14-
7.19 (m, 1H, CHAr), 7.10 (d, J = 7.2 Hz, 1H, CHAr), 7.03 (d, J = 8.4 Hz, 1H, CHAr), 6.90 (s, 
1H, CHAr), 5.46 (m, 1H, C(OH)H), 5.39 (dd, J = 7.8, 2.4 Hz, 1H, C(NO2)H), 5.32 (d, J = 1.8 
Hz, 1H, C(oxindole)H), 2.36 (bs, 1H, OH), 2.30 (s, 3H, CH3), 1.63 (s, 9H, 3 x Boc CH3);  
13C NMR (151 MHz, CDCl3, major diastereomer):  
δ = 175.4 (C=O), 149.0 (C=O), 141.3 (CAr), 138.0 (CAr), 137.8 (CAr), 137.2 (CAr), 134.3 (CAr), 
130.2 (CHAr), 129.8 (CHAr), 129.5 (CHAr), 129.4 (CHAr), 128.9 (CHAr), 127.9 (CHAr), 127.3 
(CAr), 124.9 (CHAr), 124.8 (CHAr), 124.4 (CHAr), 115.4 (CHAr), 91.9 (C(NO2)H), 85.0 (Cquad 
Boc), 75.7 (C(OH)H), 60.2 (Cquad oxindole), 57.4 (C(oxindole)H), 28.3 (3 x CH3), 21.4 (CH3) 
ppm;  
MS (ESI, pos):  
m/z (%) 539.158 (20) [M+K]+, 523.184 (95) [M+Na]+;  
IR (Capillary):  
3477, 3251, 3089, 2980, 2926, 2322, 2180, 2063, 1922, 1743, 1601, 1550, 1488, 1336, 1247, 
1148, 1066, 987, 913, 876, 819, 737, 664 cm-1;  
HRMS (ESI):  
calcd. for C29H28O6N2Na: 523.1840, found: 523.1834;  
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tert-Butyl 3-((1S,2S,3R)-5-chloro-3-hydroxy-2-nitro-2,3-dihydro-1H-inden-1-yl)-5-
methyl-2-oxo-3-phenylindoline-1-carboxylate (246b) 
 
 
246b was synthesized by GP4 and isolated as a diastereomeric mixture (>20:1 d.r.) by flash 
column chromatography (3:1 Pentane:Et2O) to yield a white solid.  
Yield: 239 mg, 89 % 
TLC: Rf =  0.20 (2:1 Pentane:Et2O) 
Melting point:  169 °C 
Optical rotation: [ ]24Dα = + 142.5 (c = 0.74, CHCl3) 
ee: 90% (major diastereomer);  
anal. chiral HPLC (major diastereomer): tR 7.34 min (major) 8.66 min (minor), n-
heptane/isopropanol, 90:10, 0.50 mL/min, Chiralpak-IC column. 
1H NMR(600 MHz, CDCl3, major diastereomer):  
δ = 7.61 (d, J = 8.4 Hz, 1H, CHAr), 7.31-7.40 (m, 5H, CHAr), 7.21 (m, 1H, CHAr), 7.13 (dd, J 
= 7.8, 1.8 Hz, 1H, CHAr), 7.08 (d, J = 8.4 Hz, 1H, CHAr), 6.99 (d, J = 8.4 Hz, 1H, CHAr), 6.92 
(s, 1H, CHAr), 5.44 (app d, J = 7.8 Hz, 1H, C(OH)H), 5.36 (dd, J = 7.8, 2.4 Hz, 1H, C(NO2)H), 
5.24 (d, J = 1.8 Hz, 1H, C(oxindole)H), 2.49 (bs, 1H, OH), 2.32 (s, 3H, CH3), 1.63 (s, 9H, 3 x 
Boc CH3) ppm. 
13C NMR (151 MHz, CDCl3, major diastereomer):  
δ = 175.2 (C=O), 148.8 (C=O), 143.3 (CAr), 137.7 (CAr), 137.0 (CAr), 136.5 (CAr), 135.2 (CAr), 
134.5 (CAr), 130.5 (CHAr), 130.0 (CHAr), 129.5 (CHAr), 129.0 (CHAr), 127.8 (CHAr), 127.1 
(CAr), 125.7 (CHAr), 125.2 (CHAr), 124.8 (CHAr), 115.6 (CHAr), 91.9 (C(NO2)H), 85.2 (Cquad 
Boc), 75.2 (C(OH)H), 60.0 (Cquad oxindole), 56.9 (C(oxindole)H), 28.3 (3 x CH3), 21.4 (CH3)  
ppm. 
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MS (EI, 70 eV):  
m/z (%) 534.0 (1) [M]+, 433.6 (3) [M−Boc]+, 322.4 (20), 222.8 (100), 193.6 (30). 
IR (Capillary):  
3464, 2979, 1742, 1557, 1480, 1366, 1228, 1143, 896, 826, 704 cm-1 
 
HRMS (ESI):  
calcd. for C29H27O6N2ClNa: 557.1450, found: 557.1455 
tert-Butyl 3-((1S,2S,3R)-3-hydroxy-5-methoxy-2-nitro-2,3-dihydro-1H-inden-1-yl)-5-
methyl-2-oxo-3-phenylindoline-1-carboxylate (246c) 
 
 
246c was synthesized by GP4 and isolated as a diastereomeric mixture (>20:1 d.r.) by flash 
column chromatography (3:1 Pentane:Et2O) to yield a pale yellow solid.  
Yield: 252 mg, 95 %  
TLC: Rf =  0.08 (2:1 Pentane:Et2O) 
Melting point: 163 °C  
Optical rotation: [ ]24Dα = + 157.7 (c = 0.73, CHCl3) 
ee: 90% ee (major diastereomer)  
anal. chiral HPLC (major diastereomer): tR 12.01 min (major) 13.19 min (minor), n-
heptane/ethanol, 90:10, 0.50 mL/min, Chiralpak-IC column. 
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1H NMR(600 MHz, CDCl3, major diastereomer):  
δ = 7.60 (d, J = 8.4 Hz, 1H, CHAr), 7.31-7.40 (m, 5H, CHAr), 7.05 (d, J = 8.4 Hz, 1H, CHAr), 
6.98 (d, J = 8.4 Hz, 1H, CHAr), 6.92 (s, 1H, CHAr), 6.67-6.73 (m, 2H, CHAr), 5.41 (d, J = 7.2 
Hz, 1H, C(OH)H), 5.38 (dd, J = 7.8, 1.8 Hz, 1H, C(NO2)H), 5.22 (app s, 1H, C(oxindole)H), 
3.72 (s, 3H, OCH3), 2.37 (bs, 1H, OH), 2.32 (s, 3H, CH3), 1.63 (s, 9H, 3 x Boc CH3) ppm.  
13C NMR (151 MHz, CDCl3, major diastereomer):  
δ = 175.4 (C=O), 160.7 (CAr), 149.0 (C=O), 142.9 (CAr), 137.9 (CAr), 137.3 (CAr), 134.3 (CAr), 
130.2 (CHAr), 129.7 (CAr), 129.4 (CHAr), 128.8 (CHAr), 127.9 (CHAr), 127.4 (CAr), 125.4 
(CHAr), 124.8 (CHAr), 116.7 (CHAr), 115.4 (CHAr), 108.9 (CHAr), 92.4 (C(NO2)H), 84.9 (Cquad 
Boc), 75.6 (C(OH)H), 60.2 (Cquad oxindole) , 56.9 (C(oxindole)H), 55.6 (OCH3), 28.3 (3 x 
CH3), 21.4 (CH3)  ppm. 
MS (ESI, pos):  
m/z (%) 553.196 (24) [M+Na]+  
IR (Capillary):  
3469, 2949, 1741, 1614, 1557, 1486, 1366, 1246, 1147, 1030, 822, 699 cm-1 
HRMS (ESI):  
calcd. for C30H30O7N2Na: 553.1945, found: 553.1941. 
tert-Butyl 3-((1S,2S,3R)-5-fluoro-3-hydroxy-2-nitro-2,3-dihydro-1H-inden-1-yl)-5-
methyl-2-oxo-3-phenylindoline-1-carboxylate (246d) 
 
246d was synthesized by GP4 and isolated as a diastereomeric mixture (>20:1 d.r.) by flash 
column chromatography (3:1 Pentane:Et2O) to yield a white solid.  
Yield: 239 mg, 83 % 
TLC: Rf =  0.18 (2:1 Pentane:Et2O) 
Experimental Part 
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Melting point: 160 °C 
Optical rotation: [ ]24Dα = + 172.7 (c = 0.66, CHCl3) 
ee: 90% ee (major diastereomer) 
anal. chiral HPLC (major diastereomer): tR 7.76 min (major) 9.02 min (minor), n-
heptane/ethanol, 90:10, 0.50 mL/min, Chiralpak-IC column. 
 
1H NMR(600 MHz, CDCl3, major diastereomer):  
δ = 7.60 (d, J = 8.4 Hz, 1H, CHAr), 7.31-7.40 (m, 5H, CHAr), 7.07 (d, J = 8.4 Hz, 1H, CHAr), 
7.03 (m, 1H, CHAr), 6.92 (app s, 1H, CHAr), 6.91 (dd, J = 8.4, 2.4 Hz, 1H, CHAr), 6.86 (td, J = 
8.4, 1.8 Hz, 1H, CHAr), 5.40-5.46 (m, 1H, C(OH)H), 5.37 (dd, J = 7.2, 1.8 Hz, 1H, C(NO2)H), 
5.24 (app s, 1H, C(oxindole)H), 2.46 (d, J = 8.4 Hz, 1H, OH), 2.32 (s, 3H, CH3), 1.63 (s, 9H, 
3 x Boc CH3) ppm. 
13C NMR (151 MHz, CDCl3, major diastereomer):  
δ = 175.3 (C=O), 163.3 (d, J = 256.7 Hz, FCAr), 148.8 (C=O), 143.6 (d, J = 7.85 Hz, CAr), 
137.8 (CAr), 137.0 (CAr), 134.4 (CAr), 133.5 (d, J = 2.42 Hz, CAr), 130.4 (CHAr), 129.5 (CHAr), 
128.9 (CHAr), 127.9 (CHAr), 127.2 (CHAr), 126.0 (d, J = 8.61 Hz, CHAr), 124.8 (CHAr), 117.2 
(d, J = 22.8 Hz, CHAr), 115.5 (CHAr), 111.9 (d, J = 23.1 Hz, CHAr), 92.2 (C(NO2)H), 85.2 
(Cquad Boc), 75.2 (C(OH)H), 60.1 (Cquad oxindole), 56.8 (C(oxindole)H), 28.3 (3 x CH3), 21.4 
(CH3)   ppm. 
19F (564 MHz, CDCl3, major diastereomer):  
δ = −112.1 ppm. 
MS (ESI, pos):  
m/z (%) 541.175 (50) [M+Na]+ 
IR (Capillary):  
3467, 2980, 1741, 1607, 1557, 1487, 1367, 1312, 1248, 1146, 935, 876, 824, 729 cm-1 
 
Experimental Part 
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HRMS (ESI):  
calcd. for C29H27O6N2FNa: 541.1745, found: 541.1744. 
tert-Butyl 3-((1S,2S,3R)-3-hydroxy-2-nitro-2,3-dihydro-1H-inden-1-yl)-2-oxo-3-phenyl 
indoline-1-carboxylate (246e) 
 
246e was synthesized by GP4 and isolated as a diastereomeric mixture (>20:1 d.r.) by flash 
column chromatography (3:1 Pentane:Et2O) to yield a white solid.  
Yield: 209 mg, 86 % 
TLC: Rf =  0.10 (2:1 Pentane:Et2O) 
Melting point:  158 °C 
Optical rotation: [ ]24Dα = + 215.2 (c = 0.61, CHCl3) 
ee: 90% ee (major diastereomer).  
anal. chiral HPLC (major diastereomer): tR 9.83 min (minor) 13.35 min (major), n-
heptane/ethanol, 70:30, 0.50 mL/min, (S, S)-Whelk O1 column. 
1H NMR(600 MHz, CDCl3, major diastereomer):  
δ = 7.71 (d, J = 8.4 Hz, 1H, CHAr), 7.33-7.40 (m, 5H, CHAr), 7.14-7.25 (m, 4H, CHAr), 7.08-
7.12 (m, 3H, CHAr), 5.50 (d, J = 6.0 Hz, 1H, C(OH)H), 5.39 (dd, J = 7.8, 2.4 Hz, 1H, 
C(NO2)H), 5.35 (d, J = 2.4 Hz, 1H, C(oxindole)H), 2.39 (bs, 1H, OH), 1.64 (s, 9H, 3 x Boc 
CH3) ppm.  
13C NMR (151 MHz, CDCl3, major diastereomer):  
δ = 175.3 (C=O), 148.9 (C=O), 141.3 (CAr), 140.2 (CAr), 138.0 (CAr), 137.1 (CAr), 129.8 
(CHAr), 129.7 (CHAr), 129.5 (CHAr), 129.4 (CHAr), 128.9 (CHAr), 127.9 (CHAr), 127.2 (CAr), 
Experimental Part 
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124.9 (CHAr), 124.6 (CHAr), 124.3 (CHAr), 115.6 (CHAr), 91.9 (C(NO2)H), 85.2 (Cquad Boc), 
75.6 (C(OH)H), 60.1 (Cquad oxindole), 57.5 (C(oxindole)H), 28.3(3 x CH3) ppm. 
 
MS (ESI, pos):  
m/z (%) 509.167 (75) [M+Na]+  
IR (Capillary):  
3475, 2981, 2931, 1739, 1606, 1556, 1466, 1369, 1316, 1286, 1250, 1146, 1106, 1066, 1024, 
921,  838, 751, 695 cm-1. 
HRMS (ESI):  
calcd. for C28H26O6N2Na: 509.1683, found: 509.1682. 
tert-Butyl 3-((1S,2S,3R)-5-chloro-3-hydroxy-2-nitro-2,3-dihydro-1H-inden-1-yl)-2-oxo-3-
phenylindoline-1-carboxylate (246f) 
OH
NO2
N
Boc
OPh
Cl
H
246f
 
246f was synthesized by GP4 and isolated as a diastereomeric mixture (>20:1 d.r.) by flash 
column chromatography (3:1 Pentane:Et2O) to yield a white solid.  
Yield: 240 mg, 92 % 
TLC: Rf =  0.16 (2:1 Pentane:Et2O) 
Melting point: 162 °C 
Optical rotation: [ ]24Dα = + 168.3 (c = 0.55, CHCl3),  
ee: 90% ee (major diastereomer) 
anal. chiral HPLC (major diastereomer): tR 3.79 min (major) 4.32 min (minor), n-
heptane/ethanol, 90:10, 1.00 mL/min, Chiralpak-IC column. 
Experimental Part 
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1H NMR(600 MHz, CDCl3, major diastereomer):  
δ = 7.74 (d, J = 7.8 Hz, 1H , CHAr), 7.32-7.40 (m, 5H, CHAr), 7.27-7.31 (m, 1H, CHAr), 7.20 
(s, 1H, CHAr), 7.10-7.16 (m, 3H, CHAr), 6.99 (d, J = 7.8 Hz, 1H, CHAr), 5.48 (d, J = 7.2 Hz, 
1H, C(OH)H), 5.36 (dd, J = 7.2, 1.8 Hz, 1H, C(NO2)H), 5.27 (d, J = 1.8 Hz, 1H, 
C(oxindole)H), 2.54 (bs, 1H, OH), 1.64 (s, 9H, 3 x Boc CH3) ppm. 
13C NMR (151 MHz, CDCl3, major diastereomer):  
δ = 175.2 (C=O), 148.8 (C=O), 143.2 (CAr), 140.1 (CAr), 136.8 (CAr), 136.4 (CAr), 135.3 (CAr), 
130.1 (CHAr), 130.0 (CHAr), 129.6 (CHAr), 129.0 (CHAr), 127.8 (CHAr), 127.0 (CAr), 125.6 
(CHAr), 125.3 (CHAr), 124.8 (CHAr), 124.3 (CHAr), 115.8 (CHAr), 91.9 (C(NO2)H), 85.5 (Cquad 
Boc), 75.1 (C(OH)H), 59.9 (Cquad oxindole), 56.9 (C(oxindole)H), 28.3 (3 x CH3) ppm. 
MS (ESI, pos):  
m/z (%) 543.127 (10) [M+Na]+ 
IR (Capillary):  
3469, 2980, 2926, 1745, 1605, 1557, 1471, 1314, 1252, 1146, 1089, 1022, 922, 879, 834, 759, 
692 cm-1. 
HRMS (ESI):  
calcd. for C28H25O6N2ClNa: 543.1293, found: 543.1289. 
tert-Butyl 3-((1S,2S,3R)-3-hydroxy-5-methoxy-2-nitro-2,3-dihydro-1H-inden-1-yl)-2-oxo-
3-phenylindoline-1-carboxylate (246g) 
 
 
246g was synthesized by GP4 and isolated as a diastereomeric mixture (>20:1 d.r.) by flash 
column chromatography (3:1 Pentane:Et2O) to yield a white solid.  
Yield: 238 mg, 92 % 
Experimental Part 
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TLC: Rf =  0.06 (2:1 Pentane:Et2O) 
Melting point: 155 °C 
Optical rotation: [ ]25Dα = + 200.1 (c = 0.70, CHCl3) 
ee: 90% (major diastereomer) 
anal. chiral HPLC (major diastereomer): tR 11.39 min (minor) 15.93 min (major), n-
heptane/ethanol, 70:30, 0.50 mL/min, (S, S)-Whelk O1 column. 
1H NMR(600 MHz, CDCl3, major diastereomer):  
δ = 7.74 (d, J = 7.8 Hz, 1H, CHAr), 7.32-7.41 (m, 5H, CHAr), 7.23-7.29 (m, 1H, CHAr), 7.10-
7.16 (m, 2H, CHAr), 6.96-7.00 (m, 1H, CHAr), 6.68-6.74 (m, 2H, CHAr), 5.44 (app t, J = 8.4 
Hz, 1H, C(OH)H), 5.38 (dd, J = 7.2, 1.8 Hz, 1H, C(NO2)H), 5.25 (d, J = 1.2 Hz, 1H, 
C(oxindole)H), 3.71 (s, 3H, OCH3), 2.31-2.38 (m, 1H, OH), 1.64 (s, 9H, 3 x Boc CH3) ppm.  
13C NMR (151 MHz, CDCl3, major diastereomer):  
δ = 175.3 (C=O), 160.8 (CAr), 148.9 (C=O), 142.9 (CAr), 140.2 (CAr), 137.1 (CAr), 129.7 
(CHAr), 129.5 (CHAr), 128.9 (CHAr), 127.9 (CHAr), 127.4 (CAr), 125.3 (CHAr), 124.6 (CHAr), 
124.4 (CHAr), 116.8 (CHAr), 115.7 (CHAr), 108.9 (CHAr), 92.3 (C(NO2)H), 85.2 (Cquad Boc), 
75.5 (C(OH)H), 60.2 (Cquad oxindole), 57.0 (C(oxindole)H), 55.6 (OCH3), 28.3 (3 x CH3) ppm. 
MS (ESI, pos):  
m/z (%) 555.152 (20) [M+K]+. 
IR (Capillary):  
3471, 2979, 2934, 1738, 1610, 1557, 1493, 1464, 1369, 1342, 1315, 1280, 1249, 1147, 1073, 
1025, 924, 835, 759, 696, 656 cm-1  
HRMS (ESI):  
calcd. for C29H28O7N2Na: 539.1789, found: 539.1787. 
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tert-Butyl 3-((1S,2S,3R)-5-fluoro-3-hydroxy-2-nitro-2,3-dihydro-1H-inden-1-yl)-2-oxo-3-
phenylindoline-1-carboxylate (246h) 
 
 
 
 
 
 
 
 
 
246h was synthesized by GP4 and isolated as a diastereomeric mixture (>20:1 d.r.) by flash 
column chromatography (3:1 Pentane:Et2O) to yield a white solid.  
Yield: 220 mg, 87 % 
TLC: Rf =  0.12 (2:1 Pentane:Et2O) 
Melting point: 149 °C 
Optical rotation: [ ]25Dα = + 170.9 (c = 0.53, CHCl3). 
ee: 89 % (major diastereomer) 
anal. chiral HPLC (major diastereomer): tR 4.00 min (major) 4.38 min (minor), n-
heptane/ethanol, 90:10, 1.00 mL/min, Chiralpak-IC column. 
1H NMR(600 MHz, CDCl3, major diastereomer):  
δ = 7.73 (d, J = 8.4 Hz, 1H, CHAr), 7.32-7.40 (m, 5H, CHAr), 7.26-7.30 (m, 1H, CHAr), 7.11-
7.15 (m, 2H, CHAr), 7.04 (dd, J = 8.4, 4.8 Hz, 1H, CHAr), 6.90 (dd, J = 8.4, 2.4 Hz, 1H, CHAr), 
6.86 (td, J = 9.0, 2.4 Hz, 1H, CHAr), 5.47 (app t, J = 7.2 Hz, 1H, C(OH)H), 5.37 (dd, J = 7.2, 
1.8 Hz, 1H, C(NO2)H), 5.26 (app s, 1H, C(oxindole)H), 2.48 (d, J = 8.4 Hz, 1H, OH), 1.64 (s, 
9H, 3 x Boc CH3) ppm. 
13C NMR (151 MHz, CDCl3, major diastereomer): 
 δ = 175.2 (C=O), 163.6 (d, J = 256.7 Hz, FCAr), 148.8 (C=O), 143.6 (d, J = 8.3 Hz, CAr), 
140.1 (CAr), 136.8 (CAr), 133.4 (CAr), 129.9 (CHAr), 129.5 (CHAr), 129.0 (CHAr), 127.8 (CHAr), 
127.1 (CAr), 125.9 (d, J = 8.6 Hz, CHAr), 124.7 (CHAr), 124.3 (CHAr), 117.2 (d, J = 23.0 Hz, 
CHAr), 115.7 (CHAr), 111.9 (d, J = 22.8 Hz, CHAr), 92.1 (C(NO2)H), 85.4 (Cquad Boc), 75.1 
(C(OH)H), 60.1 (Cquad oxindole), 56.9 (C(oxindole)H), 28.3 (3 x CH3) ppm. 
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19F (564 MHz, CDCl3, major diastereomer):  
δ = −112.1 ppm. 
MS (EI, 70 eV):  
m/z (%) 504.0 (10) [M]+, 447.8 (31), 404.4 (30) [M−Boc]+, 387.0 (12), 338.8 (21), 327.2 (14), 
308.7 (83), 294.0 (18), 283.4 (16), 253.2 (65), 234.5 (14), 207.9 (100), 189.4 (16), 179.2 (43), 
164.6 (28), 151.4 (46), 126.4 (11), 54.6 (55). 
IR (Capillary):  
3472, 2980, 2930, 2287, 2021, 1779, 1740, 1608, 1558, 1486, 1369, 1342, 1317, 1252, 1145, 
1107, 1065, 1023, 1000, 928, 875, 835, 757, 696, 656 cm-1. 
HRMS (ESI):  
calcd. for C28H25O6N2FNa: 527.1589, found: 527.1588. 
tert-Butyl 3-([1,1'-biphenyl]-4-yl)-3-((1S,2S,3R)-3-hydroxy-2-nitro-2,3-dihydro-1H-
inden-1-yl)-5-methyl-2-oxoindoline-1-carboxylate (246i) 
 
 
246i was synthesized by GP4 and isolated as a diastereomeric mixture (>20:1 d.r.) by flash 
column chromatography (3:1 Pentane:Et2O) to yield a white solid.  
Yield: 251 mg, 87 %  
TLC: Rf =  0.14 (2:1 Pentane:Et2O) 
Melting point:  174 °C 
Optical rotation: [ ]25Dα = + 166.7 (c = 0.63, CHCl3)  
ee: 98 % (major diastereomer)  
Experimental Part 
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anal. chiral HPLC (major diastereomer): tR 12.24 min (major) 14.03 min (minor), n-
heptane/ethanol, 90:10, 0.70 mL/min, Chiralcel-OD column. 
1H NMR(600 MHz, CDCl3, major diastereomer):  
δ = 7.55-7.62 (m, 5H, CHAr), 7.44 (t, J = 7.2 Hz, 2H, CHAr), 7.41 (d, J = 8.4 Hz, 2H, CHAr), 
7.36 (t, J = 7.2 Hz, 1H, CHAr), 7.16-7.25 (m, 3H, CHAr), 7.14 (d, J = 7.8 Hz, 1H, CHAr), 7.05 
(d, J = 8.4 Hz, 1H, CHAr), 6.95 (s, 1H, CHAr), 5.44-5.51 (m, 2H, C(OH)H and C(NO2)H), 5.35 
(app s, 1H, C(oxindole)H), 2.36 (d, J = 9 Hz, 1H, OH), 2.32 (app s, 3H, CH3), 1.64 (s, 9H, 3 x 
Boc CH3) ppm. 
13C NMR (151 MHz, CDCl3, major diastereomer):  
δ = 174.4 (C=O), 149.0 (C=O), 141.7 (CAr), 141.3 (CAr), 140.3 (CAr), 138.0 (CAr), 137.9 (CAr), 
136.2 (CAr), 134.4 (CAr), 130.3 (CHAr), 129.8 (CHAr), 129.5 (CHAr), 129.1 (CHAr), 128.4 
(CHAr), 128.1 (CHAr), 127.9 (CHAr), 127.3 (CHAr), 124.9 (CHAr), 124.8 (CHAr), 124.5 (CHAr), 
115.4 (CHAr), 92.0 (C(NO2)H), 85.0 (Cquad Boc), 75.8 (C(OH)H), 60.1 (Cquad oxindole), 57.4 
(C(oxindole)H), 28.3 (3 x CH3), 21.4 (CH3) ppm. 
MS (ESI, pos):  
m/z (%) 599.211 (53) [M+Na]+, 615.184 (99) [M+K]+ 
IR (Capillary):  
3482, 3033, 2980, 2928, 1736, 1601, 1556, 1485, 1396, 1370, 1332, 1308, 1279, 1248, 1149, 
1112, 1065, 1006, 950, 912, 821, 752, 696, 661 cm-1 
HRMS (ESI):  
calcd. for C35H32O6N2Na: 599.2153, found: 599.2144.  
tert-butyl 3-([1,1'-biphenyl]-4-yl)-3-((1S,2S,3R)-5-chloro-3-hydroxy-2-nitro-2,3-dihydro-
1H-inden-1-yl)-5-methyl-2-oxoindoline-1-carboxylate (246j) 
 
Experimental Part 
185 
 
246j was synthesized by GP4 with 1 mol% squaramide catalyst loading (20 min reaction time) 
and was isolated as a diastereomeric mixture (>20:1 d.r.) by flash column chromatography 
(4:1 to 2:1 Pentane:Et2O) to yield a white solid.  
Yield: 254 mg, 83 %  
TLC: Rf =  0.20 (2:1 Pentane:Et2O) 
Melting point: 193 °C 
Optical rotation: [ ]25Dα = + 135.4 (c = 0.55, CHCl3) 
ee: 99 % (major diastereomer).  
anal. chiral HPLC (major diastereomer): tR 20.86 min (major) 24.90 min (minor), n-
heptane/ethanol, 95:5, 0.70 mL/min, Chiralcel-OD column. 
1H NMR(400 MHz, CDCl3, major diastereomer):  
δ = 7.54-7.67 (m, 5H, CHAr), 7.45 (t, J = 7.2 Hz, 2H, CHAr), 7.33-7.41 (m, 3H, CHAr), 7.22 (s, 
1H, CHAr), 7.15 (d, J = 8.0 Hz, 1H, CHAr), 7.10 (d, J = 8.4 Hz, 1H, CHAr), 7.03 (d, J = 8.4 Hz, 
1H, CHAr), 6.96 (s, 1H, CHAr), 5.38-5.51 (m, 2H, C(OH)H and C(NO2)H), 5.27 (app s, 1H, 
C(oxindole)H), 2.46 (d, J = 8.8 Hz, 1H, OH), 2.34 (s, 3H, CH3), 1.64 (s, 9H, 3 x Boc CH3) 
ppm.  
13C NMR (101 MHz, CDCl3, major diastereomer):  
δ = 175.2 (C=O), 148.8 (C=O), 143.3 (CAr), 141.8 (CAr), 140.2 (CAr), 137.8 (CAr), 136.4 (CAr), 
135.9 (CAr), 135.3 (CAr), 134.6 (CAr), 130.6 (CHAr), 130.0 (CHAr), 129.1 (CHAr), 128.3 (CHAr), 
128.2 (CHAr), 128.1 (CHAr), 128.0 (CHAr), 127.9 (CHAr), 127.3 (CHAr), 127.2 (CAr), 125.8 
(CHAr), 125.2 (CHAr), 124.7 (CHAr), 115.6 (CHAr), 92.0 (C(NO2)H), 85.3 (Cquad Boc), 75.2 
(C(OH)H), 59.9 (Cquad oxindole), 56.9 (C(oxindole)H), 28.3 (3 x CH3), 21.4 (CH3) ppm. 
MS (ESI, pos):  
m/z (%) 633.178 (22) [M+Na]+, 649.152 (13) [M+K]+.  
IR (Capillary):  
3421, 2980, 2926, 2324, 2058, 1738, 1599, 1557, 1484, 1370, 1310, 1248, 1148, 1004, 956, 
917, 894, 824, 756, 696 cm-1. 
Experimental Part 
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HRMS (ESI):  
calcd. for C35H31O6N2ClNa: 633.1763, found: 633.1769. 
tert-Butyl 3-([1,1'-biphenyl]-4-yl)-3-((1S,2S,3R)-3-hydroxy-5-methoxy-2-nitro-2,3-
dihydro-1H-inden-1-yl)-5-methyl-2-oxoindoline-1-carboxylate (246k) 
 
246k was synthesized by GP4 and isolated as a diastereomeric mixture (>20:1 d.r.) after flash 
chromatography (2:1 Pentane:Et2O) as white solid.  
Yield: 282 mg, 92%  
TLC: Rf =  0.32 (1:1 Pentane:Et2O) 
Melting point: 169-172 °C  
Optical rotation: [ ]24Dα  = + 162.2 (c = 1, CHCl3). 
 
ee: 89% (major diastereomer). 
anal. chiral HPLC (major diastereomer): tR 9.07 min (major), 12.30 min (minor), n-
heptane/ethanol, 90:10, 1.00 mL/min, Chiralcel-OD column. 
1H NMR (600 MHz, CDCl3, major diastereomer):  
δ = 7.62 (d, J = 8.4 Hz, 1H, CHAr), 7.60–7.55 (m, 4H, CHAr), 7.44 (t, J = 7.7 Hz, 2H, CHAr), 
7.40 (d, J = 8.5 Hz, 2H, CHAr), 7.36 (tt, J = 7.4, 1.0 Hz, 1H, CHAr), 7.07 (dd, J = 8.4, 0.9 Hz, 
1H, CHAr), 7.02 (d, J = 8.1 Hz, 1H, CHAr), 6.96 (s, 1H, CHAr), 6.73–6.70 (m, 2H), 5.40-5.47 
(m, 2H, C(OH)H and C(NO2)H), 5.25 (app s, 1H, C(oxindole)H), 3.72 (s, 3H, OCH3), 2.39 (d, 
J = 8.5 Hz, 1H, OH), 2.33 (s, 3H, CH3), 1.64 (s, 9H, 3 x Boc CH3) ppm. 
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13C NMR (151 MHz, CDCl3, major diastereomer):  
δ =175.4 (C=O), 160.7 (CAr), 148.9 (C=O), 142.9 (CAr), 141.5 (CAr), 140.2 (CAr), 137.8 (CAr), 
136.2 (CAr), 134.3 (CAr), 130.2 (CHAr), 129.6 (CAr), 129.0 (CHAr), 128.3 (CHAr), 128.0 (CHAr), 
127.9 (CHAr), 127.4 (CAr), 127.2 (CHAr), 125.3 (CHAr), 124.7 (CHAr), 116.6 (CHAr), 115.4 
(CHAr), 108.8 (CHAr), 92.3 (C(NO2)H), 84.9 (Cquad Boc), 75.6 (C(OH)H), 60.1 (Cquad 
oxindole), 56.8 (C(oxindole)H), 55.5 (OCH3), 28.3 (3 x CH3), 21.4 (CH3) ppm. 
MS (ESI, pos):  
m/z (%) 629.226 (100) [M+Na]+, 645.200 (76) [M+K]+ 
IR (Capillary):  
3475, 2978, 2931, 2299, 2071, 1988, 1915, 1736, 1613, 1557, 1488, 1396, 1370, 1304, 1276, 
1248, 1150, 1114, 1072, 1026, 957, 928, 900, 820, 757, 696 cm-1.  
HRMS (ESI):  
calcd for C36H34N2O7K: 645.2003, found: 645.1999. 
tert-Butyl 3-([1,1'-biphenyl]-4-yl)-3-((1S,2S,3R)-5-fluoro-3-hydroxy-2-nitro-2,3-dihydro-
1H-inden-1-yl)-5-methyl-2-oxoindoline-1-carboxylate (246l) 
 
246l was synthesized by GP4 and isolated as a diastereomeric mixture (>20:1 d.r.) after flash 
chromatography (4:1 Pentane:Et2O) as pale orange solid.  
Yield: 268 mg, 90%  
TLC: Rf =  0.20 (2:1 Pentane:Et2O) 
Melting point:  161-172 °C;  
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Optical rotation: [ ]24Dα  = + 175.5 (c = 1, CHCl3)  
ee: 91% (major diastereomer)  
anal. chiral HPLC (major diastereomer): tR 14.16 min (major), 17.14 min (minor), n-
heptane/ethanol, 95:05, 1.00 mL/min, Chiralcel-OD column. 
1H NMR (400 MHz, CDCl3, major diastereomer):  
δ =7.64–7.54 (m, 5H, CHAr), 7.48–7.41 (m, 2H, CHAr), 7.41–7.33 (m, 3H, CHAr), 7.11–7.05 
(m, 2H, CHAr), 7.00–6.95 (m, 1H, CHAr), 6.88 (ddd, J = 19.4, 8.4, 2.4 Hz, 2H, CHAr), 5.47–
5.42 (m, 2H, C(OH)H and C(NO2)H), 5.28 (d, J = 8.5 Hz, 1H, C(oxindole)H), 2.59 (s, 1H, 
OH), 2.33 (s, J = 10.7 Hz, 3H, CH3), 1.63 (s, 9H, 3 x Boc CH3) ppm. 
13C NMR (101 MHz, CDCl3, major diastereomer):  
δ =175.3 (C=O), 163.5 (d, J = 248.4 Hz, FCAr), 148.8 (C=O), 143.6 (d, J = 7.8 Hz, CAr), 141.7 
(CAr), 140.1 (CAr), 137.7 (CAr), 135.9 (CAr), 134.5 (CAr), 133.3 (d, J = 2.5 Hz, CAr), 130.4 
(CHAr), 129.0 (CHAr), 128.2 (CHAr), 128.0 (CHAr), 127.86 (CHAr), 127.2 (CHAr), 127.2 (CAr), 
125.9 (d, J = 8.7 Hz, CHAr), 124.7 (CHAr), 117.1 (d, J = 23.0 Hz, CHAr), 115.5 (CHAr), 111.8 
(d, J = 23.0 Hz, CHAr), 92.2 (C(NO2)H), 85.1 (Cquad Boc), 75.2 (C(OH)H), 60.0 (Cquad 
oxindole), 56.7 (C(oxindole)H), 28.2 (3 x CH3), 21.3 (CH3) ppm. 
19F NMR (376 MHz, CDCl3, major diastereomer):  
δ = −112.09 ppm;  
MS (ESI, pos):  
m/z (%) 617.207 (100) [M+Na]+, 633.181 (76) [M+K]+ 
IR (Capillary):  
3824, 3457, 3032, 2979, 2928, 2721, 2500, 2287, 2080, 2009, 1984, 1912, 1739, 1608, 1558, 
1487, 1448, 1395, 1370, 1309, 1249, 1148, 1112, 1050, 1004, 936, 873, 820, 757, 696, 659 
cm-1. 
HRMS (ESI):  
calcd for C35H31FN2O6K: 633.1798, found: 633.1799. 
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(S)-tert-Butyl 3-((1R,2S,3R)-5-chloro-3-hydroxy-2-nitro-2,3-dihydro-1H-inden-1-yl)-3-
methyl-2-oxoindoline-1-carboxylate (246m) 
 
246m was synthesized by GP4 (3 equiv. oxindole used, reaction stirred for 220 min) and 
isolated as a diastereomeric mixture (20:1 d.r.) after flash chromatography (2:1 Pentane:Et2O) 
as a off-white solid  
Yield:  90 mg, 39%  
TLC: Rf =  0.10 (2:1 Pentane:Et2O) 
Melting point:   117 °C 
Optical rotation:
 
[ ]22Dα  = + 19.5 (c = 0.55, CHCl3) 
ee: 39% (major diastereomer) 
anal. chiral HPLC (major diastereomer): tR 7.92 min (minor), tR 9.28 min (major), n-
heptane/ethanol, 90:10, 1.00 mL/min, Daicel-OD column. 
1H NMR (600 MHz, CDCl3, major diastereomer):  
δ = 7.71 (d, J = 7.8 Hz, 1H, CHAr), 7.28 (t, J = 7.2 Hz, 1H, CHAr), 7.25 (app s, 1H, CHAr), 
7.22 (d, J = 7.8 Hz, 1H, CHAr), 7.12-7.20 (m, 3H, CHAr), 5.46 (d, J = 6.6 Hz, 1H, CHindane), 
5.40 (m, 1H, CHindane), 4.25 (app s, 1H, CHindane), 2.56 (bs, 1H, OH), 1.65 (s, 9H, 3 x Boc 
CH3), 1.64 (s, 3H, CH3) ppm. 
13C NMR (151 MHz, CDCl3, major diastereomer):  
δ = 177.0 (C=O), 148.8 (CAr), 143.5 (CAr), 139.2 (CAr), 136.1 (CAr), 135.4 (CAr), 129.7 (CHAr), 
129.6 (CHAr), 129.4 (CHAr), 126.7 (CHAr), 125.0 (CHAr), 124.9 (CHAr), 122.7 (CHAr), 115.6 
(CHAr), 91.2 (C(NO2)H), 85.3 (Cquad Boc), 75.1 (C(OH)H), 57.3 (C(oxindole)H), 51.0 (Cquad 
oxindole), 28.3 (3 x CH3), 22.7 (CH3) ppm. 
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MS (ESI, pos):  
m/z (%) 481.114 (66) [M+Na]+  
IR (Capillary):  
3455, 2979, 2928, 1776, 1607, 1557, 1472, 1368, 1346, 1315, 1285, 1252, 1145, 1092, 1012, 
961, 881, 835, 757, 679, 616, 584, 552, 522 cm-1. 
HRMS (ESI):  
calcd. for C23H23O6N2ClNa: 481.1137, found: 481.1136 
(S)-tert-butyl 3-((1S,2S,3R)-5-chloro-3-hydroxy-2-nitro-2,3-dihydro-1H-inden-1-yl)-2-
oxoindoline-1-carboxylate (246n) 
 
Compound 246n was was synthesized by GP4 (3 equiv. oxindole used) and isolated as a 
diastereomeric mixture (12:1 d.r.) after flash chromatography (2:1 Pentane:Et2O) as a off-
white solid.  
Yield:  99 mg, 44% 
TLC: Rf =  0.15 (2:1 Pentane:Et2O) 
Melting point:  73 °C 
Optical rotation: [ ]22Dα  = + 22.7 (c = 0.75, CHCl3) 
ee: 73 %  (major diastereomer) 
anal. chiral HPLC (major diastereomer): tR 10.93 min (minor), tR 19.28 min (major), n-
heptane/isopropanol, 80:20, 0.70 mL/min, Chiralpak-IC column. 
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1H NMR (600 MHz, CDCl3, major diastereomer):  
δ = 7.86 (d, J = 8.4 Hz, 1H, CHAr), 7.39-7.45 (m, 2H, CHAr), 7.20-7.25 (m, 2H, CHAr), 7.12 
(dd, J = 8.4, 1.8 Hz, 1H, CHAr), 6.33 (d, J = 8.4 Hz, 1H, CHAr), 5.87 (t, J = 6 Hz, 1H, 
C(NO2)H), 5.56 (t, J = 6 Hz, 1H, C(OH)H), 4.75 (m, 1H, C(oxindole)H), 4.21 (d, J = 3 Hz, 
1H, oxindole C3 H), 2.61-2.67 (m, 1H, OH), 1.57 (s, 9H, 3 x Boc CH3) ppm. 
13C NMR (151 MHz, CDCl3):  
δ = 174.1 (C=O), 148.8 (CAr), 142.2 (CAr), 140.6 (CAr), 137.0 (CAr), 135.1 (CAr), 130.8 (CHAr), 
129.6 (CHAr), 126.3 (CHAr), 125.3 (CHAr), 125.1 (CHAr), 125.0 (CHAr), 123.9 (CHAr), 115.7 
(CHAr), 89.8 (C(NO2)H), 85.2 (Cquad Boc), 84.3 (minor), 73.9 (C(OH)H), 47.4 (C(oxindole)H), 
47.1(C3 oxindole CH), 29.9 (minor), 28.3 (minor), 28.2 (3 x CH3)ppm. 
MS (ESI, pos):  
m/z (%) 467.099 (99) [M+Na]+  
IR (Capillary):  
3463, 2923, 2854, 2321, 2053, 1780, 1737, 1607, 1553, 1471, 1370, 1349, 1287, 1250, 1196, 
1146, 1089, 1053, 1002, 878, 835, 753, 678  cm-1  
HRMS (ESI):  
calcd. for C22H21O6N2ClNa: 467.0980, found: 467.0980 
3-((1S,2S,3R)-3-hydroxy-5-methoxy-2-nitro-2,3-dihydro-1H-inden-1-yl)-3-phenyl indolin 
-2-one (247) 
 
To a solution of 246g (300 mg, 0.581 mmol, 1 equiv.) in CH2Cl2 (4 mL) was added 
trifluoroacetic acid (0.224 mL, 2.90 mmol, 5 equiv.) and stirred at RT for 2h. Distilled water 
was then added to quench the reaction and the product was extracted with CH2Cl2 (5 x 50 mL). 
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The combined fractions are subsequently concentrated under vacuo and purified by flash 
column chromatography (2% MeOH in CH2Cl2) to yield a white solid.  
Yield: 232 mg, 96% 
TLC: Rf =  0.29 (95:5 CH2Cl2, MeOH) 
Melting point: 147 °C 
Optical rotation: [ ]25Dα = + 193.9 (c = 0.79, CHCl3) 
ee: 88 % ee (major diastereomer);  
anal. chiral HPLC (major diastereomer): tR 13.46 min (minor) 26.46 min (major), n-
heptane/ethanol, 70:30, 1.00 mL/min, Daicel-AD column. 
1H NMR(600 MHz, CDCl3, major diastereomer):  
δ = 8.18 (bs, 1H, NH), 7.41 (d, J = 8.4 Hz, 2H, CHAr), 7.31-7.38 (m, 3H, CHAr), 7.11-7.19 (m, 
2H, CHAr), 7.03 (d, J = 7.8 Hz, 1H, CHAr), 7.00 (t, J = 7.8 Hz, 1H, CHAr), 6.68-6.75 (m, 3H, 
CHAr), 5.50 (t, J = 7.2 Hz, 1H, C(OH)H), 5.36 (dd, J = 7.8, 2.4 Hz, 1H, C(NO2)H), 5.19 (d, J 
= 2.4 Hz, 1H, C(oxindole)H), 3.67 (s, 3H, OCH3), 2.76 (d, J = 7.8 Hz, 1H, OH) ppm.  
13C NMR (151 MHz, CDCl3, major diastereomer):  
δ = 178.5 (C=O), 160.6 (CAr), 142.8 (CAr), 140.8 (CAr), 137.3 (CAr), 130.0 (CAr), 129.4 (CHAr), 
129.3 (CHAr), 129.2 (CAr), 128.6 (CHAr), 127.7 (CHAr), 125.7 (CHAr), 124.9 (CHAr), 122.9 
(CHAr), 116.8 (CHAr), 110.8 (CHAr), 108.8 (CHAr), 92.4 (C(NO2)H), 75.4 (C(OH)H), 60.1 
(Cquad oxindole), 56.0 (C(oxindole)H), 55.5 (OCH3) ppm.  
MS (ESI, pos):  
m/z (%) 455.099 (98) [M+K]+  
IR (Capillary):  
3219, 2937, 2327, 2079, 1981, 1703, 1616, 1553, 1493, 1469, 1370, 1321, 1273, 1193, 1156, 
1112, 1069, 1026, 967, 861, 832, 743, 697 cm-1  
HRMS (ESI):  
calcd. for C24H20O5N2K: 455.1004, found: 455.0988  
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